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Summary 
The mitochondrion, often referred to as the energetic “powerhouse” of the eukaryotic 
cell, is a vital component for all mammalian life. The oxygen that is breathed in from 
the environment is ultimately consumed in mitochondria and in turn mitochondria 
harness energy used to maintain metabolic and biological function. The health of an 
individual is intimately related to the health of his or her mitochondria and yet much 
about the mitochondria is unknown.  
Research investigating mitochondrial function and its relationship to both health and 
disease remains at the forefront of a multitude of different scientific fields. Despite 
the significance of mitochondrial physiology in maintaining both physical and mental 
health, however, there is paucity of literature that actually examines mitochondrial 
respiration directly in vivo or in intact tissue, ex vivo, providing dynamic assessments 
of electron transfer efficacy and substrate influence on respiration. This 
dissertationwill review the origin and evolution of the mitochondrion, summarize 
metabolic pathways fundamental to mitochondrial function, introduce and discuss 
oxidative phosphorylation together with the structure and function of the electron 
transport chain, and present 7 studies specific to the investigation of mitochondrial 
function. The collection of studies included in this dissertationall focus on the study 
of mitochondrial function through systematic analysis of electron transport system 
utility. 
The results collected in seven independent studies support the following: 
1. Human skeletal muscle mitochondria are capable, independent from cytosolic
lactate dehydrogenase (LDH), of metabolizing lactate. Respiration is
stimulated with the additions of malate + lactate + ADP + NAD+ in a skeletal
muscle preparation that perforates the sarcolemma, facilitating the loss of all
soluble cytosolic components including cytosolic LDH. Lactate stimulated
respiration despite the loss of cytosolic LDH suggests the existence of a
mitochondrial-specific lactate oxidation complex. With the application of
specific four different substrate titration protocols, the site of this complex was
determined to most likely exist in the mitochondrial intermembrane space.
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2. Skeletal muscle predominantly expressing a fast-twitch, glycolytic phenotype
is predisposed to age-associated alterations in respiratory chain function.
Slow-twitch and more oxidative skeletal muscle does not share this
predisposition with aging and appears protected from the progressive lose with
senescence. Specific alterations include an amplified respiratory capacity
through mitochondrial respiratory complexes I and III with an attendant loss
of electron coupling capacity at complex I, both suggestive of a greater
oxidant production.
3. Mitochondrial respiratory capacity and control are similar between human and
mouse skeletal muscle. The similarities in function, however, are largely
dependent on skeletal muscle type with human and mouse quadricep
expressing the greatest similarities. One difference that exists across all mouse
skeletal muscle with that of human is the phosphorylative restraint of electron
transport. Murine muscle electron transport capacity is not limited by the
phosphorylative system of mitochondrial complex V, ATP Synthase, whereas
human skeletal muscle demonstrates a certain degree of restraint.
4. Eleven days of exposure to high-altitude does not markedly modify integrated
measures of mitochondrial functional capacity in human skeletal muscle
despite significant decrements in the concentrations of certain enzymes
involved in the tricarboxylic acid cycle and oxidative phosphorylation.
Though respiratory capacities and efficiency are largely unaffected throughout
an eleven-day sojourn to high altitude, mass-specific maximal state 3
respiration, oxidative phosphorylation capacity, does demonstrate a tendency
to diminish over time.
5. One month of exposure to high-altitude, however, reduces respiratory capacity
in human skeletal muscle while the efficiency of electron transport improves.
Specifically, electron transport capacity specific to complex I-, complex II-,
and maximal state-3 oxidative phosphorylation capacity all diminished
independent from any measureable loss in mitochondrial content. Leak control
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coupling, respiratory control ratio, and oligomycin-induced leak respiration, 
all measures of mitochondrial efficiency, improved with hypoxic exposure.  
6. Integrative functional differences in mitochondrial function are apparent
across groups of individuals that differ in aerobic capacities. Respiration
capacities representative of fat oxidation, maximal oxidative phosphorylation,
and electron transport system capacity all correspondingly improve with
aerobic capacity. These observations are apparent even when controlling for
differences in mitochondrial content in the skeletal muscle. Though
differences in respiratory capacity are apparent, electron-coupling control for
fat oxidation does not differ.
7. Maximal state-3 respiratory capacity, oxidative phosphorylation capacity, is
the strongest predictor of endurance performance across a group of highly
trained athletes. Mitochondrial content, however, which was similar across all
subjects, had no predictive value of performance. Overall exercise
performance, including incremental exercise performance in addition to
endurance capacity, are best predicted by the measures of maximal oxygen
consumption, total hemoglobin mass, maximal state-3 respiration, and electron
transport system capacity of the skeletal muscle.
In brief, respiratory capacity and substrate control are dependent on both quantitative 
as well as qualitative characteristics. The mammalian reliance on this dynamic 
organelle, capable of utilizing many different substrates through multiple pathways, is 
fairly consistent across species. The capacity for oxygen utilization is extremely 
plastic, and modified through various modes of metabolic stress (i.e. hypoxia and 
exercise) to optimize the benefit of the host organism.  
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Zusammenfassung 
Mitochondrien, oft als auch Kraftwerke der eukaryotischen Zelle bezeichnet, sind 
lebenswichtige Komponenten für alle Säugetiere. Der aus der Umwelt aufgenommene 
Sauerstoff wird von den Mitochondrien zur Energiegewinung für metabolische und 
biologische Funktionen eingesetzt. Die Gesundheit des Menschen hängt unmittelbar 
mit dem Gesundheitszustand der Mitochondrien zusammen, jedoch ist noch vieles 
über das Mitochondrium unbekannt. 
Die Erforschung der Mitochondrien-Funktion und deren Einfluss auf Gesundheit und 
Krankheit bleibt weiterhin ein wichtiger Bestandteil in vielen unterschiedlichen 
wissenschaftlichen Forschungsbereichen. Trotz der hohen Bedeutung der 
mitochondriale Physiologie in der Aufrechterhaltung von physischer und psychischer 
Gesundheit, gibt es nur unzureichend Literatur zur Forschung der mitochondrialen 
Respiration in vivo oder in intaktem Gewebe, ex vivo. Damit lassen sich nur schwer 
dynamische Einschätzungen zur Elektronentransfereffizienz und zum Einfluss von 
Substraten auf die Respiration abgeben. In dieser Doktorarbeit soll der Ursprung und 
die Evolution der Mitochondrien zusammengetragen werden. Zudem werden die 
fundamentalen Stoffwechselwege der Mitochondrien zusammengefasst und die 
oxidative Phosphorylierung zusammen mit der Struktur und der Funktion der 
Elektronentransportkette diskutiert. Es werden 7 spezifische Studien in die 
Doktorarbeit miteinbezogen, welche sich auf die Funktion der Mitochondrien durch 
systematischen Analyse des Elektronentransportsystems, konzentrieren. 
Die gesammelten Daten der sieben unabhängigen Studien unterstützen folgende 
Aussagen: 
1. Humane Skelettmuskelmitochondrien sind fähig, unabhängig von
zytosolischer Laktatdehydrogenase (LDH), Laktat zu metabolisieren. Die
Atmung wird mittels Malat + Laktat + ADP + NAD+ Zusatz in einem
Skelettmuskelpräparat mit perforiertem Sarkolemm stimuliert, um so den
Verlust von allen löslichen zytosolischen Komponenten, inklusive der
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zytosolischen LDH, zu erleichtern. Laktat stimuliert auch ohne zytosolisches 
LDH die Atmung welches auf die Existenz eines mitochondrien-spezifischen 
Laktatoxidationskomplexes zurückschliessen lässt. Dieser Komplex kommt 
mit grosser Wahrscheinlichkeit im Membranzwischenraum der Mitochondrien 
vor, welches anhand von mehreren unterschiedlichen Substrat-
Titrationsprotokollen bestimmt wurde. 
2. Der vorwiegend schnell-kontrahierende, glycolytische Skelettmuskel ist
besonders anfällig für altersabhängige Veränderungen in der
Atmungskettenfunktion. Langsame und hauptsächlich oxidative Skelettmuskel
unterliegen nicht dieser altersabhängigen Veränderungen und scheinen vor
dem progressiven Verlust durch Seneszenz geschützt zu sein. Spezifische
Veränderungen sind dabei die erhöhte respiratorische Kapazität durch die
respiratorischen Komplexe I und III bei gleichzeitigem Verlust der
Elektronenkopplungskapazität im Komplex I. Beides lässt auf eine grössere
oxidative Produktion zurückschliessen.
3. Die menschliche Skelettmuskulatur ähnelt – in Bezug auf respiratorische
Kapazität und mitochondrialer Kontrolle – der Skelettmuskulatur der Maus.
Funktionelle Gemeinsamkeiten sind allerdings stark vom Skelettmuskeltyp
abhängig. Der Quadrizeps bei Mensch und Maus zeigt dabei die grössten
Ähnlichkeiten auf. Ein wesentlicher Unterschied zur Maus ist jedoch die
Hemmung des Elektronentransports durch die ATP-Synthase beim Menschen.
Während die Muskelelektronentransportkapazität in allen Skelettmusklen von
Mäusen nicht durch das phosphorylierende System des
Mitochondrienkomplex V, ATP Synthase begrenzt wird, zeigt die
menschliche Skelettmuskulatur eine entsprechende Limitierung.
4. Eine 11-tägige Höhenexposition verändert die die funktionelle Kapazität der
Mitochondrien in der humanen Skelettmuskulatur – trotz signifikanter
Abnahme von Enzymen des Tricarbonsäurezyklus und der oxidativen
Phosphorylierung – nicht. Obwohl die respiratorische Kapazität und die
Effizienz weitgehend unverändert bleiben, zeigt die massespezifische
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maximale „state-3“ Respiration bzw. die oxidative Phosphorylierungskapazität 
eine tendenzielle Abnahme in dieser Zeit. 
5. Eine Höhenexpostition von einem Monat reduziert jedoch die respiratorische
Kapazität im humanen Skelettmuskel, während die Effizienz des
Elektronentransportes verbessert wird. Vor allem die
Elektronentransportkapazität im Komplex I- und Komplex II-, sowie die
maximale „state-3“ oxidative Phosphorylierungskapazität werden unabhängig
von jeglichem messbaren Verlust des Mitochondriengehalts reduziert. Die
Leak-Kontrollkopplung, das respiratorische Kontrollverhältnis und die
Oligomycin-induzierte Leak-Respiration – alles Effizienzmessgrössen der
Mitochondrien – verbesserten sich während des Aufenthaltes in der Höhe.
6. Integrative funktionelle Differenzen in den Mitochondrien kommen in
Individuen vor, welche sich in ihrer aerobischen Kapazität unterscheiden.
Respiratorische Kapazitäten wie die Fettoxidation, die maximale oxidative
Phosphorylierung und die Kapazität des Elektronentransportsystems
verbessern sich alle entsprechend der aerobischen Kapazität. Sogar wenn die
Unterschiede im Mitochondriengehalt der Skelettmuskulatur berücksichtigt
werden zeigen sich diese Beobachtungen auf. Trotz der Unterschiede in der
respiratorischen Kapazität ist kein Unterschied in der
Elektronenkopplungskontrolle der Fettoxidation zusehen.
7. Die maximale „state-3“ respiratorische Kapazität – also die Kapazität der
oxidativen Phosphorylierung - ist der beste Indikator für die Ausdauerleistung
in einer Gruppe von gut trainierten Athleten. Der Mitochondriengehalt,
welcher in allen Probanden vergleichbar war, stand jedoch nicht im
Zusammenhang mit der Leistung. Die gesamte Leistungsfähigkeit, inklusive
Stufentestleistung und Ausdauerkapazität, wird am besten durch den
maximalen Sauerstoffverbrauch, die totale Hämoglobinmasse, die maximale
state-3 Respiration und die Kapazität des Elektronetransportsystems im
Skelettmuskel bestimmt.
Zusammenfassend kann man sagen, dass die respiratorische Kapazität und 
Substratsteuerung abhängig von den quantitativen sowie auch von qualitativen 
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Eigenschaften der Mitochondrien sind. Dieses dynamische Organell mit der Fähigkeit 
viele unterschiedliche Substrate über mehrere Substratwege zu nutzen, ist in einer 
Vielzahl von Säugetieren anzutreffen. Die Kapazität der Sauerstoffumsetzung ist 
extrem plastisch und passt sich verschiedenen Arten von metabolischem Stress (z.B 
Hypoxie und körperlicher Belastung) an, um den Nutzen des Wirtsorganismus zu 
optimieren. 
	  XI 
Acknowledgments 
“If I have seen further than others it is by standing upon the shoulders of giants.”  
– Sir Isaac Newton 
 
My many, many thanks to all whose support have allowed me to reach the conclusion 
of my doctoral studies. First of all I would like to thank those who provided me the 
opportunity to learn and prosper in the world of science. I would not have been able to 
complete this work if it wasn’t for the collective support and guidance of Prof. Dr. 
Carsten Lundby and Prof. Dr.  med. vet. Max Gassmann. I would like to give an 
additional thanks to Prof. Dr. med. Hans Hoppeler for taking the necessary time to 
help steer the direction of my studies and participate in my education as a part of my 
Ph.D. committee. My committee as a whole provided the challenges and support 
necessary to shape a young scientist and I will be forever grateful.  
 
I thank my many colleagues that over the course of four years I now have the 
privilege to call friends, specifically Dr. Christoph Siebenmann, Dr. Dominik Pesta, 
Dr. Sergey Yakushev, Dr. Víctor Díaz, and Dr. Peter Rasmussen. I am truly lucky to 
have been given the chance to work with such a phenomenal group of young 
scientists. Their support, teamwork, and friendship have been of immense help and 
inspiration to me.  
 
Enough cannot be said about the loving support of my parents, Richard James and 
Jane Ellen Jacobs. They have been with me, truly, since the beginning. There is no 
monetary equivalent for the unconditional love and support they have provided me 
the over the last 31 years. It has been through their sacrifice that I was allowed to 
follow my interests and dreams. I am and will be forever indebted to them.  
 
Lastly, I without a doubt thank my beautiful wife, Angela Jeau Jacobs, for carrying 
me through the last two years of my studies. It is with her I found life anew. She 
instills in me a hunger for living that cannot be satisfied.  I am so extremely happy to 
be able to share this accomplishment with the person who functions, among many 
other relations, as my best friend and biggest supporter. I love you! 
	  1 
1.  Introduction 
Origin 
Atmospheric concentrations of molecular oxygen (O2) rapidly increased 
approximately 2.5 billion years ago (16, 90), either as a consequence of oxygenic 
photosynthesis (156) and/or via an abiotic shift of the oxidant/reducant equilibrium in 
the Earth’s surface (90, 154, 158).  
 
Figure 1. The history of oxygen on the earth. Adapted from (113). Atmospheric concentrations of 
oxygen on the earth presented in 5 stages with years (Gyr) on the x-axis with the red and green lines 
representing the estimated range: 1.) The atmosphere was essentially anoxic; 2.) Oxygen concentration 
in shallow portions of the oceans rose slightly; 3.) Maintenance period for low atmospheric 
concentrations of oxygen, with no significant changes; 4.) Acritarch and early protistan morphotypes 
sank to the sediment rich ocean floor resulting in a biological upsurge forming, among other 
organisms, algae; 5.) Oxygen formation from the ocean diffused into the environment and into land 
surfaces. 
 
Primordial life was threatened in the precipitously oxygen-rich environment and was 
forced to adapt accordingly. This ambient accumulation of O2 and the biological 
means to control it was a considerable boon in the evolution of Homo sapiens. The 
invaluable characteristic of this particular diradical gas is its instability - deficient by 
two additional electrons would spin pair both unpaired electrons in the outer orbital 
(2p) (9). While this instability has served as the lynchpin in the development and 
maintenance of mammalian life, there is a corollary threat attendant to this 
dependence on O2. The volatility of O2 can also precipitate cellular damage, as it is 
quite proficient in “stealing” electrons from various molecules through non-specific 
and non-facilitated means. In fact, O2 is so adept at taking electrons from other 
molecules that the general process has been termed “oxidation” (189). Specific 
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adaptations to a high environmental O2 concentration, in part, limited the uncontrolled 
oxidation of biological material by establishing an exact and coordinated cellular 
system of electron transfer with the final acceptor being O2. Evolution found a way to 
provide O2 with exactly what it desired, electrons, and in turn developed a system that 
harnessed the transfer of energy attendant to the transport of electrons from unusable 
organic material into biologically accessible sources, termed oxidative 
phosphorylation. This exploited O2 and the potentially undesirable characteristics in 
favor of a massive biological thermodynamic advantage. While mammalian 
bioenergetics expands beyond aerobic means, the maintenance of mammalian life is 
now ultimately determined by O2 availability and the capacity for aerobic 
metabolism. The ability to enzymatically restrain and lower the kinetic barrier of O2 
has guided adaptation over hundreds of millions of years and drastically increased the 
ceiling of metabolic potential. Cellular processes central to the utilization of O2, now 
collectively referred to as aerobic metabolism, became possible through the 
synergistic fusion and evolution of ancestral eukaryotes with α-bacterial-like 
endosymbionts such as rhizobacteria and rickettsia (239, 319) eventually forming 
what is now known as the mitochondrion. Hitherto, our understanding of this 
subcellular structure, fundamental in O2 metabolism and the transduction of energy 
into biologically usable means, has yet to catch up its evolution. Whereas primordial 
organisms labored with the initial exposure and utilization of O2, mammals now find 
themselves in an impossible struggle to maintain cellular O2 availability. The primary 
focus of this dissertation revolves around this subcellular structure that serves as the 
primary energetic source in mammals that controls the systematic conduction of 
electrons to O2, the mitochondrion. 
 
The mitochondrion 
Mitochondria are organelles common to eukaryotic cells and are ubiquitous 
throughout the organism, albeit specific content varies across cell types (176, 258). 
Mitochondrial morphologies also vary considerably across different cell types, for 
example fibroblast mitochondria present as long and thin filaments, hepatocyte 
mitochondria more spherical and individual (325), and skeletal muscle mitochondria 
exist as an intricate interconnected reticular network (148).  
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Figure 2. Mitochondrial morphology. Mitochondrial structure presenting as a reticular network 
within skeletal muscle (left) and as a spherical organelle in the liver (right). Figure adapted from 
references (148, 177, 215, 231) 
Mitochondria are extremely dynamic subcellular structures and constantly adapt to 
accommodate their cellular environment (325). For example, mitochondrial volume 
density in human skeletal muscle, percent volume of the muscle fiber taken up by 
mitochondria, is approximately 5% but can range from 3 to 7% (76, 119, 295).  
Figure 3. Skeletal muscle 
mitochondria. Figure from 
reference (233). 
Subsarcolemmal and 
intermyofibrillar mitochondrial 
morphology using scanning 
electron microscopy (EM) (A, 
B) and transmission EM (B,D)
of a freeze-fractured intact 
mouse soleus sample. PM – 
plasma membrane; Myofibr – 
myofibrils; S – sarcomeres; Cap 
– capillary. Scanning electron
microscopy (SEM) images were 
captured at magnifications of 
×10,300 (A) and ×1,140 (A, 
inset), and ×5,800 (B) and 
×1,310 (C, inset). 
Structural and morphological mitochondrial adaptations include alterations in size 
(fission/fusion) or a change in number (mitochondrial biogenesis). Mitochondrial 
fusion increases or improves reticular interconnectivity network by the amalgamation 
mitochondrial plasma membranes from two previously separate organelles (185). This 
usually occurs in response to cellular stress and metabolic demand (325). 
Mitochondrial fission involves the replication of mtDNA and division of the 
organelle, creating new mitochondria. This process is essential for adequate 
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mitochondrial population within a given cell (325). Mitochondrial biogenesis is the 
concerted process of creating mitochondria de novo through the coordinated 
upregulation of mitochondrial and nuclear transcription, translation, and assembly of 
mitochondrial proteins (317). This also occurs in response to a cellular metabolic 
stress (325). Mitochondria are even capable of moving throughout some cells, such as 
has been observed in hepatocytes, as they respond to their cellular environment (146). 
Alternatively mitochondria can also be anchored to a location by the cellular 
cytoskeleton to help maintain energy provision to an area with consistently high local 
metabolic demand. This occurs in cardiomyocytes, where mitochondria are anchored 
in close proximity to the contractile elements of the muscle (320) and also in sperm 
where they are woven around the motile flagellum (40). The regulation of 
mitochondrial morphology is extremely complex and still highly studied. This is 
important, as mitochondrial function is highly dependent upon its structure. 
 
Mitochondrial structure 
Mitochondria are composed of two separate and very different plasma membranes. 
The mitochondrial outer membrane (MOM) is a semi-permeable phospholipid bilayer 
that separates the cellular cytosol from the mitochondrial intermembrane space (MIS). 
This outer membrane encompasses the entirety of the organelle. The MOM is rich in 
transmembrane proteins called porins, which facilitate the passive diffusion of 
molecules across plasma membranes. This allows the MOM to be rather permeable to 
molecules up to approximately 4 kDa that lack a net charge and strong dipoles (20, 
50), however it remains impermeable to larger molecules, such as cytochrome c (19). 
Accordingly, MIS functions near chemical equilibrium with the cytosol in respect to 
small molecules. The mitochondrial inner membrane (MIM) is an impermeable 
phospholipid bilayer that separates the MIS and the mitochondrial matrix (MM). This 
membrane ribbons back and forth, folding over itself creating invaginations, or 
mitochondrial cristae, which creates a large surface area. The impermeability of the 
MIM is fundamental to mammalian bioenergetics and thus all ions and molecules 
require a transport protein in order to transverse the MIM. Found within the MIM are 
a series of membrane bound proteins that are collectively referred to as the electron 
transport system. This system is ultimately responsible for transferring electrons to O2 
while transforming unusable chemical energy into biologically viable sources. A 
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portion of the sequential disassembly of chemical sources ultimately used for 
energetic transduction occurs in the MM. The MM is the space within the organelle 
that is enclosed by the MIM. The mitochondrial matrix possesses hundreds of 
enzymes, including all those involved in the tricarboxylic acid (TCA) cycle, fatty acid 
metabolism, or β-oxidation, protein metabolism, and many more. The MM also 
contains the mitochondrial genome. 
 
Figure 4. Depiction of a mitochondrion from the transverse plane. Adapted from reference (54). 
 
 
Gene expression 
 Mitochondria possess their own genetic material separate from the nucleus, making 
them unique from other cellular organelles (258). This genetic material is referred to 
as mitochondrial DNA (mtDNA). Opposed to the more common α-helical structure of 
nuclear DNA (nDNA), mtDNA is a closed 16.6 kb circular double-stranded molecule 
(6, 306). Mammalian mtDNA is maternally inherited, which is also disparate from 
nDNA (141, 268). While the bacterial ancestors to the mitochondrion expressed a 
complete genome that encoded for all genes necessary to sustain autonomous and 
independent life, mitochondria are genetically semiautonomous. Mitochondria rely 
greatly on nuclear expression within their host as mtDNA have only retained the 
genes that encode for 2 rRNA, 22 tRNA, and 13 mRNA that are essential for 
mitochondrial protein synthesis, specifically 13 polypeptides that are involved in 
oxidative phosphorylation. These 13 polypeptides are translated on mitochondrial 
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ribosomes and serve as structural subunits for mitochondrial complexes involved in 
the electron transport system, including mitochondrial respiratory complexes I, III, 
IV, and V (258).  The additional ~1500 genes specific to the mitochondrial genome 
are expressed throughout nDNA. These mitochondrial proteins that are encoded in 
nDNA are incorporated into the mitochondria via selective importation following 
extramitochondrial translation via cytosolic ribosomes (91). Mitochondrial respiratory 
complex II, for example, is entirely 
encoded for by nDNA and transported 
into the mitochondria after translation 
via cytosolic ribosomes. Mitochondria 
proteins specific for the organelle 
typically undergo posttranslational 
modification once in the mitochondria 
prior to incorporation as a functional 
unit (302). Therefore the mitochondrion 
is entirely symbiotic, relying on both mt 
and nDNA for complete expression and 
function. 
 
Figure 5. Mitochondrial genetic expression. Illustration of mitochondrial (mt) DNA (top) and an 
illustration of the electron transport system with the location of their expression (bottom). nDNA – 
nuclear DNA. Both figures are from reference (258). 	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Mitochondrial function 
The term “mitochondrial function” serves as a general umbrella term in reference to 
several processes, as the mitochondria are intimately involved in many different 
cellular functions. Mitochondrial functions in cellular calcium regulation/signaling 
(6), inflammatory responses (151), redox signaling (31, 63), nitrogen metabolism 
(237), heme biosynthesis (178), and apoptosis (208) among others. The primary 
function of the mitochondrion, however, is to harness biologically inaccessible energy 
into viable sources providing the foundation of aerobic metabolism establishing life as 
we know it. Therefore, throughout this dissertation the term mitochondrial function 
specifically refers to the bioenergetic capabilities of the mitochondria. 
 
Chemical sources of biological energy 
All life requires a source of energy to survive. The energy source for life on earth 
ultimately comes from the sun. Mammals obtain this energy via indirect means 
through chemical sources in the form of nutrients including carbohydrates, fats/lipids, 
and proteins. The energy in these nutrients is stored within their chemical bonds. 
Accordingly there are necessary processes that systematically break down and 
transform this chemical form of energy from nutrients into biologically usable 
sources. This energy is used to maintain metabolic function and overall homeostasis 
in organisms. Most of these pathways involve the mitochondria either directly or 
indirectly and are discussed below. 
 
Glycolysis 
Glucose is the predominant carbohydrate metabolized by mammals for energetic 
means. The metabolism of glucose begins outside of the mitochondria in the cytosol 
by means of glycolysis. Overall, glycolysis involves the metabolism of 1 molecule of 
D-glucose to form 2 molecules of pyruvate, which also nets 2 molecules of 
adenosine-5'-triphosphate (ATP) and 2 reduced nicotinamide adenine dinucleotides 
(NADH) in the process. When one molecule of glucose (C6H12O6) is completely 
metabolized (aerobically, + 6O2) to 6CO2 + 6H2O, there is approximately 2937 
kJ/mol of energy released. The complete hydrolysis of ATP to AMP releases about 50 
kJ/mol under physiologic conditions. Thus the energetic efficiency of glycolysis alone 
is roughly 3.4%. Though glycolysis is capable of capturing some chemical energy 
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into biologically useable ATP through substrate-level phosphorylation 
(phosphorylation of ADP to ATP at the expense – oxidation – of the substrate), this 
process is incredibly inefficient and could not support a long-term, high metabolic 
demand. Some of the energy stored in the chemical bonds of glucose is lost as heat 
during glycolysis, however a significant amount of chemical energy remains in the 
bonds of the pyruvate molecules and the reduced coenzymes, NADH. To harness the 
remaining energy from pyruvate and NADH, these molecules are transferred into the 
mitochondrial matrix where they are fully metabolized and ultimately account for 
approximately 30 additional molecules of ATP, improving efficiency of energy 
transfer from glucose metabolism by 51% over glycolysis alone!  
It quickly becomes obvious that glycolysis did not persist throughout evolution as a 
result of its energetic efficiency. The benefit of this process is the rate at which 
glycogen and/or glucose can be broken down and partially metabolized, which 
functions about 100 times faster than the complete aerobic metabolism of glucose. For 
example, approximately 32 ATP are gained through the complete aerobic metabolism 
of a single molecule of glucose. Theoretically, if 100 molecules of glucose could be 
aerobically metabolized in one minute then the net gain in ATP would be about 3,200. 
In that same amount of time glycolosis, netting just 2 ATP per molecule of glucose, 
could produce approximately 20,000 ATP but at the expense of glucose expenditure 
(10,000 molecules!). This sacrifice of metabolic brevity over efficiency with 
glycolysis comes at the expense of accumulating metabolic by-products. Also, 
cytosolic redox balance becomes severely challenged during times of high metabolic 
demand with an increasing NADH to NAD ratio as glycolysis functions at a rate far 
beyond the capacity of mitochondria. If left alone this unequal distribution of reduced 
coenzymes will inhibit glycolysis and potentially threaten life with metabolic arrest. 
During the periods of high glycolytic flux, such as intense exercise like sprinting, an 
additional pathway is necessary in order to maintain cytosolic redox balance. This is 
partially achieved by converting pyruvate into lactate via lactate dehydrogenase 
(LDH), which oxidizes NADH back to NAD+ in the process. There are several fates 
then for lactate. One of the greatest debates in regards to lactate metabolism is 
whether it can then be taken up and oxidized by the mitochondria itself, similar to 
pyruvate. This specific question is tested and presented later an accompanied 
manuscript entitled Lactate oxidation in human skeletal muscle mitochondria. For this 
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to occur pyruvate is shuttled into the mitochondria and decarboxylated into acetyl-
CoA via pyruvate dehydrogenase, also forming NADH. It is then in the mitochondria 
that acetyl-CoA then enters the TCA cycle. 
 
The tricarboxylic acid (TCA) cycle 
Mitochondria generate biologically accessible energy by oxidizing carbohydrate and 
lipid metabolites alike (Lehninger AL. The Mitochondrion. New York: Benjamin, 
1965). In this process metabolites of both carbohydrates and lipids must first 
transverse the TCA cycle in the mitochondrial matrix. The first step in the TCA cycle 
is the formation of citrate and coenzyme A (CoA)-SH through the condensation of 
acetyl-CoA and oxaloacetate. Acetyl-CoA is primarily produced via glycolysis in the 
case of carbohydrates, which was previously discussed, or from β-oxidation during 
lipid metabolism, which will be discussed in the next section. This exergonic reaction 
is catalyzed by citrate synthase (CS) and is irreversible. Feedback inhibition is 
necessary to limit this reaction, as NADH and succinyl-CoA, both by products of the 
TCA cycle, allosterically inhibit CS. Next in the TCA cycle is the isomerization of 
citrate into isocitrate. This step is catalyzed by aconitase. This reaction occurs near 
equilibrium. The facilitated shift of the hydroxyl group changes a tertiary alcohol of 
which is very difficult to oxidize, citrate, into a secondary alcohol that is much easier 
to further oxidize, isocitrate. Accordingly, isocitrate dehydrogenase then catalyzes the 
oxidation of isocitrate to oxalosuccinate and NADH, which then spontaneously 
decarboxylates to form α-ketoglutarate and CO2. This is another exergonic and 
irreversible reaction, allosterically activated by ADP and inhibited by both NADH 
and ATP. Then there is another oxidative decarboxylation reaction that occurs with α-
ketoglutarate being converted to succinyl-CoA, CO2 and NADH. Similar to the 
previous reaction, this is highly exergonic and irreversible. Succinyl-CoA synthetase 
then converts succinyl-CoA to succinate. This highly exergonic reaction is coupled to 
the endergonic substrate level phosphorylation of guanosine-5'-diphosphate (GDP) 
and inorganic phosphate into a high-energy phosphate, GTP. This GTP is later 
converted to the more common energetic cellular currency, ATP. Succinate 
dehydrogenase then oxidizes succinate to form fumarate and reduce flavin adenine 
dinucleotide (FADH2). This is also an exergonic reaction, however the energy 
released is not sufficient to reduce NAD and thus FAD serves as the electron acceptor 
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in the reaction. Succinate dehydrogenase is the only membrane bound protein in the 
TCA cycle, as all other enzymes involved in the TCA cycle are soluble. Succinate 
dehydrogenase also serves as a respiratory complex II in the electron transport 
system. The role of succinate dehydrogenase in the electron transport system will be 
discussed later in greater detail. Fumerate is then hydrated to form malate via 
fumarase. Finally, the last step in the TCA cycle is the oxidation of malate back to 
oxaloacetate, also reducing NAD+ to NADH. In all, the TCA cycle alone only 
accounts for the production of two ATP via substrate level phosphorylation, however 
there is still the energy that was transferred into the reduced coenzymes produced, 
NADH and FADH2. These coenzymes are then shuttled into the electron transport 
system. 
 
 
Figure 6. The tricarboxylic acid (TCA) cycle and mitochondrial function. A summary of the TCA 
cycle in the mitochondrial matrix, which demonstrates its integration with other mitochondrial 
functions. This graph is from reference (303). 
 
Amino acids can also be metabolized for energetic means through the TCA cycle, 
however under normal conditions their contribution to total energy transduction is low 
respective to carbohydrates and lipids. A more significant contribution of amino acids 
to aerobic metabolism include their role in the anaplerotic reactions that help maintain 
the necessary concentration of TCA cycle intermediates. A significant amount of 
amino acids, specifically the branched-chain amino acids, can be metabolized during 
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times of extreme metabolic stress such as starvation, however this is transient and 
progressively shifts primarily to fat oxidation (38, 39, 236).  
 
β-oxidation 
Fat is the most energetically rich and abundant nutrient for mammals, with a large 
capacity for fat storage. In addition to their favorable energetic abundance, lipids are 
hydrophobic molecules, ergo they are stored without water (non hydrated), as is the 
case with glucose when stored as glycogen. Fatty acids are stored as triacylglycerols 
primarily in adipocytes however various tissues also are capable of limited fat storage. 
The metabolism of fatty acids for energy primarily occurs in the mitochondria. Short 
chain fatty acids are directly transported into the mitochondria for oxidation whereas 
long chained fatty acids require activation prior to their entry. This is done by acyl-
CoA sythetase located on the MOM (250). The activated acyl-CoA requires specific 
transport into the mitochondrial matrix. This is done in a series of steps. First, the acyl 
group is transferred from CoA to the hydroxyl group of carnitine via carnitine 
acyltransferase I, which is bound to the MOM forming acyl-carnitine. Acyl-carnitine 
is transported across the MIM, where in the matrix it is converted back to acyl-CoA 
via carnitine acyltransferase II returning carnitine to the MIS.  
 
In the mitochondrial matrix the fatty acyl-CoA molecules are broken down through an 
enzymatic process referred to as β-oxidation. The first reaction is catalyzed by the 
enzyme acyl-CoA dehydrogenase, which has a FAD prosthetic group that is reduced 
during the metabolism of the fatty acid molecule. The now reduced FADH2 then 
transfers its electrons to a flavoprotein known as electron transfer flavoprotein (ETF). 
ETF reoxidizes by transferring electrons to an oxidoreductase that directly transports 
the electrons to coenzyme Q10 (CoQ, also known as ubiquinone) of the electron 
transport system, discussed later in more detail. The next step in β-oxidation is the 
hydration of the fatty acid moiety by enoyl-CoA hydratase, converting transenoyl-
CoA into L-β-hydroxyacyl-CoA. L-hydroxyacyl-CoA dehydrogenase then oxidizes 
L-β-hydroxyacyl-CoA to β-ketoacyl-CoA, reducing NAD+ to NADH. This reducing 
agent is then transported to mitochondrial respiratory complex I of the electron 
transport system. In the final step of β-oxidation, thiolase ultimately catalyzes the 
formation of acetyl-CoA and an acyl-CoA molecule that is 2 carbons shorter. This 
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cycle is repeated until the fatty acid has been completely broken down into acetyl 
CoA molecules. The acetyl-CoA produced from β-oxidation is then transported into 
the TCA cycle as discussed previously. 
Up to this point in the discussion only 3 molecules of ATP have been formed through 
one cycle of glycolysis and the TCA cycle. Activation of fatty acids in order to enter 
the mitochondrion requires energy, so with one round of β-oxidation included there 
has only been one net ATP produced. There are several reduced coenzymes that have 
also been produced as well. These reducing agents are then transported to the electron 
transport system. The mitochondrial electron transport system serves as the 
bioenergetic hub of aerobic metabolism. The analysis and study of respiratory control 
and efficiency involves the examination of the electron transport system directly.  
Oxidative phosphorylation 
Uncovering the science behind cellular respiration, and explaining oxidative 
phosphorylation through Peter Mitchell’s chemiosmotic theory (199) not only led to a 
Nobel Prize in Chemistry in 1978 but easily serves as one of the most important 
biological findings of the past century. Our understanding of mitochondrial 
respiration is now much more complete however much remains unknown in regards 
to mitochondrial respiration. The fundamental force facilitating oxidative 
phosphorylation is the proton motive force (pmf) that is developed from the active 
traslocation of protons across the MIM into the MIS via a system of enzymes that 
couples this translocation with a systemic transfer of electrons. The pmf describes the 
electrochemical gradient across the MIM composed of both a chemical gradient and 
an electrical gradient. This gradient is established by a selective set of enzymes 
associated with the MIM referred to as the electron transport system. 
The electron transport system 
The electron transport system is a collection of mitochondrial enzymes located either 
within or attached to the MIM. These enzymes serve as electrogenic proton pumps 
and oxidizing agents that reduce products (NADH and FADH2) of the TCA cycle and 
β-oxidation. This occurs through a systematic transfer of electrons down a gradient 
while simultaneously pumping protons into the MIS, creating an electrochemical 
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gradient across the MIM. This electrochemical potential is often referred to as 
mitochondrial membrane potential. The mitochondrial membrane potential that 
develops across the MIM facilitates the conduction of energy into the phosphate 
bonds of ATP (199). Each enzyme of the electron transport system plays a specific 
role in the final step of aerobic metabolism. Electron input occurs from four sources: 
1.) NADH transmitted through mitochondrial respiratory complex I; 2.) TCA cycle 
specific FADH2 through mitochondrial respiratory complex II; 3.) electron transfer 
from the metabolism of fatty acids through β-oxidation through the electron-
transferring-flavoprotein (ETF) dehydrogenase (flavoprotein–ubiquinone 
oxidoreductase); and 4.) electrons transferred from glycerophosphate dehydrogenase 
to CoQ that originated from cytosolic NADH via the glycerophosphate shuttle. (321). 
Figure 7. Electron transport system. Electron transport chain complexes I to V; NAD+ – 
nicotinamide adenine nucleotide; NADH – reduced NAD+; TCA – tricarboxilic acid cycle; MnSOD – 
manganese superoxide dismutase; GPx – glutathione peroxidase; TPx – thioredoxin peroxidase; AA – 
antimycin A; and TMPD – N,N,N′,N′-tetramethyl-p-phenylenediamine.	  Modified from reference (232). 
1.1 Mitochondrial respiratory complex I (CI) – NADH dehydrogenase 
Mitochondrial respiratory complex I (CI) is the largest and most complicated enzyme 
of the respiratory system. It is composed of 14 central units (310) and 32 accessory 
subunits (41, 74, 111), making it one of the largest membrane-bound proteins in 
general, with the size of about 1,000 kDa. Seven of the 46 polypeptides that compose 
CI are genetically encoded in the mtDNA (302). There are two primary sections of CI 
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that give it an L-shaped appearance, a hydrophobic membrane-bound arm of the 
protein and a hydrophilic peripheral arm, which extends into the mitochondrial matrix 
(28, 256, 257). The specific mechanisms by which CI functions and the roles of all 
accessory subunits remain largely unknown (28, 68). In general there are three 
primary functions of CI: i.) electron attainment and subsequent oxidation of NADH; 
ii.) electron release to CoQ; and iii.) the translocation of protons across the MIM. 
First, NADH binds (44) and transfers its electrons to the flavin mononucleotide 
(FMN) prosthetic group, similar to FAD, creating FMNH2 (245). FMNH2 delivers a 
single electron (in a two-to-one conversion) onto an iron-sulfur cluster binding motif 
(104, 216), which is then shuttled from one set of iron-sulfur clusters to another 
before finally being transferred to CoQ (57, 104, 216). The FMN and up to 8 or 9 
iron-sulfur clusters exist in the peripheral arm of CI (104) while the membrane-bound 
arm contains the proton-pumping structures (256, 257). For every 2e- transferred 
through CI, there is a reciprocal 4 H+ pumped across the MIM into the MIS (79, 80). 
The mechanism linking these two phenomena are not clear but evidence suggests that 
there is an indirect redox-dependent conformational change that occurs in the 
membrane-bound arm of CI facilitating the translocation of protons (17, 29, 66).  
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Figure 8. Mitochondrial respiratory complex I (CI) – NADH dehydrogenase. Illustrations depicting CI. 
IMS - intermembrane space; O2- - superoxide dismutase; N – iron-sulfur clusters; CoQ and Q – 
coenzyme Q. Modified from references (68, 155). 
The impermeability of the MIM is not perfect and sometimes electrons slip from their 
molecular transfer cascade or protons leak across the MIM back into the matrix. The 
uncontrolled leak of electrons from coenzymes or prosthetic groups of the electron 
transport system then reacts with O2 to form reactive oxygen species (ROS). 
Mitochondria are a primary site of ROS production. The progression of ROS 
production beyond hormetic concentrations precipitates deleterious and indiscriminate 
oxidation of nucleic acids, proteins, and lipids (128, 272, 285). Mitochondrial-derived 
ROS are largely accounted for by superoxide (O2-) production into the mitochondrial 
matrix at mitochondrial complex I (CI) (161, 162, 287) and into both the matrix and 
mitochondrial intermembrane space at mitochondrial complex III (CIII) (43, 96, 99, 
205, 286, 323). There are three different conditions in which CI is postulated to 
produce ROS: 1.) During conditions where the respiratory system is blocked 
downstream from CI and electrons become congested in the iron-sulfur clusters (65, 
78); 2.) reduced FMN reacts with O2 dependent on the ratio of NADH/NAD+ (110); 
and 3.) during reverse electron transfer (RET) as electrons flow back to CI from CoQ 
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via mitochondrial complex II (95, 298). A high mitochondrial membrane potential is 
necessary for the latter to occur (64, 298). 
 
In summary, mitochondrial CI oxidizes NADH, transfers the associated electrons 
down the electron transport system to CoQ, and reciprocally pumps the coupled H+ 
ions across the MIM (330). Mitochondrial CI is also one of the principal contributors 
to mitochondrially-derives ROS. As NADH serves as a substrate for CI, rotenone is a 
common inhibitor. It works as an antagonist for the reduction of CoQ by inhibiting 
the transfer of electrons from the iron-sulfur clusters to CoQ (28). All the actions of 
CI work in parallel oppose to linearly with those of mitochondrial complex II during 
oxidative phosphorylation. 
 
1.2 Mitochondrial respiratory complex II (CII) – Succinate dehydrogenase  
Mitochondrial respiratory complex II (CII) is the smallest respiratory complex in the 
electron transport system at approximately 120 kDa and is completely nDNA-
encoded (302). In most mammals, CII is composed of four polypeptide subunits, all 
encoded for by nDNA (248, 276, 302). Additionally it contains 5 prosthetic groups: 
one covalently linked FAD, a b-type heme, and three iron-sulfur clusters (281). The 
series of redox centers are arranged so that there is limited ROS formation at CII, 
accounting for approximately 0.1–0.2% total ROS formation (238, 321). CII is the 
only enzyme that participates directly in both the TCA cycle and the electron 
transport system.  
 
In the TCA cycle CII catalyzes succinate to fumarate, reducing FAD+, and in the 
respiratory system it transfers the electrons gained from reducing equivalents 
(FADH2) first to a iron-sulfur cluster and then onto CoQ (165). Two of its larger 
subunits out of the four and one of the three iron-sulfur clusters catalyze the transfer 
of electrons from succinate to an electron acceptor (165, 184). Unlike mitochondrial 
complexes I, III, and IV, the enzymatic activity of CII is not coupled with the 
pumping of protons across the MIM (61). While this is the only respiratory complex 
with no portion of the enzyme within the MIM, CII is anchored to the inner 
membrane by two subunits (217).  
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Figure 9. Mitochondrial respiratory complex II (CII) – Succinate dehydrogenase. Q – coenzyme Q; FP 
– flavoprotein; IP – iron protein. Modified from reference (97). 
 
In summary, mitochondrial complex II transfers electrons from FADH2 to 
mitochondrial complex III via CoQ. Substrates for CII include flavin based redox 
cofactors, specifically those reduced in the reaction catalyzed by succinate 
dehydrogenase during the TCA cycle. The flavin based reducing agents specific to β-
oxidation are often mistakenly referred as CII substrates (157, 167, 168, 170), 
however their electrons are transferred through the electron transfer flavoprotein 
(ETF) discussed above, during β-oxidation. Malonate and oxaloacetate are 
competitive inhibitor of CII (97). Malonate serves as a CII competitive inhibitor as it 
binds to the same catalytic site as succinate (235). 
 
1.3 Mitochondrial respiratory complex III (CIII) – Cytochrome bc1 complex  
A dissolved pool of CoQ molecules in the MIM function to transport electrons from 
CI and CII to mitochondrial respiratory complex III (CIII) (18, 172, 173). CIII is a 
248 kDa enzyme consisting of 11 polypeptide subunits and four prosthetic groups 
(259). All four points of entry into the electron transport system (CI, CII, ETF, and 
glycerophosphate shuttle) converge at CIII. In addition to CoQ, the essential redox 
components of CIII are three heme components, two b-type hemes and one c-type 
(bL, bH, and c1, respectively), one high potential iron-sulfur cluster, and cytochrome 
c (318). Cytochrome b is the one of 11 polypeptides that is mtDNA-encoded in CIII 
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(302). The role of CIII in electron transport is to transfer the electrons received from 
CoQ to a soluble cytochrome c. This transfer of electrons is coupled to the 
concomitant translocation of two H+ across the MIM for every CoQ oxidized (109, 
200, 201, 282).  
 
Figure 10. Mitochondrial respiratory complex III (CIII) – cytochrome bc1 complex. Red arrows 
show the translocation of protons across the mitochondrial inner membrane and the purple arrows show 
the pathway of electron transport. Qi-site – catalytic site on the negative side of the mitochondrial inner 
membrane; Qo-site – catalytic site on the positive side of the mitochondrial inner membrane; Q and 
QH2 – oxidized and reduced coenzyme Q, respectively. Modified from references (318, 328) 
 
The mechanism that connects the translocation of protons with the transfer of 
electrons within CIII is the proton-motive Q cycle (201). While the mechanistic 
specifics involved in the proton-motive Q cycle are still being discussed, the most 
general and widely accepted model involves the bifurcated flow of electrons through 
CIII (200, 282). There are two CoQ binding sites on CIII: one specific for CoQ 
oxidation (Qp or Qo on the positive side or MIS of the enzyme) and the other for CoQ 
reduction (Qn or Qi located on the negative side or matrix side of the enzyme) (82, 
329). During the proton-motive Q cycle, a fully reduced CoQ (ubiquinol) binds to Qo 
and is sequentially oxidized. One of these electrons is transferred to cytochrome c via 
the iron-sulfur cluster and cytochrome c1 prosthetic groups. The other electron is 
transferred directly to the bL and then bH heme groups before partially reducing CoQ 
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(ubiquinone) bound to the Qi site. The CoQ at the Qi site is only partially reduced 
(semiquinone). Thus another Q cycle is necessary for the CoQ in the Qi site to 
become fully reduced, and a total of 4 H+ (2 per cycle) are translocated across the 
MIM into the MIS (53, 58, 200, 201, 218, 244, 282).   
 
Although the process is exceptionally efficient overall, the two catalytic sites 
facilitating the same reaction in opposing directions (oxido-reduction of CoQ) leads to 
the potential for electron build-up and potential backflow allowing oxygen serve as an 
oxygen donor, producing superoxide (O2•−) (53, 277) O2•− can be generated at two 
different sites, QO and Qi, within complex III. The two catalytic site result in two 
points of ROS production. The QO site on the positive side of the enzyme releases 
O2•− into the MIS, whereas Qi associated ROS production is released into the 
mitochondrial matrix (43, 96, 99, 205, 286, 323). Most of the O2•− generated by 
complex III, however, is generated at the QO catalytic center (26). 
 
In summary, mitochondrial complex III is responsible for catalyzing the transfer of 
electrons from a fully reduced CoQ to cytochrome c. This transfer of electrons is 
coupled to the translocation of protons across the MIM from the matrix the MIS at a 
ratio of 4H+ per 2e-. Accordingly mitochondrial complex III assists in developing the 
electrochemical proton gradient that ultimately drives energy transduction. The 
transfer of electrons, while efficient, is not perfect and serves as a primary source of 
ROS production in the mitochondria. While technically CoQ serves as the substrate 
for CIII, durohydroquinone (duroquinol oxidase, DHQ) can serve as an artificial 
electron donor for CIII for analysis of electron transport from CIII to mitochondrial 
complex IV (100, 174, 246, 308). Antimycin A is an inhibitor of CIII as it binds to the 
Qi catalytic site of the enzyme rendering it incapacitated (82).  
 
1.4 Mitochondrial complex IV (CIV) – Cytochrome c oxidase 
Mitochondrial complex IV (CIV; cytochrome c oxidase) is a large transmembrane 
protein (200 kDa) that serves as the terminal electron-accepting enzyme in the 
respiratory system and is responsible for approximately 95% of all oxygen 
metabolism in mammals (189, 283). Thirteen subunits collectively represent CIV with 
3 of those 13 encoded by mtDNA, subunits I-III (9, 284, 302).  
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In general, CIV transfers electrons from cytochrome c to naturally unstable O2, 
forming metabolic H2O (292). The reduction of O2 by CIV is also linked with the 
translocation of protons across the MIM, further developing the proton motive force 
across the inner membrane (23, 315). This occurs at a ratio of 4e- to 2H2O and 2H+ 
(193). All redox centers in CIV are located on just 2 of the 13 subunits; subunits I and 
II (9). Accordingly these two subunits are responsible for the entirety of the protein’s 
energy transduction as the rest are involved in enzyme regulation (107). Electrons are 
transferred from soluble cytochrome c to the copper A (CuA) center of subunit two. 
The electrons are then transferred to heme a and onto the binuclear center consisting 
of heme a3 and copper B (CuB), all located on subunit one. The binuclear center is 
where O2 is reduced to H2O (127, 283, 284). The catalytic cycle of CIV can be 
divided into 2 parts, the oxidative and the reductive phases (292). In the oxidative 
phase the enzyme is reduced, which consists of the heme and copper centers all 
possessing electrons with four in total. The heme a3-CuB center on subunit II then 
interacts with the bound O2, reducing it to H2O (9). All redox centers are then re-
reduced by cytochrome c during the reductive phase prior to the binding of the next 
O2 (292).  
 
The evolutionary dominance of O2 metabolism by CIV most likely occurred as a 
result of the chemical difficulty of executing the complete reaction with the effective 
and efficient success that CIV achieves (189). Despite the high traffic of electron 
transport and close proximity to O2, CIV is not considered a primary site of ROS 
production (26). Endogenously, reduced cytochrome c serves as the primary CIV 
substrate however non-biological substances such as N,N,N′,N′-tetramethyl-p-
phenylenediamine dihydrochloride (TMPD) can also serve as electron donors to CIV 
for analysis. For example, respiratory rates following inhibition of respiratory 
complexes upstream of CIV allows for assessment of CIV activity with TMPD 
serving as the electron donor to cytochrome c and ascorbate maintaining TMPD in the 
reduced state (89). The binuclear catalytic center of CIV is inhibited by cyanide (209, 
214, 316), which blocks O2 binding and respiration (229). The transport of electrons 
across the MIM at CIV is the final step along the respiratory chain that builds the 
proton motive force of which is used for energy transduction at ATP synthase. 
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Figure 11. Mitochondrial respiratory complex IV (CIV) – Cytochrome c oxidase. The Blue arrow 
shows the translocation of protons across the mitochondrial inner membrane and the red arrows show 
the pathway of electron transport. MIS – mitochondrial intermembrane space; TMPD – N,N,N′,N′-
tetramethyl-p-phenylenediamine dihydrochloride. Modified from reference (123). 
1.5 Mitochondrial complex V (CV) – ATP synthase 
The ability to harness and utilize energy is a requisite of life. The most fundamental 
molecule in mammalian bioenergetics is ATP. The average person synthesizes his/her 
body weight in ATP per day (25). Mitochondrial respiratory complex V (CV, ATP 
synthase) is the enzyme responsible for the majority of this ATP synthesis, excluding 
that obtained from substrate level phosphorylation. The characteristic folds of the 
mitochondrial cristae have been observed via electron tomography to possess high 
concentrations of CV dimers (55, 275).  
 
 The fifth mitochondrial respiratory complex, with a mass of ~600 kDa (10), is a 
bipartite molecule consisting of an embedded membrane domain (F0) involved in 
proton translocation and a peripheral catalytic domain (F1) that extends into the 
mitochondrial matrix (265). This enzyme, which can also function as an ATPase, is 
collectively comprised of, including the regulatory subunit (IF1), 16 polypeptides (48, 
247, 301), two of which are encoded on mtDNA (302). The membranous subcomplex 
F0 consists of subunits a, b, c8, d, e, f, g, A6L, and F6 (10, 48) and the 
extramembranous F1 subcomplex consists of subunits α3, β3, γ, δ, and ε (2, 3, 24). A 
central stalk, consisting of the γ, δ, and ε subunits from the F1 domain, and a 
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peripheral stalk composed of the oligomycin sensitivity conferral protein (OSCP) and 
subunits b, d, and F6 from the F0 domain connect the two subcomplexes (48, 49, 84). 
Collectively this enzyme functions 
similar to a hydroelectric dam with 
the electrochemical gradient 
established by CI, CIII, and CIV 
being the dammed water and CV as 
both the turbine and generator used 
to convert gradient (potential) 
energy into chemical energy. This 
chemical energy is harnessed by 
converting ADP and phosphate (Pi) 
into ATP. 
 
 
 
 
Figure 12. Mitochondrial respiratory complex V (CV) – ATP synthase. The F1 domain resides in 
the mitochondrial matrix as the F0 domain is primarily in the mitochondrial inner membrane. OSCP – 
oligomycin sensitivity conferral protein. Modified from reference (265). 
 
The specifics of ATP synthesis and hydrolysis are complex and intricate. Simply put, 
the flow of protons through F0 creates a torque that facilitates the synthesis of ATP at 
F1. This process is fully reversible such that ATP hydrolysis at F1 can actively pump 
protons back out of the matrix through F0 (70, 147, 305). Much of the mechanism 
explaining the synthesis of ATP via CV in fact has derived from studies investigating 
the effect of ATP hydrolysis on enzyme mechanics (142, 211) although the forward 
mechanism has also been observed (126).  
 
The process of ATP synthesis at CV begins with proton translocation from the MIS 
down the gradient into the mitochondrial matrix through the F0 domain causing its c8 
(subunit) ring to rotate (211). The protons ionize carboxylate residues on glutamate in 
the c8 subunit. This ionization drives the movement of these residues via Brownian 
motion in attempt to reach a more hydrophobic environment, causing the c-ring to 
turn. Eventually the carboxylate reaches an environment where it is reionized and the 
proton is released (140). This rotational force causes the entire asymmetric central 
stalk to turn which then applies a rotary torque on the γ chain that runs through core 
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of the α3β3 assemblage of the F1 domain (222, 255, 274). Rotation of this γ chain 
propagates conformational changes in the β subunits and facilitates ATP synthesis 
(152, 211). Rotation of the γ subunit occurs in discrete 120° clockwise increments – 
from an F0 vantage point – of which are composed of 80° and 40° substeps, at 
approximately 100 rotations per second (210, 307, 322). This rotational torque is 
however resisted by the peripheral stalk, which stabilizes the catalytic component of 
F1 (300). The globular F1 domain has three catalytic β chains, and each chain is 
separated by a corresponding non-catalytic α subunit (2). There are three potential 
nucleotide-binding sites on the β subunits located at the αβ interface (25, 152, 265). 
These catalytic sites undergo conformational changes facilitated by the rotational 
torque of the central stalk and the γ subunit. The catalytic conformations correspond 
to the binding of the nucleotide, which are “open”, “loose”, and “tight” (25). Within a 
360° turn each site progresses through all three conformations, and so each 120° 
rotation of the central stalk approximately 1 molecule of ATP is made (307). 
 
The synthesis of ATP is highly efficient with the P/O ratio varying according to c-ring 
size. The P/O ratio is defined as the number of ATP molecules synthesized per pair of 
electrons that traverse the electron transport system (75). The number of translocated 
protons necessary to generate one 360° turn is the same as the number of c-subunits 
on the c-ring (307). A mammalian c-ring with eight c-subunits has an electrochemical 
cost of 3.7 protons per ATP produced (307). This equates with a P/O ratio of 2.7 and 
1.6 for CI and CII specific electron entry into the respiratory system, respectively 
(108, 307). Every 2e- that enters the respiratory system at CI results in 10 H+ ions 
translocated across the MIM (4 at CI, 2 at CIII, and 4 at CIV) and thus the P/O ratio is 
2.7 (10÷3.7). Alternatively, electron entry at CII only result in 6 H+ translocated since 
CII does not actively transport protons across the MIM (2 at CIII and 4 at CIV) 
resulting in a P/O ratio of 1.6 (6÷3.7) (75, 108, 307).  
 
While ADP and ATP obviously function as substrates for CV, oligomycin acts as an 
inhibitor. Oligomycin reacts with OSCP facilitating a conformational change in the 
OSCP-bdF6 subcomplex of F0, which prevents binding of ADP or the release of ATP 
at the catalytic sites of F1 (225, 247). 
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Synopsis of the mitochondrion and cellular respiration 
In summary, the mammalian mitochondrion is believed to have evolved from the 
synergistic fusion of ancestral glycolytic proto-eukaryotes with oxidative α-bacterial-
like endosymbionts. Overtime a mitonuclear coadaptation occurred such that the 
previously autonomous bacterial ancestors became reliant on its host’s nuclear DNA 
despite retaining some genetic self-sufficiency, specifically the genes that encode for 
12S and 16S rRNA, 22 tRNAs essential for mitochondrial protein synthesis, and 13 
polypeptides that are involved in oxidative phosphorylation. In addition to the genetic 
reliance of the mitochondrion on the eukaryotic cell came the energetic reliance of the 
eukaryotic cell on the mitochondrion. The mitochondrion emerged as the lynchpin in 
mammalian evolution allowing for the exploitation of oxygen’s instability and 
providing the facilities to transduce energy from chemical sources into biologically 
accessible forms of which are used to maintain metabolic homeostasis. This process, 
termed oxidative phosphorylation, oxidizes the metabolites of macronutrients 
(glucose, fatty acids, and amino acids) via a superlative and intricate set of 
synchronized and coupled reactions. Though the origin of the process varies 
depending on the macronutrient oxidized, ultimately all carbon sources coalesce in 
the mitochondrial matrix and precede through the TCA cycle. The systematic 
metabolization and oxidation of these chemical sources generate reducing equivalents 
such as NADH and FADH2. These reducing equivalents serve as the electron sources 
necessary to build an electrochemical gradient across the MIM that facilitates the 
energetic transduction. Electron input occurs from four sources: 1.) NADH 
transmitted through mitochondrial respiratory complex I; 2.) TCA cycle specific 
FADH2 through mitochondrial respiratory complex II; 3.) electron transfer from the 
metabolism of fatty acids through β-oxidation through the electron-transferring-
flavoprotein (ETF) dehydrogenase (flavoprotein–ubiquinone oxidoreductase); and 4.) 
electrons transferred from glycerophosphate dehydrogenase to CoQ that originated 
from cytosolic NADH via the glycerophosphate shuttle. All electrons are passed onto 
dissolved pool of CoQ molecules in the MIM where they converge and are passed 
onto mitochondrial respiratory complex III. The electrons are then shuttled to 
mitochondrial respiratory complex IV via soluble cytochrome c. It is here that oxygen 
is reduced to metabolic water and carbon dioxide. The transport of electrons through 
complexes I, III, and IV result in the attendant transfer of protons from the 
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mitochondrial matrix, across the MIM and into the MIS. This develops a proton 
motive force that is then channeled through mitochondrial respiratory complex V 
(ATP synthase), which is coupled to the phosphorylation of ADP to ATP. As this 
process is vital to metabolic homeostasis and the maintenance of life, small alterations 
in mitochondrial function can have drastic influences on health.  
 
Figure 13. Oxidative phosphorylation. This figure illustrates the process of oxidative 
phosphorylation with: Substrate provision to mitochondrial complex I and complex II from the TCA 
cycle and to mitochondrial complex III via electron transferring flavoprotein from β-oxidation; The 
collective flow of electrons (red-dashed lines and white arrows); Translocation of hydrogen (grey 
arrows); The production of superoxide (O2-); The reduction of molecular O2 to H2O at mitochondrial 
complex IV; and The phosphorylation of ADP + inorganic phosphate (Pi) to ATP at mitochondrial 
complex V. ims – intermitochondrial space; Q and QH2 – oxidized and reduced coenzyme Q, 
respectively; cyt c – cytochrome C. Figure modified from reference (326). 
 
Appropriately, research investigating mitochondrial function and its relationship to 
both health and disease remains at the forefront of a multitude of different scientific 
fields. Despite the significance of mitochondrial physiology in maintaining both 
physical and mental health, however, there is paucity of literature that actually 
examines mitochondrial respiration directly in vivo or in intact tissue, ex vivo, 
providing dynamic assessments of electron transfer sufficiency and substrate 
influence on respiration. In the following section the specific reason for conducting 
the studies included in this dissertationwill be addressed. 
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Aim of Study 1: Analysis of lactate metabolism in human skeletal 
muscle mitochondria 
Lactate is an intermediate metabolite of glucose, a by-product of glycolysis, and is 
essential for human bioenergetics and maintaining overall homeostasis (85, 87, 289). 
The cell-cell lactate shuttle (CCLS) has been confirmed throughout the years (12, 21, 
106, 187, 196, 290), verifying that lactate released from one cell can serve as a carbon 
source for bioenergetic means throughout the body (32, 34). Though many different 
tissues, including the heart, brain, kidney, adipose tissue, liver and skeletal muscle, 
consume lactate (62, 195, 289, 290), the mechanism of lactate metabolism is debated.  
 
The lactate shuttle hypothesis (34), which has served as the epicenter of the debate, 
initially proposed that lactate was transported into the mitochondrial matrix where it 
was oxidized (35, 36). While much evidence refutes this hypothesis, the specifics of 
lactate metabolism within skeletal muscle mitochondria remain obscure (33, 36, 37, 
86, 241, 249, 324). One similarity across the majority of studies is the mitochondrial 
preparation utilized to assess mitochondria-specific lactate oxidation (36, 234, 241, 
249, 324). This crude method of mitochondrial extraction results in a varying % yield 
of mitochondria by mechanical homogenization and differential centrifugation. 
Although the methods were grossly similar across labs, the dispute regarding the 
mechanisms of mitochondrial lactate oxidation consists of challenging the exact 
method used for mitochondrial isolation or the success achieved in purity and 
completeness of the mitochondrial isolations (33, 37, 241).  
 
As reviewed in the introduction, mitochondria subsist in skeletal muscle as a reticular 
tubular network and not as the discrete organelles achieved with mitochondrial 
isolation (148). The isolation procedures disrupt this native reticulum resulting in 
artificially spherical and discrete organelles that represent only a portion of the entire 
mitochondrial network (231, 263). Such disruption carries the risk of: i) 
contaminating the mitochondrial fraction with proteins foreign to the mitochondria 
(46, 231), ii) depleting mitochondrial specific contents (33, 37, 231), and iii) altering 
mitochondrial function (164, 251, 254). Indeed, mitochondrial isolation has 
repeatedly been shown to affect mitochondrial respiratory function (19, 159, 198, 221, 
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230, 294). Unlike those studies that have utilized isolation techniques, we wanted to 
examined the ability of mitochondria to oxidize lactate by means of high-resolution 
respirometry on preparations of human skeletal muscle in situ. This technique allows 
for the analysis of mitochondrial function by chemically permeabilizing the 
sarcolemma, allowing access to unaltered mitochondria for direct manipulation. In the 
process of sarcolemmal perturbation, soluble cytosolic proteins, including LDH, are 
concomitantly lost (160, 164, 254). This is an additional benefit of this technique, as it 
not only allows access to an entire innate mitochondrial network within the skeletal 
muscle but also eliminates the confounding effects of cytosolic LDH on lactate 
metabolism. 
 
Accordingly, the primary aim of this study was to challenge the hypothesis that 
mitochondria can directly oxidize lactate. Assuming that a lactate oxidation complex 
exists within skeletal muscle mitochondria (102), our hypothesis was that 
mitochondrial preparations of human skeletal muscle in situ would display the ability 
for lactate to facilitate mitochondrial respiration independent from any addition of 
exogenous LDH.  
 
Aim of Study 2: Identify and describe age-induced alterations in 
mitochondria 
As introduced in the prologue, oxygen is unstable, and because of that instability there 
are varying degrees of oxidant production with aerobic metabolism (101). As the 
mitochondrion monopolizes aerobic metabolism, these subcellular structures also 
consequently serve as the primary source of in vivo oxidant production (11, 15, 285, 
304), mostly accounted for the production at CI (161, 162, 287) and CIII (43, 96, 99, 
205, 286, 323). A certain degree of oxidant production is beneficial and facilitates 
healthy adaptation via systematic and controlled cellular signaling cascades. Oxidant 
production beyond these hormetic concentrations, however, precipitates deleterious 
and indiscriminate oxidation of nucleic acids, proteins, and lipids (128, 272, 285). The 
mitochondrial theory of aging asserts that the actual biological aging process is 
facilitated by a gradual impairment in electron transport efficiency that increases 
oxidant production, which damages mtDNA damage causing additional functional 
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impairment, and so on; a vicious cycle of functional impairment, oxidant production, 
and cellular damage (77). This theory has yet to be entirely confirmed.  
 
Senescence does correlate with evidence of nuclear and mtDNA damage (98, 194, 
266, 267) and mtDNA induced mutations are associated with premature aging (224). 
Additionally, models of increased oxidant production also associate with premature 
aging (71, 153, 191), while prevention of oxidative stress via upregulation of 
endogenous antioxidant alternatively increases lifespan (262). Despite these findings, 
any age-induced alterations in actual electron transport function have not been 
demonstrated (11). 
 
Accordingly the aim of this study was to examine mitochondrial protein expression 
and both respiratory capacity and control via high-resolution respirometry. The use of 
isolated mitochondrial preparations to study the effects of aging on mitochondrial 
amplifies the age induced changes in mitochondrial function, embellishing the actual 
alterations (230). Mitochondrial isolation techniques alter innate mitochondrial 
characteristics (33, 37, 46, 122, 159, 198, 221, 230, 294) such as the loss of 
mitochondrial membrane integrity (19, 314) and the ability to oxidize fatty acids 
(221). For respirometric analysis we used saponin permeabilized skeletal muscle 
preparations allowing direct access to skeletal muscle mitochondria while maintaining 
both the cytocellular ultrastructure (88, 164, 179, 226, 231, 252, 254) and subcellular 
interactions with mitochondria (164, 179, 198, 231, 254, 291). Cellular bioenergetics 
and metabolic channeling are predicated upon these factors (88, 144, 164, 254). 
Accordingly, this specific mitochondrial preparation serves as the best model to 
examine respiratory capacity and control with aging. Respirometric analyses were 
carried out on soleus (SOL), quadricep (QUAD), and lateral gastrocnemius (GAST) 
skeletal muscles, which represent type 1 slow twitch oxidative (SOL) and type 2 fast 
twitch glycolytic muscle (QUAD and GAST), respectively, in young (10-12 wk) and 
mature (74-76 wk) mice. We hypothesized that actual electron transport function is 
modified with age however the effects of age may vary across skeletal muscle types,. 
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Aim of Study 3: Compare and contrast mitochondrial function in 
mouse and man 
Mouse modeling for the study of both human health and disease is an extremely 
powerful tool that is widely used. The degree of conservation between mouse and 
human genomes allows for the study of murine biology to largely characterize that of 
humans (52). There remains, however, a biological divergence between species that 
are not always so apparent and can lead to scientific misdirection if not properly 
recognized. The exact biological processes differ between humans and mice regards 
to certain aspects of cancer (240), aging (59), and metabolic disease (83, 278). 
Mechanisms of sarcopenia in rodents and humans are different (242) as are those 
regulating hemodynamic control (22, 60), and even the metabolic profile of skeletal 
muscle (260). These differences must be accounted for when applying the results 
from rodent studies towards the progression of human health and well-being.  
Our understanding and interpretation of mitochondrial physiology is often derived 
from mouse models (197, 220, 230, 264). Furthermore, one of the most common 
tissues used to analyze mitochondria is skeletal muscle because of its accessibility, 
relative mass to body weight ratio, and high metabolic rate. Differences between 
mouse and human skeletal muscle have brought into question the validity of studying 
mouse mitochondria and alternative animal models have already been proposed to 
ostensibly replace the mouse for the study of human mitochondrial physiology (171). 
Additionally, differences in metabolic expression across skeletal muscle types has 
brought into question the proper mouse muscle to analyze when attempting to mimic 
human biology (145).  
Accordingly our objective was to compare and contrast mitochondrial function across 
different skeletal muscle types in the mouse and determine if they can properly 
represent human skeletal muscle mitochondrial function. If so, we wanted to identify 
the mouse skeletal muscle that best represents human muscle. We hypothesize that i) 
the mouse can serve as a viable model for the study of mitochondrial function in 
humans, and ii) that the mouse soleus would best represent mitochondrial function in 
human skeletal muscle as a result of the molecular similarities between muscles (145). 
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Aim of Studies 4 & 5: Examine the adaptation of skeletal muscle 
mitochondria to hypoxia 
The study of acclimatization and adaptation to hypoxia in humans is a timely topic of 
research. Approximately 16.5 million km2 of the earth’s surface exists at or above an 
elevation of 2,000 m (69), and between 140 and 150 million people reside at high 
altitudes while 35 million lowland dwellers visit or commute to elevation above 3,000 
m annually (203, 313). Exposure of humans to high altitudes is a challenge to 
biological homeostasis as oxygen delivery becomes progressively more limited as a 
result of the gradual decrease in the partial pressure of oxygen (PO2) attendant to the 
diminishing barometric pressure (311). The collection of past literature that has 
examined mitochondrial alterations with high altitude exposure are difficult to 
collectively interpret. While early studies (112, 243, 280, 288) reported greater 
expression of indirect markers suggestive of oxidative potential in both animals and 
humans native to high altitude (112), later studies reported a loss of skeletal muscle 
mitochondria with altitude exposure (120, 124, 175) or negligible changes in 
mitochondrial characteristics (92-94, 175, 181, 202).  
 
The majority of these studies investigating mitochondrial modifications during 
acclimatization have focused primarily on morphological examinations and 
biochemical analysis of expression. Relying exclusively, however, on static 
measurements to characterize the very dynamic activities of the mitochondrion is 
incomplete. A proper evaluation of mitochondrial-specific adaptations requires a 
complement of direct and functional measures in intact mitochondria to, for example, 
assess potential changes in oxidative phosphorylation, electron transport, coupling 
control and efficiency. In two separate studies we set out to assess hypoxia-facilitated 
changes to mitochondrial respiratory chain function and biochemical expression of 
mitochondrial specific enzymes using high-resolution respirometry. We hypothesized 
that the previous literature suggesting a diminished oxidative phosphorylation 
capacity with altitude exposure would be represented in functional measurements 
with an attendant loss in respiratory capacity.  
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Aim of Studies 6 & 7: Investigate mitochondrial differences across 
various athletes 
The majority of mitochondrial research is directed toward understanding the 
integrative functions of the organelle in relation to various diseases and disorders. The 
good intensions of this research may be limited to an extent, as it is difficult to 
characterize mitochondrial “dysfunction” prior to fully understanding healthy 
mitochondrial function. The physiological boundaries of human skeletal muscle 
mitochondrial performance are unknown, as are the benefits having healthy and fully 
functional mitochondria. Measures of whole-body cardiorespiratory fitness ostensibly 
represent the state of health in humans (1, 81, 136, 143, 150, 180, 219).  Accordingly 
we sought to i) identify and describe mitochondrial function across of healthy, young 
individuals that possess different aerobic capacities; and ii) analyze mitochondrial 
function in a more homogenous group, composed of highly-trained athletes.  
 
Mitochondrial expression and function seem to parallel that of overall health and 
fitness. Mitochondrial density increases in response to training (114, 115, 119) and 
differ between untrained and trained individuals (121, 166, 192, 331). Skeletal muscle 
oxidative capacity also increases with training (228) and varies across groups 
differing in activity level (166, 192, 331). There is debate whether the increase in 
skeletal muscle respiration capacity that parallels aerobic fitness can be explained by 
quantitative differences in mitochondrial content alone (263, 309) or whether 
qualitative adaptations such as functional modifications in respiratory control and 
capacity also improve along with whole body aerobic capacity (88). The aim of this 
study was therefore to analyze mitochondrial differences, both quantitative and 
qualitative, across four different groups of healthy and physically active subjects that 
differ in aerobic capacity. We hypothesized that differences in mitochondria from AT 
to ET individuals would possess distinct qualitative differences. 
 
Differences in mitochondrial function across groups that largely differ in aerobic 
capacity should be more obvious than the more subtle differences within a more 
homogenous group of individuals.  Highly trained endurance athletes place a 
inordinate amount of metabolic strain on their bodies and greatly rely on aerobic 
metabolism to perform. Yet, the description of respiratory capacity and/or efficiency 
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in the top athletes is lacking. Overall endurance performance can roughly be 
determined by the product of an athlete’s maximal oxygen consumption (VO2max) x 
lactate threshold x exercise efficiency can predict endurance performance (14, 137-
139), but this general calculation is vague in regards to specific physiological 
variables important to exercise performance. The purpose of this study is therefore to 
isolate the most dominant physiological variables of performance and identify the 
strongest determinant(s) of exercise performance in highly trained endurance athletes. 
As oxidative capacity of the skeletal muscle appears to have the most common 
interrelation between VO2max, lactate threshold, and exercise efficiency we 
hypothesize that maximal oxidative phosphorylation capacity of the skeletal muscle is 
the strongest determinant time trial performance in highly trained athletes. 
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Jacobs RA, Meinild AK, Nordsborg NB, Lundby C. Lactate
oxidation in human skeletal muscle mitochondria. Am J Physiol
Endocrinol Metab 304: E686–E694, 2013. First published February
5, 2013; doi:10.1152/ajpendo.00476.2012.—Lactate is an important
intermediate metabolite in human bioenergetics and is oxidized in
many different tissues including the heart, brain, kidney, adipose
tissue, liver, and skeletal muscle. The mechanism(s) explaining the
metabolism of lactate in these tissues, however, remains unclear.
Here, we analyze the ability of skeletal muscle to respire lactate by
using an in situ mitochondrial preparation that leaves the native
tubular reticulum and subcellular interactions of the organelle unal-
tered. Skeletal muscle biopsies were obtained from vastus lateralis
muscle in 16 human subjects. Samples were chemically permeabilized
with saponin, which selectively perforates the sarcolemma and facil-
itates the loss of cytosolic content without altering mitochondrial
membranes, structure, and subcellular interactions. High-resolution
respirometry was performed on permeabilized muscle biopsy prepa-
rations. By use of four separate and specific substrate titration proto-
cols, the respirometric analysis revealed that mitochondria were ca-
pable of oxidizing lactate in the absence of exogenous LDH. The
titration of lactate and NAD into the respiration medium stimulated
respiration (P  0.003). The addition of exogenous LDH failed to
increase lactate-stimulated respiration (P  1.0). The results further
demonstrate that human skeletal muscle mitochondria cannot directly
oxidize lactate within the mitochondrial matrix. Alternately, these data
support previous claims that lactate is converted to pyruvate within the
mitochondrial intermembrane space with the pyruvate subsequently taken
into the mitochondrial matrix where it enters the TCA cycle and is
ultimately oxidized.
lactate metabolism; mitochondrial function; lactate oxidation complex
OUR UNDERSTANDING OF LACTATE METABOLISM has evolved greatly
over the past century (30, 32, 86). The omnipresent interme-
diate by-product of glycolysis is now recognized as an essential
and common metabolite involved in human bioenergetics. It is
ubiquitously utilized by different tissues throughout the body,
including the heart, brain, kidney, adipose tissue, liver, and
skeletal muscle (25, 59, 86, 87) and is produced even at rest
despite a sufficient supply of oxygen to the tissue (7, 17, 34,
59). The lactate shuttle hypothesis (15) helped propel our
current understanding of lactate metabolism. The premise for
the cell-cell lactate shuttle (CCLS) is that lactate released from
one cell could serve as a precursor carbon source for either
oxidative phosphorylation or gluconeogenesis in other cells
throughout the body (13, 15). The majority of this theory has
been confirmed throughout the years (4, 8, 38, 56, 60, 87).
The observations of high cytosolic ratios of lactate to pyru-
vate in skeletal muscle, especially apparent during exercise,
along with the understanding that lactate can serve as a pre-
cursor for cellular respiration, led to the intracellular lactate
shuttle (ILS) hypothesis. This hypothesis has transformed over
the years from the initial speculation that lactate was trans-
ported into the mitochondrial matrix where it was subsequently
oxidized (16, 18) into its current position (36, 37). It is now
proposed that glycolytically produced lactate passively diffuses
across the mitochondrial outer membrane (MOM) into the
mitochondrial intermembrane space (MIS). An increase in
lactate concentrations in the MIS facilitates conversion back
into pyruvate catalyzed by an isoform of lactate dehydrogenase
(LDH) located in the mitochondria (mLDH). Pyruvate is then
shuttled across the mitochondrial inner membrane (MIM) into
the matrix via a mitochondrial monocarboxylate transporter
(mMCT), where it is oxidized (37), The MCTs most likely
involved are MCT1 (36, 37) and/or the high-affinity pyruvate
transporter MCT2, which has been reported to subsist in both
subsarcolemmal and intermyofibrillar mitochondrial popula-
tions (95).
The specifics of lactate metabolism within skeletal muscle
mitochondria are ardently debated (14, 18, 19, 31, 74, 75, 95).
Previous investigations into the functional assessment of mi-
tochondria-specific lactate oxidation have primarily utilized
isolated mitochondrial preparations (18, 73–75, 95), for which
mitochondria are extracted and purified by mechanical homog-
enization and differential centrifugation. Consequently, the
dispute regarding mitochondrial lactate oxidation consists of
challenging either the method used for mitochondrial isolation
or the success achieved in purity and completeness of the
mitochondrial isolations (14, 19, 74).
Mitochondria subsist in skeletal muscle as a reticular tubular
network as opposed to discrete organelles (45). Mitochondrial
isolation disrupts the native heterogeneous reticulum, produc-
ing somewhat artificially homogeneous spherical and discrete
organelles (71, 82). Such disruption carries the risk of 1) con-
taminating the mitochondrial fraction with proteins foreign to
the mitochondria (21, 71), 2) depleting contents specific to
mitochondria (14, 19, 71), and 3) altering mitochondrial func-
tion (51, 76, 80). Indeed, mitochondrial isolation has repeat-
edly been shown to affect mitochondrial respiratory function
(5, 48, 61, 67, 70, 90).
Unlike previous studies, here we test the ability of mito-
chondria to oxidize lactate by means of high-resolution respi-
rometry on preparations of human skeletal muscle biopsies.
With this technique, the sarcolemma is chemically permeabil-
ized, and soluble cytosolic proteins, including LDH, are lost
without affecting native mitochondrial structure, allowing ac-
cess to unaltered mitochondria for direct manipulation and
investigation of respiratory control (49, 51, 80). The primary
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aim of the current study is to challenge the hypothesis that
mitochondria can directly oxidize lactate. Assuming that a
lactate oxidation complex exists within skeletal muscle mito-
chondria (36), our hypothesis was that mitochondrial prepara-
tions of human skeletal muscle in situ would display the ability
for lactate to facilitate mitochondrial respiration independent of
any addition of exogenous LDH. Indeed, we demonstrate the
ability of unaltered, intact mitochondria to utilize lactate as a
substrate for respiration in human skeletal muscle. The addi-
tional titration of exogenous LDH fails to further stimulate
respiration. Our results provide evidence that demonstrate the
ability of human skeletal muscle mitochondria to utilize lactate
as a substrate.
Glossary
C1 Complex I (NADH dehydrogenase)
C2 Complex II (succinate dehydrogenase)
CCLS Cell-cell lactate shuttle
DTT Dithiothreitol
ILS Intracellular lactate shuttle
K-MES 2-(N-morpholino)ethanesulfonic acid hydrate
LDH Lactate dehydrogenase
LN Leak respiration in absence of adenylates
MIM MMitochondrial inner membrane
MiR05 Mitochondrial respiration medium
MiR06 MiR05  catalase
MIS Mitochondrial intermembrane space
mLDH Mitochondria-specific LDH
mMCT Mitochondrial-specific monocarboxylate transporters
MOM Mitochondrial outer membrane
NAD Nicotinamide adenine dinucleotide
PETF Fatty acid oxidative capacity
PC1 Submaximal respiratory state specific to complex I
PC2 Submaximal respiratory state specific to complex II
P Maximal state 3 respiration and oxidative phos-
phorylation capacity
ROX Residual oxygen consumption
SIRT Sirtuin
MATERIALS AND METHODS
Ethical Approval
Experimental protocols involving human subjects were approved
by the ethics committees for the Eidgenössische Technische Hoch-
schule in Zürich (EK 2011-N-51) and the Regional Ethics Committee
of Region Hovedstaden in Denmark (H-1-2011-052), in accordance
with the Declaration of Helsinki. Prior to the start of the experiments,
informed oral and written consent was obtained from all participants.
Experimental Design
Sixteen young and healthy subjects (14 male and 2 female) volun-
tarily participated in this study. For logistic reasons, the subjects were
divided into two groups of eight. The first eight subjects (group 1, 6
males and 2 females) and the second group of eight subjects (group 2,
8 males) had their skeletal muscle samples analyzed with separate
substrate titration protocols. These protocols are explained in detail
below.
Skeletal Muscle Sampling
Skeletal muscle biopsies were obtained from the vastus lateralis
muscle under local anesthesia (1% Lidocaine) of the skin and super-
ficial muscle fascia, using the Bergström technique (9) with a needle
modified for suction. The biopsy was immediately dissected free of fat
and connective tissue and divided into sections for measurements of
mitochondrial respiration.
Skeletal Muscle Preparation
The biopsy was sectioned into parts to measure mitochondrial
respiration. Each part was immediately placed in ice-cold biopsy
preservation solution (BIOPS) containing 2.77 mM CaK2EGTA buf-
fer, 7.23 mM K2EGTA buffer, 0.1 M free calcium, 20 mM imida-
zole, 20 mM taurine, 50 mM 2-(N-morpholino)ethanesulfonic acid
hydrate (K-MES), 0.5 mM dithiothreitol (DTT), 6.56 mM
MgCl2·6H2O, 5.77 mM ATP, and 15 mM phosphocreatine (pH 7.1).
Muscle samples were then gently dissected with the tips of two
18-gauge needles, achieving a high degree of fiber separation verified
microscopically, followed by chemical permeabilization via incuba-
tion in 2 ml of BIOPS with saponin (50 g/ml) for 30 min at 4°C (50).
Last, samples were washed with a mitochondrial respiration medium
(MiR05) containing 0.5 mM EGTA, 3 mM MgCl2·6H2O, 60 mM
K-lactobionate, 20 mM taurine, 10 mM KH2P04, 20 mM HEPES, 110
mM sucrose, and 1 g/l bovine serum albumin (pH 7.1) for 10 min at
4°C. Cytosolic components of the skeletal muscle sample are lost during
skeletal muscle preparation, including LDH (49, 53, 69, 78, 89).
Mitochondrial Respiration Measurements
Muscle bundles were blotted dry and measured for wet weight in a
balance-controlled scale (XS205 DualRange Analytical Balance; Met-
tler-Toledo, Switzerland) maintaining constant relative humidity, pro-
viding hydration consistency as well as stability of weight measure-
ments. Respiration measurements were performed in mitochondrial
respiration medium 06 (MiR06; MiR05  catalase 280 IU/ml).
Measurements of oxygen consumption were performed at 37°C using
the high-resolution Oxygraph-2k (Oroboros, Innsbruck, Austria) with
all additions in each protocol added in series. The Oxygraph-2k is a
two-chamber titration-injection respirometer with an oxygen detection
limit of 0.5 pmol·s1·ml1. Standardized instrumental calibrations
were performed to correct for back-diffusion of oxygen into the
chamber from the various components, leak from the exterior, oxygen
consumption by the chemical medium, and sensor oxygen consump-
tion. Oxygen flux was resolved by software allowing nonlinear
changes in the negative time derivative of the oxygen concentration
signal (DatLab; Oroboros, Innsbruck, Austria). All experiments were
carried out in a hyperoxygenated environment to prevent any potential
oxygen diffusion limitation. This technique of permeabilization al-
lows for the study of mitochondrial function in intact skeletal muscle
samples in situ without altering the natural mitochondrial reticulum in
small biopsy samples using high-resolution respirometry (41, 42, 51).
Respiratory Titration Protocols
Four different titration protocols were applied in the study, and they
are illustrated in Table 1. Each protocol was specific to the examina-
tion of individual aspects of lactate-stimulated respiratory control
through a sequence of coupling and substrate states induced via
separate titrations. All titrations were added in series as presented.
LDH/NAD Titration Protocol
Leak respiration in absence of adenylates (LN) was induced with
the addition of malate (2 mM) and octanoyl carnitine (0.2 mM). This
state represents the resting oxygen consumption of an unaltered and
intact electron transport system in the absence of adenylates. In the LN
state, the chemiosmotic gradient is at maximum, specific to the
substrates provided, and oxygen flux is at a minimum indicating
proton leak, slip, cation cycling, and overall dyscoupling (33, 69).
Fatty acid oxidative capacity and maximal electron transport through
electron transferring flavoprotein (ETF) was determined following the
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addition of ADP (PETF, 5 mM). Here, the transfer of electrons requires
the metabolism of CoA, hence the previous addition of malate, to
allow -oxidation to proceed. Following PETF, lactate (30 mM) was
added to the chamber to measure the oxidation of lactate. Next,
pyruvate (5 mM) was added. Pyruvate is a common substrate used to
stimulate electron flow through complex I (C1; NADH dehydroge-
nase) providing a submaximal state 3 respiratory state specific to C1
(PC1). Maximal state 3 respiration, oxidative phosphorylation capacity
(P), was induced with the addition of succinate (10 mM). Maximal
state 3 P represents respiration that is resultant to saturating concen-
trations of ADP as well as substrates specific for C1 and succinate
dehydrogenase, complex II (C2) and demonstrates an intact electron
transport system’s capacity to catalyze a sequential set of redox
reactions that are partially coupled to the production of ATP via ATP
synthase. Convergent electron input to C1 and C2 provides higher
respiratory values compared with the isolated respiration of either C1
(pyruvate/glutamate  malate) or C2 (succinate  rotenone) (33);
accordingly, it is more representative and physiologically relevant to
the study of mitochondrial function and necessary to establish con-
firmation of a complete and intact electron transport system (10). As
an additional internal control for damaged mitochondria, the integrity
of the outer mitochondrial membrane was assessed with the addition
of cytochrome c (10 M). Rotenone (0.5 M) and antimycin A (2.5
M) were finally added, in sequence, to terminate respiration by
inhibiting C1, achieving state 3 respiration through C2 (PC2), and
complex III (cytochrome bc1 complex), respectively. Inhibition of
respiration allows for the determination and correction of residual
oxygen consumption (ROX), indicative of nonmitochondrial oxygen
consumption in the chamber. The concentrations of substrates and
inhibitors used were based on prior experiments conducted for opti-
mization of the titration protocols.
NAD/LDH Titration Protocol. The only difference in the
NAD/LDH titration protocol was that NAD (2 mM) was titrated
into the respiration medium following the addition of lactate and
before the addition of pyruvate.
NAD/LDH Titration Protocol. The NAD/LDH titration pro-
tocol also titrated NAD (2 mM) following the addition of lactate.
However, LDH (3 IU/ml) was then added following stabilization of
NAD-stimulated respiration and prior to the titration of pyruvate. This
concentration of LDH, which has been previously used (75, 95), is
supraphysiological and not limited to lactate-stimulated respiration.
LDH/NAD Titration Protocol. Finally, the LDH/NAD titra-
tion protocol had LDH (3 IU/ml) titrated into the respiratory medium
following the addition of lactate followed by the addition of NAD (2
mM) before the addition of pyruvate.
Control for Sirtuin Influence on Mitochondrial Respiration
To address any question of whether respiration in the presence of
lactate is truly due to lactate or rather to an enhancement of fatty acid
metabolism or electron transport chain activity in response to the
NAD, we measured PEFT and mitochondrial lactate respiration in 18
separate human subjects from another study. As opposed to the
titration protocols detailed above in this study, we added NAD
(6 mM) prior to lactate (60 mM) in the titration protocol. We analyzed
respirometric values using a one-way ANOVA on repeated measure-
ments with a Bonferroni adjustment to specify location of differences
(SPSS Statistics 17.0; SPSS, Chicago, IL).
Enzyme Activities
LDH activities were assayed in homogenates of the skeletal muscle
samples used in respiration measurements: The contents of the Oxy-
graph-2k chambers (2 ml each) were removed after each respiration
experiment and washed once with 2 ml of MiR05. One percent Triton
X-100 and 2 l of a protease inhibitor cocktail (Sigma Aldrich cat.
539134) were added to the combined solutions (content and wash) and
then homogenized for 30 s with a T10 basic ULTRA-TURRAX
homogenizer near maximum speed. The homogenate was then cen-
trifuged for 15 min at 4°C, and the supernatant was removed, frozen
in liquid nitrogen, and stored at 80°C. LDH activity was measured
fluorometrically at 450 nm and 37°C according to the manufacturer
(LDH-Cytotoxicity Assay Kit, BioVision).
Data Analysis
For all statistical evaluations, a P value of 0.05 was considered
significant. Statistical analysis of changes to respiration within each
respective titration protocol was analyzed by one-way ANOVA on
repeated measurements (SPSS Statistics 17.0). Differences in percent
changes among respiratory states across all titration protocols and
LDH activities across samples were analyzed using a one-way
ANOVA. When appropriate, a Bonferroni adjustment was used to
specify location of differences.
RESULTS
Lactate Dehydrogenase
There was a significant difference in LDH between samples
that did not have exogenous LDH added from those samples
that did (Fig. 1, P  0.001). The LDH group showed trace
amounts of LDH (38.9  13.4 mU/mg wet wt), whereas the
LDH, as expected, presented with a concentration of LDH
indicative of the amount added to the mitochondrial medium
during respirometric analysis (2,850  687 mU/ml).
Respirometric Analysis
Differential respiratory capacities across the mitochondrial
respiratory system were made evident throughout each separate
titration protocol (Fig. 2, A–D).
LDH/NAD respirometric analysis. Respirometric analy-
sis of the skeletal muscle samples using the LDH/NAD
titration protocol is illustrated in Fig. 2A. Malate and octanoyl
carnitine induced leak respiration, LN. Respiration significantly
Table 1. Experimental design of respirometric analysis
M OC ADP Lac Pyr S CytC Rot AmA
LDH/NAD group 1 (n  8) 2 mM 0.2 mM 5 mM 30 mM X X 5 mM 10 mM 10 M 0.5 M 2.5 M
NAD/LDH/ group 2 (n  8) 2 mM 0.2 mM 5 mM 30 mM X NAD(2mM) 5 mM 10 mM 10 M 0.5 M 2.5 M
NAD/LDH group 2 (n  8) 2 mM 0.2 mM 5 mM 30 mM NAD(2mM) LDH(6IU/l) 5 mM 10 mM 10 M 0.5 M 2.5 M
LDH/NAD group 1 (n  8) 2 mM 0.2 mM 5 mM 30 mM LDH(6IU/l) NAD(2mM) 5 mM 10 mM 10 M 0.5 M 2.5 M
Four different titration protocols were used in this study. They are indicated in the furthest left column, from top to bottom: 1) LDH/NAD; 2) NAD/LDH;
3) NAD/LDH; 4) LDH/NAD. Below the protocol is the subject group for which skeletal muscle specimens were analyzed with that specific protocol.
Top: substrate or inhibitor added to the respiration medium. The sequence of the titrations into the chamber follows the order of substrates and inhibitors presented
from left to right. Concentration of substrate or inhibitor (columns) added during respirometric analysis is indicated in the box located in the respective protocol
of interest (row). M, malate; OC, octanoyl carnitine; ADP, adenosine diphosphate; Lac, lactate; NAD, nicotinamide adenine dinucleotide; LDH, lactate
dehydrogenase; Pyr, pyruvate; S, succinate; Cyt C, cytochrome c; Rot, rotenone; AmA, antimycin A.
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increased following the addition of ADP, demonstrating the
capacity for fatty acid oxidation, PETF (P  0.001). There was
no increase from fat respiration following the addition of
lactate (L). Respiration did, as expected, increase following
pyruvate addition (PC1, P  0.001) and again following the
titration of succinate (P 0.001), the latter of which represents
oxidative phosphorylation capacity, P. Finally, respiration di-
minished after inhibition of C1 with rotenone (PC2, P 0.001).
NAD/LDH respirometric analysis. Respirometric analy-
sis of the skeletal muscle samples using the NAD/LDH
protocol is illustrated in Fig. 2B. Malate and octanoyl carnitine
induced LN. Respiration significantly increased following the
addition of ADP signifying PETF (P 0.001). No increase was
evident following the addition of lactate (L; 30 mM). Respi-
ration did increase with the titration NAD (P  0.01). There
was another increase following the addition of pyruvate (PC1,
P  0.05). Respiration again increased with the addition of
succinate (P, P  0.001). Finally, respiration diminished after
inhibition of C1 with rotenone (PC2, P  0.001).
NAD/LDH respirometric analysis. Respirometric analy-
sis of the skeletal muscle samples using the NAD/LDH
protocol is illustrated in Fig. 2C. Malate and octanoyl carnitine
induced LN. Respiration significantly increased following the
addition of ADP signifying PETF (P 0.001). No increase was
evident following the addition of lactate (L; 30 mM). Respi-
ration did then increase with the titration NAD (P  0.001).
There was no further increase, however, with the addition of
LDH. Respiration showed a trend to increase with pyruvate
(PC1, P  0.062). Respiration did increase with the addition of
succinate (P  0.001). Finally, respiration diminished after
inhibition of C1 with rotenone (PC2, P  0.05).
LDH/NAD respirometric analysis. Respirometric analy-
sis of the skeletal muscle samples using the LDH/NAD
protocol is illustrated in Fig. 2D. Malate and octanoyl carnitine
induced LN. Respiration significantly increased following the
addition of ADP signifying PETF (P 0.001). No increase was
evident following the addition of lactate (L; 30 mM). Again,
there was no increase in respiration following the titration of
LDH. Respiration did then increase with the addition of NAD
(P  0.01). There was an increase following the addition of
pyruvate (PC1, P  0.01). Respiration again increased with the
addition of succinate (P, P  0.01). Finally, respiration dimin-
ished after inhibition of C1 with rotenone (PC2, P  0.01).
Test of Mitochondrial Membrane Integrity
Across all titration protocols, cytochrome c had no additive
effect on respiration. Respiration changed by0.4% (P 0.962),
3.1% (P 0.758),0.3% (P 0.971), and0.9% (P 0.846)
in groups LDH/NAD, NAD/LDH, NAD/LDH, or
LDH/NAD, respectively (Figs. 2, A–D). The negligible
changes in respiration from oxidative phosphorylation capacity, P,
to the exogenous cytochrome c-stimulated respiration confirmed
MOM intactness throughout all skeletal muscle samples.
Differences in Percent Changes Between Respiratory States
Across Groups
Table 2 displays specific percent changes in respiration rates
between different substrate-induced respiratory states across all
groups. Only two significant differences were calculated, and
both were between the NAD/LDH and LDH/NAD pro-
tocols. 1) There was a difference in percent change from lactate-
stimulated respiration and respirometric values obtained following
the titration of LDH (P  0.001); and 2) There was a difference
in percent change from the recorded LDH-stimulated respiration
and respirometric values obtained following the titration of pyru-
vate (P  0.001). The only difference between these two proto-
cols is the order in which LDH and NAD were titrated into the
respiratory chambers during analysis. As such, the former proto-
col, NAD/LDH, contained 2 mM NAD in the LDH-induced
respiratory state, whereas the latter protocol, LDH/NAD,
did not.
DISCUSSION
The current study was conducted to test whether human
skeletal muscle mitochondria can oxidize lactate. The results
1) confirm that lactate cannot be taken up directly by human
skeletal muscle mitochondria into the mitochondrial matrix and
oxidized; 2) suggest that lactate is converted to pyruvate within
the mitochondrial intermembrane space and that the pyruvate is
then taken into the mitochondrial matrix where it consequently
enters the TCA cycle and is ultimately oxidized; and 3) is
consistent with the existence of a functional lactate oxidation
complex in human skeletal muscle mitochondria. The novelty
of this study is the mitochondrial preparation and multiple
substrate titrations utilized to examine the mechanism by
which lactate is oxidized. In contrast to mitochondrial fractions
from isolated preparations, the mitochondrial preparation ap-
plied in the current study preserved both structural integrity
and functional interactions with cellular components (Figs. 2).
Lactate is undoubtedly a metabolic precursor for oxidative
phosphorylation in human skeletal muscle (3, 56, 59, 60, 62,
87) as well as other tissues such as the brain (88). Hitherto, the
primary disagreement in regard to the metabolism of lactate is
whether mitochondria, independently of cytosolic enzymes and
pathways, are capable of lactate metabolism and how, specif-
ically, lactate is used as a substrate for cellular respiration.
It was reported that, in mitochondrial preparations isolated
from rat hindlimb skeletal muscle, “malatelactate”-stimu-
lated respiration was similar to “malatepyruvate”-stimulated
respiration (18). Moreover, malatelactate-stimulated respira-
tion was greatly diminished when oxamate, a competitive
Fig. 1. Box-whisker plot representing lactate dehydrogenase (LDH) concen-
trations. Measurements of LDH activity (mU/mg wet wt) in permeabilized
samples (left y-axis) that never had exogenous LDH added to the respiratory
chamber and those that did have LDH activity (mU/ml) added to the respiro-
metric chamber (right y-axis). LDH activity between the 2 sets of samples was
significantly different (P  0.0001). Black dashed line represents average
skeletal muscle LDH activity (763 mU/mg wet wt) resported from active and
inactive males and females (20, 43).
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inhibitor of LDH (58), was included in the respirometric
analysis. The presence of LDH was reported in the intermem-
brane space, inner membrane, and matrix fractions of the
skeletal muscle (18). Mitochondria isolated from skeletal mus-
cle, however, are often so fraught with cytosolic LDH contam-
ination that the inclusion of an LDH inhibitor, such as oxamate,
is recommended to improve enzymatic analyses in mitochon-
drial preparations (21).
Several studies (73–75, 94, 95) across different laboratories
have reported evidence in opposition to these findings (18),
challenging the capacity for lactate oxidation in skeletal muscle
mitochondria. These studies (73–75, 94, 95) reported the in-
ability of various skeletal muscles across different species,
including humans, to directly oxidize lactate. These studies
were also unable to verify the presence of LDH in the mito-
chondrial fraction of skeletal muscle homogenates, further
challenging the existence of a lactate oxidation complex in
skeletal muscle mitochondria (74, 75, 95). All respirometric
measurements collected in these studies, however, were ob-
tained using isolated mitochondrial preparations. Accordingly,
Fig. 2. Mass-specific respirometric analysis. Titration protocols for skeletal muscle samples with all titrations, presented from left to right, added in series.
A: protocol without addition of LDH or NAD (LDH/NAD). B: protocol with NAD added but without LDH (NAD/LDH). C: protocol with NAD and LDH
both added to respiration medium in successive order (NAD/LDH). D: protocol with LDH and NAD both added to respiration medium in successive order
(LDH/NAD). LN, respiration in absence of adenylates; PETF, capacity for fatty acid oxidation; L, lactate; PCI, submaximal state 3 respiration through complex
I stimulated with pyruvate; P, maximal state 3 respiration minus oxidative phosphorylation capacity; Cyt C, cytochrome c; PC2, submaximal state 3 respiration
through complex II following addition of rotenone. Differential respiratory capacities across the mitochondrial respiratory system were made evident throughout
the titration protocol utilized, validating our mitochondrial preparation. Values are presented as means SD. *, **, and ***, difference in the specific respiration
state between groups; P  0.05, P  0.01, P  0.001, respectively.
Table 2. Percent changes in respiration across all groups
LN to FAT FAT to Lac Lac to NAD Lac to LDH NAD to Pyr NAD to LDH LDH to NAD LDH to Pyr Lac to Pyr
LDH/NAD group 1 (n  8) 307  71 2 4 69  14*
NAD/LDH group 2 (n  8) 233  69 2 6 75.2  28.1 29  18 126  52*
NAD/LDH group 2 (n  8) 182  87 1 9 60.7  20.9 62 19* 30  20 1 5 29 19* 108  34
LDH/NAD group 1 (n  8) 226  66 2 4 50.9  10.3 2 2* 35  14 41.7  17.2 90  20* 93  18
Values are presented as means  SD. Percent change from one substrate-induced respiratory state to another (columns) is presented across all titration
protocols (rows) used throughout the study. Respiration in absence of adenylates (LN), capacity for fatty acid oxidation (PETF), lactate (Lac), LDH, and pyruvate
(Pyr). *Significant difference in specific respiration state between groups, P  0.05.
E690 LACTATE OXIDATION IN HUMAN SKELETAL MUSCLE MITOCHONDRIA
AJP-Endocrinol Metab • doi:10.1152/ajpendo.00476.2012 • www.ajpendo.org
 at Universitaet Zuerich on M
ay 16, 2013
http://ajpendo.physiology.org/
D
ow
nloaded from
 
38
they have been theoretically rebutted due to the possibility of
mLDH depletion during the isolation procedure (14, 19).
Mitochondrial isolation techniques disrupt the native mito-
chondrial reticular networks in skeletal muscle, producing
unnaturally discrete and spherical organelles through unknown
and unregulated means (6, 71, 82). This is often associated
with an alteration to natural mitochondrial characteristics (14,
19, 21, 48, 61, 67, 70, 90) such as the loss of mitochondrial
membrane integrity (5, 93) and the ability to oxidize fatty acids
(67). Crude skeletal muscle homogenizations often result in
mitochondrial damage but are required for high fractional
yield. Maintaining integrity of mitochondrial membranes dur-
ing isolation using a more temperate homogenization comes at
the expense of a lower mitochondrial yield (52). Consequently,
the isolation procedure often limits mitochondrial yield, pre-
venting examination of the total mitochondrial population. As
such, conclusive deductions regarding mitochondrial utiliza-
tion of lactate through respirometric investigations using iso-
lated mitochondria are difficult to establish.
Eukaryotic cells represent an integrated multicompartmental
system, making it difficult to isolate and study mitochondrial
function in living cells. Mitochondrial structure and function
are intricately associated (76). Techniques using selective per-
meabilization in skeletal muscle samples, as applied in the
current study, allow direct access to skeletal muscle mitochon-
dria unaffected by the preparation and remain intact within
their natural cytoarchitectural environment (33, 51, 53, 69, 71,
77, 80). They also preserve subcellular interactions with the
nucleus, endoplasmic reticulum (51), and sarcoplasmic reticu-
lum (71, 89) in addition to the cytoskeleton (53, 61, 80).
Metabolic channeling and the intracellular transfer of energy
are dependent on these interactions (33, 44, 51, 80).
The current study used saponin treatment to permeabilize the
skeletal muscle samples. Saponin preferentially interacts with
membranes rich in cholesterol such as the sarcolemmal mem-
brane, which has a greater cholesterol concentration than both
the MOM and MIM (24, 47). This preferential perforation of
the sarcolemma initiates the loss of soluble cytosolic metabo-
lites, cofactors, enzymes, and coenzymes (49, 53, 78, 89),
allowing rapid equilibration with the respiration medium and
the ability to manipulate mitochondrial respiration (Fig. 2). The
samples in the current study showed LDH concentrations that
were 5% of previously reported LDH activities from the
vastus lateralis muscle in both males and females (20, 43),
which is similar to the volume density of mitochondria in
skeletal muscle (29, 40, 91). The presence of LDH within
mitochondria has repeatedly been demonstrated in different
tissues and cell types across several species (1, 2, 11, 12, 18,
22, 26–28, 37, 46, 54, 55, 57, 63, 65, 68, 83–85, 92), and there
is also evidence that LDH has a genetic tag for mitochondrial
allocation (39); yet opposing reports maintain skepticism as to
its mitochondrial subsistence (74, 75, 95). The most likely
explanation to this discrepancy is the location of LDH in the
mitochondria, which appears to reside in the MIS on the out-
side layer of the MIM (2, 37), making this soluble enzyme
easily lost with the disruption of mitochondrial membrane
integrity (68). Another possibility that cannot be fully dis-
counted is the tethering of LDH to the outside of the MOM,
opposed to within the MIS. The coprecipitation of LDH and
mitochondrial respiratory complex IV cytochrome c oxidase,
however, supports the existence of LDH to be within the MIS
(37). The results of the current study closely reflect those
presented from rat liver mitochondria that also identified the
location of mitochondrial LDH in the intermembrane space
(84). While we cannot definitively exclude the possibility that
lactate- and NAD-stimulated respiration was facilitated by
remnants of cytosolic LDH, our data, specifically the required
addition of NAD in combination with the negligible response
to exogenous LDH titration and successful control of mito-
chondrial membrane integrity, suggest a successful preparation
in which cytosolic LDH is routinely lost (49, 51, 80) and the
existence of LDH is within the MIS but not the matrix.
Despite the loss of cytosolic LDH concomitant to the per-
foration of the sarcolemma, the integrity of the mitochondrial
outer and inner membranes was confirmed, as exogenous
cytochrome c had no effect on respiration across all groups
(respiration LDH/NAD, NAD/LDH, NAD/LDH, and
LDH/NAD groups changed by 0.4%, 3.1%, 0.3%, and
0.9%, respectively; Fig. 2). Endogenous cytochrome c is lost
during skeletal muscle preparations that corrupt mitochondrial
membrane integrity. Titration of exogenous cytochrome c
confirms damage by stimulating respiration (51, 79). Accept-
able elevation in respiration following exogenous cytochrome
c that substantiates membrane integrity is typically between 5
and 15% (51). In addition to our control of mitochondrial
membrane integrity, we also show a functional capacity for
fatty acid oxidation, which can be altered with mitochondrial
isolation (67), as well as discernible responses in respiration to
all substrates and inhibitors alike (Fig. 2), all of which dem-
onstrate a complete, intact, and functional respiratory system.
The results presented in this study directly conflict with
those reported in a prior study using similar mitochondrial
preparation techniques. They reported the inability of rat skel-
etal muscle to directly oxidize lactate (72). These results were
later challenged with the suggestion that mLDH was lost
during skeletal muscle preparation (37). While the MOM is
rather permeable to molecules up to 4 kDa that lack a net
charge and strong dipoles (6, 23), it is impermeable to large
molecules, such as cytochrome c (5). Cytochrome c has a
molecular mass of 12 kDa, whereas LDH has a molecu-
lar mass of 140 kDa. The loss of mLDH is highly unlikely if
much smaller molecules, such as cytochrome c, are not lost
during mitochondrial preparation (Fig. 2). Unfortunately, Pon-
sot et al. (72) failed to confirm the integrity of the MOM.
A more likely explanation for the inability of rat skeletal
muscle to oxidize lactate in the study by Ponsot et al. (72) is the
loss of cytosolic reducing agents during the skeletal muscle
preparation. Assuming that a lactate oxidation complex exists
in skeletal muscle mitochondria as proposed (37), then the
presence of both lactate and NAD are necessary to facilitate
the conversion to pyruvate and NADH in the MIS via mLDH.
Small molecules in the MIS such as NAD equilibrate with
cytosolic concentrations and would be lost during skeletal
muscle preparation. We demonstrate that “lactate-stimulated”
respiration does increase above PEFT with the addition of
NAD (Fig. 2, B and C); however, lactate-stimulated respira-
tion was not sufficient to support PC1.
The failure of lactate to stimulate respiration independently
from exogenous titrations of NAD brought into question our
interpretation of the results. Certain mitochondrial proteins,
such as sirtuins (SIRT), are bioenergetic cellular sensors that
are dependent on NAD concentrations (64). Specifically,
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SIRT3, in skeletal muscle mitochondria (66), modifies func-
tional expression of mitochondrial proteins involved in -ox-
idation and electron transport by deacetylation (35, 81). Post-
translational modification of these enzymes via SIRT3 are
reported to alter mitochondrial fatty acid oxidation and oxida-
tive phosphorylation (64). However, we found no difference
(P  0.958) between PETF (with mean  SD of 20.4  3.5
pmol O2·min1·mg wet wt1) and respiration following NAD
(6 mM) titration into the respiration medium (20.1  3.0 pmol
O2·min1·mg wet wt1). In agreement with the current study’s
findings, we did observe an increase (P  0.001) when lactate
was then added into the respiration medium (46.5  9.5 pmol
O2·min1·mg wet wt1; data not shown).
In conclusion, we have demonstrated the ability of skeletal
muscle mitochondria to utilize lactate as a substrate for respi-
ration, which is consistent with the existence of a lactate
oxidation complex in human skeletal muscle mitochondria.
The data suggest that the mitochondrial utilization of lactate as
a substrate requires conversion of lactate to pyruvate prior to
entry into the mitochondrial matrix and that this conversion
occurs independently of cytosolic LDH. These findings were
obtained using a mitochondrial preparation that prevents mi-
tochondrial disruption and provides direct access to intact
mitochondria in their natural reticular network with functional
subcellular interactions. This allows for data interpretation to
be autonomous of possible contamination of nonmitochondrial
proteins or loss of mitochondrial-specific proteins.
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Fast-Twitch Glycolytic Skeletal Muscle Is Predisposed to 
Age-Induced Impairments in Mitochondrial Function
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The etiology of mammalian senescence is suggested to involve the progressive impairment of mitochondrial function; 
however, direct observations of age-induced alterations in actual respiratory chain function are lacking. Accordingly, 
we assessed mitochondrial function via high-resolution respirometry and mitochondrial protein expression in soleus, 
quadricep, and lateral gastrocnemius skeletal muscles, which represent type 1 slow-twitch oxidative muscle (soleus) and 
type 2 fast-twitch glycolytic muscle (quadricep and gastrocnemius), respectively, in young (10–12 weeks) and mature 
(74–76 weeks) mice. Electron transport through mitochondrial complexes I and III increases with age in quadricep and 
gastrocnemius, which is not observed in soleus. Mitochondrial coupling efficiency during respiration through complex 
I also deteriorates with age in gastrocnemius and shows a tendency (p = .085) to worsen in quadricep. These data dem-
onstrate actual alterations in electron transport function that occurs with age and are dependent on skeletal muscle type.
Key Words: Mitochondria—Respiratory chain—Function theory of aging.
Received October 2, 2012; Accepted December 19, 2012
Decision Editor: Rafael de Cabo, PhD
AN inherent flaw of the bioenergetic reliance on  aerobic metabolism to sustain life is the corollary 
oxidant production (1), and consequently mitochondria 
serve as the primary source of in vivo oxidant produc-
tion (2–5). Mitochondria-derived reactive oxygen species 
are largely accounted for by superoxide (O2−) production 
into the mitochondrial matrix at mitochondrial complex 
I  (CI) (6–8) and into both the matrix and mitochondrial 
intermembrane space at mitochondrial complex III (CIII) 
(9–14). The progression of reactive oxygen species pro-
duction beyond hormetic concentrations precipitates del-
eterious and indiscriminate oxidation of nucleic acids, 
proteins, and lipids (5,15,16). These pernicious effects 
then correspondingly impair mitochondrial function, 
which result in greater oxidant production, and so on 
leading to a “vicious cycle” and eminent cellular demise 
(4,15,17). The mitochondrial theory of aging asserts that 
the biological aging process is facilitated by this progres-
sive accrual of mitochondrial DNA (mtDNA) damage 
and reciprocal decline of mitochondrial function (18). 
Although evidence of increasing mtDNA alteration with 
age is supported by the literature, data suggestive of an 
impairment of mitochondrial function with aging are 
inconsistent.
Senescence corresponds with mounting indications of 
nuclear and mtDNA damage in both humans and animals 
(19–22). Moreover, mtDNA facilitated mutations lead to 
premature aging in mice (23) and humans (24). Transgenic 
studies show that reducing whole-body or tissue-specific 
mitochondrial superoxide dismutase, the enzyme that catal-
yses the dismutation of mitochondria-generated O2− to H2O2 
(25), increases evidence of oxidative damage and premature 
aging (26–28). Alternatively, overexpression of endogenous 
mitochondrial catalase lessens oxidant damage, reduces an 
overall burden of disease (29), and increases life span (30). 
Indications of impaired mitochondrial function extend-
ing beyond measures of oxidant production or damage are 
lacking. Whether there are age-induced alterations in actual 
electron transport function remain unanswered (4).
Reports of functional impairments to mitochondria with 
aging are seemingly paradoxical. Mitochondrial enzymatic 
expression, protein synthesis, volume density, and oxidative 
capacity have been reported to decrease with age in humans 
and animals quadricep (QUAD) skeletal muscle (19,31–37) 
as well as in a collection of lower limb skeletal muscle 
representative of mixed glycolytic and oxidative fibers 
(38–40). The age-induced loss of mitochondrial protein 
expression and oxidative capacity, however, fails to decrease 
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in skeletal muscle primarily composed of type 2 fast-twitch 
glycolytic fibers (41–43). Modifications of mitochondrial 
content also differ with aging between m. vastus lateralis 
and m. gastrocnemius in humans (44). These differences 
have led to speculation that mitochondrial impairment with 
aging may differ across different skeletal muscle types 
(19,45). In vivo metabolic imaging techniques have provided 
preliminary evidence to support this assumption with skeletal 
muscle primarily composed of fast-twitch fibers exhibiting 
the greatest age-induced impairments (46,47).
Accordingly, the aim of this study is to examine mito-
chondrial protein expression along with analysis of respira-
tory capacity and control via high-resolution respirometry. 
Respirometric analyses using isolated mitochondrial prep-
arations have been reported to exaggerate age-induced 
changes in mitochondrial function (48). Mitochondrial 
isolation techniques disturb native mitochondrial reticu-
lar networks in skeletal muscle (49) producing atypi-
cal and individual organelles through unregulated means 
(50–52). This alters innate mitochondrial characteristics 
(48,53–60) such as the loss of mitochondrial membrane 
integrity (61,62) and the ability to oxidize fatty acids (56). 
For respirometric analysis, we use saponin-permeabilized 
skeletal muscle preparations. This preparation allows for 
direct access to skeletal muscle mitochondria while main-
taining both the cytocellular ultrastructure (51,63–68) and 
subcellular interactions with mitochondria (51,53,64,67–
69). Cellular bioenergetics and metabolic channeling are 
predicated upon these factors (63,64,67,70). We have pre-
viously demonstrated that respirometric analysis using this 
in situ preparation in conjunction with biochemical assess-
ment of mitochondria is more appropriate when attempt-
ing to differentiate between isolated changes in enzymatic 
expression versus an alteration in the functional capacity 
of a subcellular system (71–74). Accordingly, this spe-
cific mitochondrial preparation serves as the best model 
to examine respiratory capacity and control with aging. 
Respirometric analyses were carried out on soleus (SOL), 
QUAD, and lateral gastrocnemius (GAST) skeletal mus-
cles, which represent type 1 slow-twitch oxidative muscle 
(SOL) and type 2 fast-twitch glycolytic muscle (QUAD and 
GAST), respectively, in young (10–12 weeks) and mature 
(74–76 weeks) mice. Taking into account the inconsistent 
reports of mitochondrial impairment with age across dif-
ferent skeletal muscles, we hypothesize that alterations in 
mitochondrial function with age vary across skeletal mus-
cle types, explaining the seemingly inconsistent past find-
ings on this topic.
Experimental Procedures
Ethical Approval
The experimental protocols using laboratory animals 
were approved by the Kantonales Veterinäramt Zürich 
(217/2010) and were performed in accordance with the 
Swiss animal protection laws and institutional guidelines.
Experimental Animals
A total of 24 male C57Bl/6 mice were used in the comple-
tion of this study, 12 young (10–12 week old) and 12 mature 
(74–76 week old) mice. All mice were housed in standard 
rodent cages (T3) with fixed temperature (21 ± 1°C), free 
access to food and water, and a 12-hour light–dark cycle. 
Animals were euthanized by means of carbon dioxide fol-
lowed by rapid excision of SOL, QUAD, and GAST. These 
muscles represent a type 1 slow-twitch oxidative muscle 
(SOL) and a type 2 fast-twitch glycolytic muscle (QUAD 
and GAST), respectively. The skeletal muscles from one leg 
were quickly excised and placed in ice-cold biopsy solu-
tion for immediate respirometric analyses. The correspond-
ing skeletal muscles from the opposite hind limb were then 
removed, frozen in liquid nitrogen, and stored at −80°C until 
processed for protein expression analysis (see Muscle Lysate 
Preparation, and Sodium Dodecyl Sulfate–Polyacrylamide 
Gel Electrophoresis and Western Blotting sections).
Muscle Lysate Preparation
The muscle samples were homogenized (Qiagen 
TissueLyser II, Retsch, Haan, Germany) in a fresh batch of 
buffer containing the following (in millimolar): 10% glycerol, 
20 sodium-pyrophosphate, 150 NaCl, 50 4-(2-hydroxyethyl)
piperazine-1-ethanesulfonic acid (HEPES) (pH 7.5), 1% 
NP-40, 20 β-glycerophosphate, 2 Na3VO4, 10 NaF, 2 phe-
nylmethanesulfonyl fluoride, 1 ethylenediaminetetraacetic 
acid (pH 8.0), 1 ethylene glycol-bis(2-aminoethylether)-
N,N,N′,N′-tetraacetic acid (EGTA) (pH 8.0), 10 µg/mL apro-
tinin, 10  µg/mL leupeptin, and 3 benzamidine. Afterward 
samples were rotated end over end for 1 hour at 4°C and cen-
trifuged at 16,500g for 30 minutes at 4°C, and the supernatant 
(lysate) was used for further analysis. Total protein concen-
tration in each sample was determined by a bovine serum 
albumin standard kit (Pierce, Rockford, IL), and all samples 
were diluted to the same protein concentration in ddH2O and 
a modified 6× Laemmli buffer (7 mL 0.5 M Tris base [pH 
6.8], 3 mL glycerol, 0.93 g dithiothreitol, 1 g sodium dodecyl 
sulfate, and 1.2 mg bromophenol blue).
Sodium Dodecyl Sulfate–Polyacrylamide Gel 
Electrophoresis and Western Blotting
Methods have been previously described in detail (75–
77). Equal amounts (10 µg) of total muscle lysate proteins, 
determined during optimization of the different antibodies, 
were loaded in each well. Samples were loaded together with 
protein markers (Precision Plus All Blue and Dual Color, 
Bio-Rad Laboratories, Hercules, CA) on precasted gels 
(Bio-Rad Laboratories). Proteins were separated by sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis and 
 by guest on January 31, 2013
http://biom
edgerontology.oxfordjournals.org/
D
ow
nloaded from
 
44
 SKELETAL MUSCLE MITOCHONDRIAL FUNCTION WITH AGING Page 3 of 13
semidry transferred to a polyvinylidene fluoride membrane 
(Millipore). The membranes were blocked in either 
2% skimmed milk or 3% bovine serum albumin in Tris-
buffered saline, including 0.1% Tween 20 before an 
overnight incubation in primary antibody at 4°C. Thereafter, 
membranes were washed in Tris-buffered saline, including 
0.1% Tween 20 and incubated for 1 hour at room temperature 
in horseradish peroxidase-conjugated secondary antibody. 
Membranes were then washed 3  × 15 minutes in Tris-
buffered saline, including 0.1% Tween 20 before the bands 
were visualized with ECL (Millipore) and recorded with a 
digital camera (ChemiDoc MP Imaging System, Bio-Rad). 
Quantification of the Western blot band intensity was done 
using the Image Lab software programme (Bio-Rad) and 
determined as the total band intensity minus the background 
intensity. Primary antibodies were optimized by use of 
mouse muscle lysates to secure that the protein amount 
loaded would result in band signal intensities localized on 
the steep and linearly part of a standard curve. To determine 
changes in total protein expression, the following antibodies 
were used with the localization of the quantified signal 
noted: 3-hydroxyacyl coenzyme a dehydrogenase (HAD): 
83 kDa, polyclonal ab54477 (Abcam, UK); Mitochondrial 
Complex IV subunit 4, COXIV, (CIV): 16 kDa, monoclonal 
sc-58348 (Santa Cruz Biotechnology, Santa Cruz, CA); 
and Mitochondrial Complex I  subunit NDUFB8 (CI): 
20 kDa (monoclonal ab110242), Mitochondrial Complex II, 
Succinate Dehydrogenase complex subunit B (CII): 30 kDa 
(monoclonal ab14714), Mitochondrial Complex III subunit 
Core 2 (CIII): 45 kDa (monoclonal ab14745), Mitochondrial 
Complex V ATP Synthase subunit alpha (CV): 55 kDa 
(monoclonal ab14748) all four included in the MitoProfile 
Total OXPHOS Human WB Antibody Cocktail (ab110411, 
Abcam). The secondary antibodies used were horseradish 
peroxidase-conjugated goat anti-mouse and goat anti-rabbit 
(P-0447 and P-0448, DAKO, Denmark). All samples from 
the same muscle type were loaded on the same gel with 
young and mature muscles mixed. Signal intensity from 
each muscle sample was normalized to the mean signal 
intensity of the human standard.
Skeletal Muscle Preparation
Each part was immediately placed in ice-cold biopsy 
preservation solution containing 2.77 mM CaK2EGTA 
buffer, 7.23 mM K2EGTA buffer, 0.1  µM free calcium, 
20 mM imidazole, 20 mM taurine, 50 mM 2-(N-morpholino)
ethanesulfonic acid hydrate (K-MES), 0.5 mM dithiothreitol, 
6.56 mM MgCl2•6H2O, 5.77 mM ATP, and 15 mM phospho-
creatine (pH 7.1). Muscle samples were then gently dissected 
with a pair of fine-tipped forceps achieving a high degree of 
fiber separation verified microscopically. Chemical permea-
bilization followed via incubation in 2 mL of biopsy pres-
ervation solution with saponin (50 μg/mL) for 30 minutes 
in 4°C. Last, samples were washed with a mitochondrial 
respiration medium (MiR05) containing 0.5 mM EGTA, 
3 mM MgCl2•6H2O, 60 mM K-lactobionate, 20 mM taurine, 
10 mM KH2PO4, 20 mM HEPES, 110 mM sucrose, and 1 g/L 
bovine serum albumin (pH 7.1) for 10 minutes at 4°C.
Mitochondrial Respiration Measurements
Muscle bundles were blotted dry and measured for wet 
weight in a balance-controlled scale (XS205 DualRange 
Analytical Balance, Mettler-Toledo AG, Switzerland) main-
taining constant relative humidity, providing hydration 
consistency as well as stability of weight measurements. 
Respiration measurements were performed in mitochondrial 
respiration medium 06 (MiR06; MiR05 + catalase 280 IU/
mL). Measurements of oxygen consumption were performed 
at 37°C using the high-resolution Oxygraph-2k (Oroboros, 
Innsbruck, Austria) with all additions in each substrate, 
uncoupler, and inhibitor titration protocol added in series. 
Standardized instrumental calibrations were performed to 
correct for back diffusion of oxygen into the chamber from 
the various components, leak from the exterior, oxygen 
consumption by the chemical medium, and sensor oxygen 
consumption. Oxygen flux was resolved by software allow-
ing nonlinear changes in the negative time derivative of the 
oxygen concentration signal (Oxygraph-2k, Oroboros). All 
experiments were carried out in a hyperoxygenated environ-
ment to prevent any potential oxygen diffusion limitation.
Respiratory Titration Protocols
Each titration protocol was specific to the examination of 
individual aspects of respiratory control through a sequence 
of coupling and substrate states induced via separate titra-
tions, which were added in series as presented. The concen-
trations of substrates, uncouplers, and inhibitors used were 
based on prior experiments conducted for optimization of 
the titration protocols (71–73). A  description of all three 
protocols is given in Table 1.
Table 1. Respirometric Titration Protocols
1 M: 2 mM OC: 0.2 mM ADP: 5 mM G: 10 mM S: 10 mM Cyt C: 10 μM FCCP: 1.5–3 µM Rot: 0.5 μM AmA: 2.5 μM
2 M: 2 mM P: 5 mM ADP: 5 mM Cyt C: 10 μM FCCP: 1.5–3 µM Rot: 0.5 μM AmA: 2.5 μM — —
3 Rot: 0.5 μM S: 10 mM ADP: 5 mM Cyt C: 10 μM FCCP: 1.5–3 µM AmA: 2.5 μM — — —
Notes: The three different titration protocols utilized in this study. Each row presents the substrate, uncoupler, or inhibitor and concentration titrated into the 
respiration medium, with all additions occurring sequentially as presented from left to right. ADP = adenosine diphosphate; AmA = antimycin A; Cyt C = cytochrome 
c; FCCP = carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone; G = glutamate; M = malate; OC = octanoyl carnitine; Rot = rotenone; S = succinate.
 by guest on January 31, 2013
http://biom
edgerontology.oxfordjournals.org/
D
ow
nloaded from
 
45
Page 4 of 13 JACOBS ET AL.
Titration protocol 1
 • Leak respiration in absence of adenylates (LN) was 
induced with the addition of malate (2 mM) and octanoyl 
carnitine (0.2 mM). The LN state represents the resting 
oxygen consumption of an unaltered and intact electron 
transport system (ETS) free of adenylates.
 • Maximal electron flow through electron-transferring 
flavoprotein (ETF) and fatty acid oxidative capacity, 
PETF, were both determined following the addition of 
ADP (5 mM). In the PETF state, the ETF-linked transfer of 
electrons requires the metabolism of acetyl-CoA, hence 
the addition of malate, in order to facilitate convergent 
electron flow into the Q-junction from both CI and 
ETF allowing β-oxidation to proceed. The contribution 
of electron flow through CI is far below capacity and 
so here the rate-limiting metabolic branch is electron 
transport through ETF such that malate + octanoyl 
carnitine + ADP-stimulated respiration is representative 
of, rather than specific to, electron capacity through ETF 
(71,78,79).
 • Submaximal state 3 respiratory capacity specific to CI, 
PCI, was induced following the additions of glutamate 
(10 mM).
 • Maximal state 3 respiration, oxidative phosphorylation 
capacity, P, was then induced with the addition of suc-
cinate (10 mM). P demonstrates a naturally intact ETS’s 
capacity to catalyze a sequential set of redox reactions 
that are partially coupled to the production of ATP via 
ATP Synthase. P maintains an electrochemical gradient 
across the inner mitochondrial membrane dictated by 
the degree of coupling to the phosphorylation system 
(63,65). This maximal state 3 state represents respira-
tion that is resultant to saturating concentrations of ADP 
and substrate supply for both CI and succinate dehydro-
genase, CII. Convergent electron input to CI and CII 
provides higher respiratory values compared with the 
isolated respiration of either CI (pyruvate and/or gluta-
mate + malate or glutamate + malate) or CII (succinate + 
rotenone) (63, 80). Consequently, P presents more phys-
iological relevance to the study of mitochondrial func-
tion (81) and is necessary to establish confirmation of a 
complete and intact ETS.
 • As an internal control for compromised integrity of 
the mitochondrial preparation, the mitochondrial outer 
membrane was assessed with the addition of cytochrome 
c (10 μM). If respiration significantly increased follow-
ing titration of cytochrome c, then the measurement 
was removed and not included in statistical analysis. 
There was no indication of mitochondrial damage in the 
measurements included in the study as demonstrated by 
the average 3.5%, 2.9%, 7.5%, 5.3%, 6.3%, and 2.3% 
change in young and mature QUAD, SOL, and GAST 
respiration, respectively. All were either below or within 
the accepted 5%–15% elevation in respiration following 
exogenous cytochrome c titration, successfully verifying 
the integrity of the outer mitochondrial membrane (64).
 • Phosphorylative restraint of electron transport was 
assessed by uncoupling ATP Synthase, CV from the ETS 
with the titration of the proton ionophore, and carbonyl 
cyanide p-(trifluoromethoxy) phenylhydrazone (0.5 μM 
per addition up to optimum concentrations ranging from 
1.5 to 3 µM) reaching ETS capacity. The inner mitochon-
drial membrane potential is completely collapsed with 
an open transmembrane proton circuit in the ETS res-
piratory state. The uninhibited flow of electrons through 
the respiratory system can, therefore, indirectly serve 
as an indication of maximal mitochondrial membrane 
potential.
 • Finally, rotenone (0.5  µM) and antimycin A  (2.5 μM) 
were added, in sequence, to terminate respiration by 
inhibiting CI and CIII, respectively. With CI inhibited, 
electron flow is specific to CII, providing submaximal 
state 3 respiration through CII (PCII).
•	 Inhibition of respiration with antimycin A  then allows 
for the determination and correction of residual oxygen 
consumption, indicative of nonmitochondrial oxygen 
consumption in the chamber.
Titration protocol 2.—This titration protocol was nec-
essary for determination of coupling control of electrons 
through CI.
 • LN–malate (2 mM) and pyruvate (5 mM).
 • PCI–ADP (5 mM).
 • Internal control for mitochondrial outer membrane 
integrity–cytochrome c (10  μM). There was no indi-
cation of mitochondrial damage in the measurements 
included in the study as demonstrated by the 0.3%, 
1.3%, 0.1%, −0.3%, 4.3%, and −0.1% change in mouse 
young and mature QUAD, SOL, and GAST respiration, 
respectively.
 • ETS–carbonyl cyanide p-(trifluoromethoxy) phenylhy-
drazone (0.5 μM per addition up to optimum concentra-
tions ranging from 1.5 to 3 µM).
 • CI inhibition–rotenone (0.5 µM).
•	 Residual oxygen consumption–antimycin A (2.5 μM).
Titration protocol 3.—This titration protocol was nec-
essary for determination of coupling control of electrons 
through CII.
 • CI inhibition–rotenone (0.5 µM).
 • LN–succinate (10 mM).
 • PCII–ADP (5 mM).
 • Internal control for mitochondrial outer membrane integ-
rity–cytochrome c (10 μM). There was no indication of 
mitochondrial damage in the measurements included 
in the study as demonstrated by the 7.3%, 2.6%, 9.8%, 
13.4%, 5.1%, and 7.3% change in mouse young and 
mature QUAD, SOL, and GAST respiration, respectively.
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 • ETS–carbonyl cyanide p-(trifluoromethoxy) phenylhy-
drazone (0.5 μM per addition up to optimum concentra-
tions ranging from 1.5 to 3 µM).
•	 Residual oxygen consumption–antimycin A (2.5 μM).
Respirometric values representing PCI and PCII did not differ 
across titration protocols. Consequently all PCI and PCII val-
ues achieved with the titration protocols for 2 and 3, respec-
tively, were grouped with complementing respiratory state 
from titration protocol 1.
Data Analysis
All mass-specific respirometric values were controlled 
to account for the differences in mitochondrial content, as 
indicated by CII protein expression, across age and fiber 
types. In doing so, all CII protein expression data were 
adjusted to a value of 1. The degree by which the protein 
expression had to be adjusted to equal 1 was then applied to 
all mass-specific respirometric values corresponding with 
the appropriate age and skeletal muscle type, respectively. 
Values of PCI controlling for CI protein expression, PETF 
controlling for HAD protein expression, and P controlling 
for CIII protein expression all were also adjusted using the 
same method.
For all statistical evaluations, a p value of less than .05 was 
considered significant. Differences in respiratory capacities 
and protein expression with age and across skeletal muscle 
groups were initially compared using a two-way analysis 
of variance. When an analysis of variance was significant, 
differences in respiratory capacities and protein expression 
with age and across skeletal muscle groups were evaluated 
using pairwise comparisons with a Bonferroni adjustment 
(SPSS Statistics 17.0, SPSS, Inc., Chicago, IL). Indices of 
mitochondrial efficiency did not express a Gaussian distri-
bution and therefore a Kruskal–Wallis analysis of variance 
and the U-Mann Whitney tests were used to reveal differ-
ences between younger and older muscle as well as com-
parisons across muscle groups within the respective age 
groups.
Results
Skeletal Muscle Protein Expression
As shown in Figure 1, protein expression for all mito-
chondrial enzymes was greatest in the slow-twitch SOL 
muscle. In young animals only the expression of CII and 
CIV differed between QUAD and GAST, both of which 
were lost with age. Only SOL expressed a change in mito-
chondrial protein content with age as CI, CII, and CV all 
increased (Figure 1A, B, and E, respectively). Though no 
significant changes in protein expression of CIII (Figure 1C) 
or CIV (Figure 1D) were apparent, both complexes showed 
a tendency to diminish with age in GAST (p  =  .060 and 
.063, respectively). Collectively, this analysis illustrates 
that the protein content for enzymes involved in mitochon-
drial oxidative phosphorylation is largely unaffected in pri-
marily fast-twitch glycolytic muscle (QUAD and GAST) 
but slightly increased in primarily slow-twitch oxidative 
muscle (SOL) with age.
Mitochondrial Respiration
Main effects of age on mass-specific respiration (pmol 
O2/min/mg ww) were observed for PETF (p = .011) and PCII 
(p = .008). This was reflected by the higher PETF and PCII in 
mature QUAD (p = .031 and .037, respectively; Figure 2E) 
and GAST (p  =  .011 and .016, respectively; Figure  2I) 
versus their younger counterparts. There was also a main 
effect of muscle type on mass-specific respiration as SOL 
has greater respiration across all states compared with both 
QUAD and GAST (p < .001; Figure 2A).
Mass-specific respiration does not take into account 
differences in mitochondrial content between samples 
(Figure  1). Accordingly, all respirometric analyses were 
adjusted for CII protein content, a biomarker shown to 
express the best concordance with mitochondrial content 
and total cristae area as measured by transmission elec-
tron microscopy as well as myocellular respiratory capac-
ity over protein concentrations for all other mitochondrial 
complexes (82). When controlling respiration to mitochon-
drial content, the main effect of age on respiration capacity 
(pmol O2/min/CII) appeared to be silenced by the divergent 
fluctuations in mitochondrial function across skeletal mus-
cle types in response to age. Respiratory states representing 
PCI, P, and ETS in QUAD and PCI, P, ETS, and PCII in SOL 
all lost respiratory capacity in response to age (Figure 2F 
and H). Conversely, GAST increased respiratory capacity 
at every respiratory state measured (Figure 2J) in response 
to age. The differences in respiratory capacity when con-
trolling for mitochondrial content across skeletal muscle 
in younger and older mice are shown in Figure 2B and D, 
respectively.
Respiratory Capacity and Coupling Control Specific to 
Mitochondrial Complexes I and III
Electron transport and control specifically through CI 
and CIII are of particular interest as reactive oxygen spe-
cies production at each respective complex accounts for the 
majority of mitochondria-specific oxidant production (9–
14). In order to isolate analysis to these specific complexes, 
all PCI values, including respirometric values from both 
titration protocols 1 and 2, and maximal state 3 respiromet-
ric values, P, were adjusted to account for the differences in 
CI and CIII protein expression, respectively, with age and 
across muscle groups (Figure 1A and C).
There were main effects of age (p = .001) on PC1 respira-
tion when controlling for CI expression (pmol O2/min/CI), 
which increased with age in both QUAD and GAST (p < 
.001) and decreased in SOL (p = .003; Figure 3A–C). The 
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coupling efficiency during PCI respiration deteriorated with 
age in GAST (p = .043) and showed a tendency to diminish 
in QUAD as well (p = .085; Table 2). Though no differences 
in respiratory capacity were observed across all young mus-
cle groups during PCI when controlling for CI, the coupling 
control was superior in young QUAD and GAST over SOL 
(p = .021 and .009, respectively). In the older muscle both 
QUAD and GAST presented with higher PCI than SOL 
(p < .001) and both, again, expressed a tighter coupling effi-
ciency than SOL (p = .004 and p < .001).
There were also main effects of age (p  =  .009) on 
maximal state 3 respiration and oxidative phosphorylation 
capacity, P, when controlling for CIII protein expression 
(pmol O2/min/CIII) (Figure 4A–C). Respiration capacity in 
both QUAD and GAST increased with age (p =  .009 and 
.001, respectively), whereas SOL did not change (p = .144). 
A B
C D
E F
Figure 1. Protein expression of mitochondrial complexes and proteins with age. Skeletal muscle protein expression determined in young (10–12 weeks) and 
mature (74–76 weeks) C57Bl/6 mice. Protein expression for (A) CI, mitochondrial complex I or NADH dehydrogenase; (B) CII, mitochondrial complex II or 
succinate dehydrogenase; (C) CIII, mitochondrial complex III or cytochrome bc1 complex; (D) CIV, mitochondrial complex IV or cytochrome c oxidase; (E) CV, 
mitochondrial complex V or ATP Synthase; and (F) HAD, 3-hydroxyacyl coenzyme a dehydrogenase, is illustrated in response to age and across skeletal muscles. 
Example blots for one analysis from one animal are shown above the graph. Values are means ± SD. In figure, a indicates significant difference in age within a skeletal 
muscle, p < .05; b shows significant difference between soleus (black) from both quadricep (grey) and lateral gastrocnemius (white) within the same age, p < .05; and 
c indicates differences between quadricep and gastrocnemius within the same age, p < .05.
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Figure 2. Skeletal muscle respirometric analysis. Mass-specific respiration across muscle groups in (A) young and (C) mature animals. Mass-specific respiration 
with age in mouse (E) quadricep, (G) soleus, and (I) gastrocnemius skeletal muscles. Mitochondrial-specific respiration controlling for mitochondrial content, as 
assessed by mitochondrial complex II protein expression (82), across skeletal muscles in (B) young and (D) mature animals. Mitochondrial-specific respiration with 
age in mouse (F) quadricep, (H) soleus, and (J) gastrocnemius skeletal muscles. LN, leak respiration without adenylates; PEFT, maximal fatty acid oxidation; PCI, sub-
maximal state 3 respiration through mitochondrial complex I (CI); P, maximal state 3 respiration–oxidative phosphorylation capacity; Cyt C, cytochrome c, internal 
test of mitochondrial membrane integrity; ETS, electron transport system capacity; and PCII, submaximal state 3 respiration through mitochondrial complex II (CII). 
Data presented as mean ± SD. *, **, and *** indicate significant difference of p ≤ .05, p ≤ .01, and p ≤ .001, respectively.
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Differences across young muscle groups were evident 
between both QUAD and SOL versus GAST (p = .023 and 
.001, respectively) and across mature muscle groups with 
QUAD greater than SOL (p = .020).
Respiratory Capacity and Control Specific to 
β-Oxidation
Only values of fatty acid oxidative capacity, PETF, were 
adjusted to account for the differences in HAD protein 
expression (Figure 1D). PETF (pmol O2/min/HAD) increased 
with age in QUAD (p  =  .004) and showed a tendency to 
increase in GAST (p = .065) (Figure 5). Differences across 
young and mature muscle groups were evident with both 
QUAD and GAST far below SOL (p < .001). Though PETF, 
when controlling for HAD, did not change in SOL (Figure 5), 
the coupling efficiency during β-oxidation diminished with 
age (Table 2). Despite this decrease with age, the coupling 
control of electron transport during β-oxidation in SOL was 
significantly better than younger and older QUAD (p = .01 
and .05, respectively). Coupling control during fat oxida-
tion did not change with age in QUAD or GAST, though it 
did differ between young SOL and GAST (p =  .05). This 
difference was lost with age (Table 2).
Discussion
The aim of this study was to analyze the effect of bio-
logical aging on respiratory capacities and mitochondrial 
coupling control across different skeletal muscle types as 
a function of age. Our main findings are (i) mitochondrial 
function is dependent on skeletal muscle type, irrespec-
tive of age; (ii) submaximal state 3 respiration specific to 
CI, PCI, increased in both QUAD and GAST but decreased 
in SOL when controlling for complex I  protein expres-
sion; (iii) coupling control during PCI was also lost with 
age in GAST and indicated a tendency for deterioration 
in QUAD but remained unchanged in SOL; (iv) maximal 
state 3 respiration and oxidative phosphorylation capacity, 
P, increased with age in QUAD and GAST but not SOL 
when controlling for CIII protein expression; and finally 
(v) although the capacity for fat respiration increased 
with age in QUAD when controlling for differences in 
HAD protein expression across skeletal muscle types, the 
Figure 3. Respiratory capacity and control through mitochondrial complex 
I (CI). Submaximal state 3 respiratory capacity specific to CI (PCI) when con-
trolling for CI protein expression with age in (A) quadricep, (B) soleus, and (C) 
gastrocnemius skeletal muscles. *, **, and *** indicate significant difference of 
age, p ≤ .05, p ≤ .01, and p ≤ .001, respectively.
Table 2. Mitochondrial Coupling Efficiency With Age
Young QUAD Mature QUAD Young SOL Mature SOL Young GAST Mature GAST
LCRETF 0.54 ± 0.16† 0.53 ± 0.18† 0.33 ± 0.09*,†,‡ 0.41 ± 0.05*,† 0.57 ± 0.29‡ 0.52 ± 0.10
LCRCI 0.15 ± 0.03†,§ 0.20 ± 0.07†,§ 0.24 ± 0.11†,‡ 0.29 ± 0.06†,‡ 0.12 ± 0.06*,‡ 0.17 ± 0.03*,‡
LCRCII 0.69 ± 0.13 0.76 ± 0.07 0.54 ± 0.25 0.72 ± 0.11 0.68 ± 0.19 0.66 ± 0.11
Notes: Leak control ratios (LCR) as indices of mitochondrial coupling and respiratory control across different skeletal muscles with age. GAST = gastrocnemius; 
LCRETF = coupling efficiency of electron transfer through electron-transferring flavoprotein (ETF) during β-oxidation; PCI = coupling efficiency of electron transfer 
during respiration through mitochondrial complex I (CI); PCII = coupling efficiency of electron transfer during respiration through mitochondrial complex II (CII); 
QUAD = quadriceps; SOL = soleus.
*,†,‡Effect of age, difference between QUAD vs SOL, and difference in SOL vs GAST, respectively, with p < .05.
§Difference with age, p = .085. Data are presented as mean ± SD.
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coupling control during fat oxidation worsened with age 
only in SOL.
Variations in Mitochondrial Function Across 
Fiber Types
There is some dispute on whether differences in 
respiratory capacity fluctuate across different skeletal 
muscle types that vary in their biochemical makeup, tailoring 
oxidative function to specific metabolic demand (83). Initial 
reports suggested that respiratory differences could be 
accounted for simply by the differences in mitochondrial 
content (50,84). This has since been refuted as various 
skeletal muscles have been shown to express respiratory 
differences across muscle types (46,47,85,86). We recently 
substantiated these differences in mitochondrial function 
across muscle types as respiration capacities in both GAST 
and QUAD were greater than those in SOL at PCI, PCII, P, 
and ETS respiratory states when normalizing mass-specific 
respiration to citrate synthase activity (87). Although it 
seems evident that differences in function exist across 
different skeletal muscle fiber types, even when controlling 
for the disproportionate expression of mitochondria, the data 
Figure 4. Respiratory capacity and control through mitochondrial complex 
III (CIII). Maximal state 3 respiration and oxidative phosphorylation capacity 
(P) when controlling for CIII protein expression with age in (A) quadricep, (B) 
soleus, and (C) gastrocnemius skeletal muscles. *, **, and *** indicate signifi-
cant difference of age, p ≤ .05, p ≤ .01, and p ≤ .001, respectively.
Figure 5. Respiratory capacity and control through electron transferring fla-
voprotein (ETF) during maximal fat respiration. Submaximal state 3 respiratory 
capacity specific to the capacity for fat oxidation and electron transfer through 
ETF (PETF) when controlling for 3-hydroxyacyl coenzyme a dehydrogenase 
(HAD) protein expression with age in (A) quadricep, (B) soleus, and (C) gas-
trocnemius skeletal muscles. *, **, and *** indicate significant difference of 
age, p ≤ .05, p ≤ .01, and p ≤ .001, respectively. # indicates a tendency of a dif-
ference with age, p = .065.
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presented here demonstrate how important normalization of 
the mass-specific respirometric values can be to overall data 
interpretation.
Our findings specific to mitochondrial protein expres-
sion are contrary to studies suggestive of a progressive loss 
of mitochondria with age (34,48). We cannot exclude the 
possibility that some mitochondrial protein/fragments may 
have been lost as a result of our homogenization and cen-
trifugation procedures. Thus, we cannot confirm that our 
mitochondrial protein determination is representative of 
the total per volume of muscle mass, possibly explaining 
the differences between studies. Alternatively, however, 
our results are in accordance with several studies report-
ing negligible to minor changes in mitochondrial protein 
expression with age, including an increase of expression 
that is dependent on skeletal muscle type (32,33,45,88). 
There is also evidence in mice of increased skeletal muscle 
mitochondrial protein synthesis with advancing age (88). 
Although it is unlikely that the preferential loss of mito-
chondrial protein during homogenization and centrifuga-
tion procedures biased our results, we cannot definitively 
exclude this possibility.
Skeletal Muscle Mitochondrial Respiratory Capacity 
and Control Across Skeletal Muscle Types With Age
Mitochondrial respiratory capacities across several dif-
ferent states diminished with age in QUAD and SOL 
(Figure  2F and H). These results coincide with previous 
reports where oxidative capacity is reported to decline 
with age in either QUAD or mixed muscle homogenates 
(19,31,33,35,36,38,39). Alternatively, mitochondrial res-
piratory capacities across all states increased with age in 
GAST (Figure  2J). The increase in respiratory capacity 
with age in GAST also corresponds with previous work 
that demonstrated a greater reliance with age of oxidative 
phosphorylation for ATP synthesis in primarily type 2 fast-
twitch glycolytic skeletal muscle (41,42,89).
Mitochondria serve as a primary source of in vivo 
oxidant production (2–5) with the primary oxidant 
production occurring at CI (6–8) and CIII (9–14). Despite 
the macro decreases in mitochondrial-specific respiratory 
capacity in QUAD (Figure  2F), respiration and electron 
flow specifically through CI and CIII increased (Figures 3A 
and 4A). Coupling control during PCI also had a tendency to 
deteriorate in QUAD (p = .085) in response to age (Table 2). 
Respiration and electron flow specifically through CI and 
CIII also increased in GAST, whereas coupling control 
during PCI worsened with age (Table 2). Electron coupling 
control is indicative of oxidant production as mitochondrial 
production of superoxide is closely related to mitochondrial 
coupling efficiency during respiration (9). Moreover, 
increased mitochondrial respiration capacity also results 
in increased oxidative damage and shorter life span (27). 
Respiratory capacity through CI diminished, whereas 
capacity through CIII and electron coupling control through 
CI remained unaffected by age in the slow-twitch oxidative 
SOL (Figures 3B and 4B, and Table  2, respectively). 
Highly glycolytic skeletal muscle has been shown to have 
higher oxidant production with a reciprocal lower capacity 
for oxidant scavenging compared with highly oxidative 
muscle (90). Predominantly fast-twitch skeletal muscle 
also has been reported to accrue age-associated oxidative 
damage, as assessed with protein carbonyl profiles across 
different skeletal muscle types, more rapidly than slow-
twitch oxidative muscle (91). Collectively, the results from 
this study, in corroboration with these previous findings, 
provide the direct evidence of a predisposition to ETS 
dysfunction with age in type 2 fast-twitch glycolytic skeletal 
muscle that is not observed in type 1 slow-twitch oxidative 
muscle and has been previously suggested in humans using 
indirect metabolic imaging techniques (46,47). Preliminary 
evidence suggests that caloric restriction (92) and exercise 
(93) reduce mitochondrial oxidant production and may 
serve to counterbalance these age-related impairments in 
electron transport.
Ratios of coupling control are based on the supposi-
tion that a tightly coupled system can be distinguished 
from a dyscoupled system by the magnitude of difference 
between two steady respiratory states with identical sub-
strate supply (94). We used leak control ratios as our indi-
ces of mitochondrial coupling control efficiency (Table 2). 
Leak control ratios are produced between two reciprocal 
respiratory states; a low flux state (ie, LN with malate and 
pyruvate, state 4 respiration) compared with an equiva-
lent high respiratory flux state (ie, PCI, submaximal state 
3 respiration). An identical substrate supply is necessary 
to pair corresponding states. Flux control ratios demon-
strate coupling efficiency using a theoretical minimum of 
0.0, which indicates a fully coupled system, to a value of 
1.0 representing a fully noncoupled or dyscoupled system 
(63). Although we show evidence of a loss of coupling 
control with aging during PCI in GAST and a tendency in 
QUAD, unfortunately coupling efficiency during maximal 
state 3 respiration could not be determined with the titra-
tion protocols utilized as there was no reciprocal leak state 
measured for P.
Respiratory Capacity and Control of Fat Oxidation 
With Aging
We found that the capacity for fat respiration increased 
with age without a reciprocal loss of coupling efficiency 
during β-oxidation in QUAD when controlling for 
differences in HAD protein expression (Figure 5 and Table 2, 
respectively). Conversely, capacity for fat respiration was 
unaltered with age in SOL, though the coupling control 
during fat oxidation diminished. Neither respiratory 
capacity nor control of fat oxidation was altered in GAST. 
Skeletal muscle intramyocellular lipid stores increase in 
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parallel with age-related decreases in mitochondria (37). 
Moreover, intramyocellular lipid content is also reported to 
drift away from the mitochondrial reticulum with age (37). 
The dysregulation of fat metabolism within skeletal muscle 
is associated with the development of insulin resistance 
and metabolic disease (95–97). The loss of mitochondrial 
coupling efficiency in type 1 slow-twitch fibers, such as 
observed here, may in part explain the reported insulin 
resistance in healthy, lean, elderly participants (38). This is 
of interest in regards to metabolic disease as well as aging 
and merits further investigation.
Conclusions
Here, we directly demonstrate impairments of mitochon-
drial function in response to aging in skeletal muscle. The 
specific age-induced alteration in function is dependent on 
skeletal muscle type. Skeletal muscle composed primar-
ily of type 2 fast-twitch glycolytic fibers are predisposed 
to progressive impairments in mitochondrial function with 
age as type 1 slow-twitch oxidative fibers appear to protect 
against this effect.
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The C57Bl/6 mouse serves as a suitable model of human
skeletal muscle mitochondrial function
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4Institute of Physiology, University of Zurich, Switzerland
2Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Switzerland
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New Findings
 What is the central question of this study?
Do mouse skeletal muscle mitochondria resemble human skeletal muscle mitochondria
sufficiently to serve as a proper model and how do differences of skeletal muscle type affect
the comparison?
 What is the main finding and its importance?
We find that mouse skeletal muscle respiratory capacity and control function rather similar
to human m. vastus lateralis, with the mouse quadricep being overall the most similar. This
resemblance is not universal, however, because the coupling control of electron transport
during fat oxidation in type I murine muscle is more comparable to human vastus lateralis.
It is debatable whether differences in mitochondrial function exist across skeletal muscle types
and whether mouse skeletal muscle mitochondrial function can serve as a valid model for
human skeletal muscle mitochondrial function. The aims of this study were to compare and
contrast three different mouse skeletal muscles and to identify the mouse muscle that most
closely resembles human skeletal muscle respiratory capacity and control. Mouse quadriceps
(QUADM), soleus (SOLM) and gastrocnemius (GASTM) skeletal muscles were obtained from
8- to 10-week-old healthy mice (n= 8), representing mixed, oxidative and glycolytic muscle,
respectively. Skeletal muscle samples were also collected from young, active, healthy human
subjects (n= 8) from the vastis lateralis (QUADH). High-resolution respirometry was used
to examine mitochondrial function in all skeletal muscle samples, and mitochondrial content
was quantified with citrate synthase activity. Mass-specific respiration was higher across all
respiratory states in SOLM versus both GASTM and QUADH (P < 0.01). When controlling
for mitochondrial content, however, SOLM respiration was lower than GASTM and QUADH
(P < 0.05 and P < 0.01, respectively). When comparing respiratory capacity between mouse
and human muscle, QUADM exhibited only one different respiratory state when compared
with QUADH. These results demonstrate that qualitative differences in mitochondrial function
exist between different mouse skeletal muscles types when respiratory capacity is normalized to
mitochondrial content, and that skeletal muscle respiratory capacity in young, healthy QUADM
does correspond well with that of young, healthy QUADH.
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Mouse modelling for the study of human health and
disease is an extremely powerful tool that is widely
used. The degree of conservation between mouse and
human genomes permits the study of murine biology
largely to characterize that of humans (Mouse Genome
Sequencing Consortium et al. 2002). There remains,
however, a biological divergence between species that is
not always readily apparent and can lead to scientific
misdirection if not properly recognized. There are certain
fundamental differences in mouse models that mimic
human disease with regard to cancer (Rangarajan &
Weinberg, 2003), ageing (Demetrius, 2006) andmetabolic
disease (Svenson et al. 2007; Garland et al. 2011)
that must be taken into account. The use of rodents
for research on human muscle disuse and sarcopenia
is fraught with dissimilarities between species (Rennie
et al. 2010). The differences between mice and humans
extend beyond diseased states. Haemodynamic control
differs between healthy humans and mice (Desai et al.
1997; Bernstein, 2003), as do normal metabolic profiles of
some skeletalmuscles (Schiaffino et al. 2007). Accordingly,
data extrapolation from mouse studies modelling human
physiological function, in both healthy and diseased states,
can have limitations if the differences between species are
not identified and controlled for.
Mitochondria are associated with the aetiology ofmany
disease states and disorders, including ageing (Jacobs,
2003) and metabolic disease (Lowell & Shulman, 2005;
Chomentowski et al. 2011). The roles of mitochondrial
function in these diseases are often studied using mouse
models (Picard et al. 2010; Miller et al. 2012; Paglialunga
et al. 2012; Sebastia´n et al. 2012). The most common
tissue used to analyse mitochondria is skeletal muscle,
because of its accessibility, relative mass-to-body weight
ratio and high metabolic rate. Differences between mouse
and human skeletalmuscle have brought into question the
validity of studying mouse mitochondria, and alternative
animal models have already been proposed ostensibly to
replace the mouse for the study of human mitochondrial
physiology (Lemieux & Warren, 2012).
Skeletal muscle anatomy and function vary between
mice and humans. These recognized differences have led
to comparisons of molecular expression across different
mouse and human muscles in an attempt to identify
the best phenotypic association between species (Kho et
al. 2006). The mouse soleus (SOLM) has been reported
to express the closest molecular resemblance to several
human skeletal muscles (Kho et al. 2006). However,
mitochondrial function across different murine skeletal
muscles has never been empirically compared with a
human skeletalmuscle, namely the vastus lateralis, because
that is the most common human skeletal muscle sampled.
The aim of this study, therefore, is to analyse respiratory
capacity and control across several mouse muscles and to
evaluate those results with skeletal muscle mitochondrial
function measured from young and healthy human
subjects.
Our first objective is to compare and contrast
mitochondrial functionacross the lateral portionofmouse
quadriceps (QUADM), SOLM and lateral gastrocnemius
(GASTM).Hitherto, differences inmitochondrial function
across skeletal muscles have been attributed primarily
to the differences in mitochondrial content (Hoppeler
et al. 1987; Schwerzmann et al. 1989). Such studies,
however, used preparations of isolated mitochondria
for respirometric analysis with limited substrate supply,
never reaching maximal state 3 respiration or oxidative
phosphorylation capacity (P) of the entire respiratory
system. We have previously demonstrated that differences
in mitochondrial respiratory capacity and control are
apparent only when substrate provision for both
complex I (CI; NADH dehydrogenase) and complex II
(CII; succinate dehydrogenase) is provided (Jacobs &
Lundby, 2012). Our first objective is to confirmdifferences
in respiratory capacity and control between different
skeletal muscles as suggested by previous studies in
humans (Amara et al. 2007; Conley et al. 2007). Our
second objective is to determine whether mouse skeletal
muscle can properly represent human skeletal muscle
mitochondrial function and, if so, to identify the mouse
skeletal muscle that best represents human muscle.
Our hypotheses are as follows: (i) that the mouse can
serve as a viable model for the study of mitochondrial
function in humans; and (ii) that SOLM will best represent
mitochondrial function in human skeletal muscle, as a
result of the molecular similarities between muscles (Kho
et al. 2006).
Methods
Ethical approval
The experimental protocols using laboratory animals
were approved by the Kantonales Veterina¨ramt Zu¨rich
(73/2011) and were performed in accordance with the
Swiss animal protection laws and institutional guidelines.
The Regional Ethics Committee of Region Hovedstaden
in Denmark approved experimental protocols involving
human subjects (H-1-2011-052), which were in
accordance with the Declaration of Helsinki. Prior to
the start of the experiments, informed oral and written
consent was obtained from all participants.
Experimental animals
A total of eight C57Bl/6J wild-type mice were used in
this study. All mice were housed in standard rodent cages
with fixed temperature (21± 1◦C), free access to food
and water, and a 12 h–12 h light–dark cycle. Mice ranged
from 8 to 10 weeks of age when they were killed and
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skeletal muscles collected. Animals were killed by means
of carbon dioxide inhalation, followed by rapid excision
of QUADM, SOLM and GASTM. These muscles represent a
mixedoxidative and glycolyticmuscle, an oxidativemuscle
and a glycolytic muscle, respectively.
Human subjects
Eight young and physically active subjects voluntarily
participated in this study. Subject characteristics
(means± SD) were as follows: age, 26± 5 years; height,
175± 9 cm; and body weight, 70± 7 kg. All subjects were
recreationally active. No subjects were taking any sort
of prescription medication or had any known family
history of type 2 diabetes, severe obesity or cardiovascular
diseases.
Human skeletal muscle sampling
Skeletal muscle biopsies were obtained from the vastus
lateralis. Samples were collected under local anaesthesia
(1% lidocaine) of the skin and superficial muscle fascia,
using the Bergstro¨m technique (Bergstro¨m, 1962) with a
needle modified for suction. The biopsy was immediately
dissected free of fat and connective tissue and divided into
sections for measurements of mitochondrial respiration.
Skeletal muscle preparation
Both human and mouse skeletal muscle samples were
immediately placed in ice-cold biopsy preservation
solution containing 2.77 mM CaK2EGTA buffer, 7.23 mM
K2EGTA buffer, 0.1μM free calcium, 20mM imidazole,
20 mM taurine, 50mM 2-(N-morpholino)ethanesulfonic
acid hydrate (K-Mes), 0.5 mM dithiothreitol, 6.56 mM
MgCl2.6H2O, 5.77mM ATP and 15mM phosphocreatine
(pH 7.1). Muscle samples were then gently dissected with
either a pair of fine-tipped forceps or the tip of two 18-
gauge needles for murine and human skeletal muscle
samples, respectively, achieving a high degree of fibre
separation that was verified microscopically. Chemical
permeabilization was carried out by incubation in 2ml of
biopsy preservation solution with saponin (50μgml−1)
for 30min at 4◦C (Kuznetsov et al. 2004). Finally, samples
were washed with amitochondrial respirationmedium 05
(MiR05) containing 0.5 mM EGTA, 3mM MgCl2.6H2O,
60mM potassium lactobionate, 20 mM taurine, 10mM
KH2P04, 20 mMHepes, 110mM sucrose and 1 g l−1 bovine
serum albumin (pH 7.1) for 10min at 4◦C.
Mitochondrial respiration measurements
Muscle bundles were blotted dry and measured for wet
weight in a balance-controlled scale (XS205 DualRange
Analytical Balance; Mettler-Toledo AG, Greifensee,
Switzerland), at constant relative humidity in order
to provide hydration consistency as well as stability
of weight measurements. Respiration measurements
were performed in mitochondrial respiration medium 06
(MiR06; MiR05+ catalase 280 IUml−1). Measurements
of oxygen consumption were performed at 37◦C using
the high-resolution Oxygraph-2k (Oroboros, Innsbruck,
Austria), with all additions in each substrate, uncoupler
and inhibitor titration protocol being added in series.
Standardized instrumental calibrations were performed
to correct for back diffusion of oxygen into the chamber
from the various components, leak from the exterior,
oxygen consumption by the chemicalmedium and oxygen
consumption by the sensor. Oxygen flux was resolved by
software allowing non-linear changes in the negative time
derivative of the oxygen concentration signal (Oxygraph-
2k; Oroboros). All experiments were carried out in a
hyperoxygenated environment to prevent any potential
oxygen diffusion limitation.
Respiratory titration protocol
The titration protocol was specific to the examination
of individual aspects of respiratory control through a
sequence of coupling and substrate states induced via
separate titrations. All respirometric analyses were made
in duplicate, and all titrations were added in series as
presented. The concentrations of substrates, uncouplers
and inhibitors used were based on prior experiments
conducted for optimization of the titration protocols
(Jacobs et al. 2011, 2012; Jacobs & Lundby, 2012).
Leak respiration in the absence of adenylates (LN) was
induced with the addition of malate (2 mM) and octanoyl
carnitine (0.2 mM). The LN state represents the resting
oxygen consumption of an unaltered and intact electron
transport system free of adenylates.
Maximal electron flow through electron-transferring
flavoprotein (ETF) and fatty acid oxidative capacity (PETF)
were both determined following the addition of ADP
(5mM). In the PETF state, the ETF-linked transfer of
electrons requires the metabolism of acetyl-CoA, hence
the addition of malate, in order to facilitate convergent
electron flow into the Q-junction from both CI and
ETF, allowing β-oxidation to proceed. The contribution
of electron flow through CI is far below capacity and
so here the rate-limiting metabolic branch is electron
transport through ETF such that malate + octanoyl
carnitine + ADP-stimulated respiration is representative
of, rather than specific to, electron capacity through ETF
(Eaton et al. 1996; Saks et al. 1998; Gnaiger, 2009; Pesta &
Gnaiger, 2011; Pesta et al. 2011).
Submaximal state 3 respiratory capacity specific to
CI (PCI) was induced following the additions of
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pyruvate (5 mM) and glutamate (10mM). Maximal state 3
respiration, oxidative phosphorylation capacity (P), was
then induced with the addition of succinate (10mM).
Oxidative phosphorylation capacity demonstrates the
capacity of a naturally intact electron transport system
to catalyse a sequential set of redox reactions that
are partially coupled to the production of ATP
via ATP synthase. Oxidative phosphorylation capacity
maintains an electrochemical gradient across the inner
mitochondrial membrane that is dictated by the degree of
coupling to the phosphorylation system (Gnaiger, 2009;
Pesta & Gnaiger, 2011). This maximal state represents
respiration that is resultant to saturating concentrations of
ADP and substrate supply for bothCI andCII. Convergent
electron input to CI and CII provides higher respiratory
values compared with the isolated respiration of either
CI (pyruvate/glutamate+malate or glutamate+malate)
or CII (succinate + rotenone; Rasmussen & Rasmussen,
2000; Gnaiger, 2009). Consequently, P presents more
physiological relevance to the study of mitochondrial
function (Brand & Nicholls, 2011) and is necessary to
establish confirmation of a complete and intact electron
transport system.
As an internal control for compromised integrity
of the mitochondrial preparation, the mitochondrial
outer membrane was assessed with the addition of
cytochrome c (10μM). There was no indication of
mitochondrial damage, because the 3.5, 2.1, 5.5 and –0.4%
change in mouse QUADM, SOLM, GASTM and QUADH
respiration, respectively, was either below or within
the accepted 5–15% elevation in respiration following
exogenous cytochrome c, verifying integrity of the outer
mitochondrial membrane (Kuznetsov et al. 2008).
Phosphorylative restraint of electron transport was
assessed by uncoupling ATP synthase (complex V) from
the electron transport system with the titration of the
proton ionophore, carbonyl cyanide p-(trifluoromethoxy)
phenylhydrazone (FCCP; 0.5μM per addition up to
optimal concentrations ranging from 1.5 to 3μM),
reaching electron transport system (ETS) capacity. In
the ETS respiratory state, the inner mitochondrial
membrane potential is completely collapsed, with an open
transmembrane proton circuit. The uninhibited flow of
electrons through the respiratory system can therefore
serve indirectly as an indication ofmaximalmitochondrial
membrane potential.
Finally, rotenone (0.5μM) and antimycin A (2.5μM)
were added, in sequence, to terminate respiration by
inhibiting CI and complex III (CIII; cytochrome bc1
complex), respectively. With CI inhibited, electron flow is
specific to CII, providing submaximal state 3 respiration
through CII (PCII). There are negligible differences in
PCII when measured with or without a prior addition
of FCCP (Jacobs et al. 2012), because the capacity for
electron flow through CII is much less than that of CIII
and complex IV (CIV; cytochrome c oxidase), and thus
is rate limiting (Gnaiger, 2009). Inhibition of respiration
with antimycin A then allows for the determination and
correction of residual oxygen consumption, indicative of
non-mitochondrial oxygen consumption in the chamber.
Citrate synthase activities
Citrate synthase (CS) activities were assayed in
homogenates of the skeletal muscle samples used in
respirationmeasurements. The contents of the Oxygraph-
2k chambers (2 ml each) were removed after each
respiration experiment and washed once with 2ml of
MiR05. One per cent Triton X-100 and 2μl of a protease
inhibitor cocktail (Sigma Aldrich catalogue no. 539134)
were added to the combined solutions (content and
wash) and then homogenized for 30 s with a T10
basic ULTRA-TURRAX R© homogenizer near maximal
speed (setting 4). The homogenate was then centrifuged
for 15min at 4◦C, and the supernatant was removed,
frozen in liquid nitrogen and stored at –80◦C. As has
been previously described (Srere, 1969), CS activity was
measured fluorometrically at 412 nm and 25◦C (Citrate
Synthase Assay Kit; Sigma-Aldrich), according to the
manufacturer.
Muscle lysate preparation
Muscle tissue (QUADM, SOLM and GASTM) was collected
from a subgroup of mice (n= 4) to measure the protein
expression of several mitochondria-specific proteins and
compare quantification of those with our measure of
CS activity to establish its validity as a biomarker of
mitochondrial content in mouse skeletal muscle. The
muscle samples were homogenized (Qiagen Tissuelyser II,
Retsch, Haan, Germany) in a fresh batch of buffer
containing the following: 10% glycerol, 20 mM sodium
pyrophosphate, 150mMNaCl, 50 mMHepes (pH 7.5), 1%
NP-40, 20mM β-glycerophosphate, 2 mMNa3VO4, 10 mM
NaF, 2 mM phenylmethylsulfonyl fluoride, 1 mM EDTA
(pH 8.0), 1 mM EGTA (pH 8.0), 10μgml−1 aprotinin,
10μgml−1 leupeptin and 3mMbenzamidine. Afterwards,
samples were rotated end over end for 1 h at 4◦C
and centrifuged at 16,500g for 30min at 4◦C, and
the supernatant (lysate) was used for further analysis.
The total protein concentration in each sample was
determined by a bovine serum albumin standard kit
(Pierce, Rockford, IL, USA), and samples were mixed
with a modified 6× Laemmli buffer [7 ml 0.5 M Tris base
(pH 6.8), 3 ml glycerol, 0.93 g dithiothreitol, 1 g SDS and
1.2 mg Bromophenol blue].
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SDS-PAGE and Western blotting
Methods have been described in detail previously
(Nordsborg et al. 2008, 2012; Thomassen et al.
2011). Equal amounts (10μg) of total muscle lysate
proteins, determined during optimization of the different
antibodies, were loaded in each well. Samples were
loaded together with protein markers (Precision Plus All
Blue and Dual Colour; Bio-Rad Laboratories, Hercules,
CA, USA) on precasted gels (Bio-Rad Laboratories).
Proteins were separated by SDS-PAGE and semi-dry
transferred to a polyvinylidene fluoride membrane
(Millipore, Billerica, MA, USA). The membranes were
blocked in either 2% skimmed milk or 3% bovine serum
albumin in Tris-buffered saline, including 0.1% Tween 20
(TBST) before an overnight incubation in primary
antibody at 4◦C. Thereafter, membranes were washed
in TBST and incubated for 1 h at room temperature in
horseradish peroxidase-conjugated secondary antibody.
Membranes were then washed three times for 15min
in TBST before the bands were visualized with ECL
(Millipore) and recordedwith adigital camera (ChemiDoc
MP Imaging System; Bio-Rad). Quantification of the
Western blot band intensity was done using the
Image Lab software program (Bio-Rad) and determined
as the total band intensity minus the background
intensity. Primary antibodies were optimized by use of
mouse muscle lysates to ensure that the amount of
protein loaded would result in band signal intensities
localized on the steep and linear part of a standard
curve.
In order to determine changes in total protein
expression, the following antibodies were used, with the
localization of the quantified signal noted: 3-hydroxyacyl
coenzyme a dehydrogenase (HAD), 83 kDa, polyclonal
ab54477 (Abcam, Cambridge, UK); citrate synthase (CS),
48 kDa, polyclonal ab96600 (Abcam); mitochondrial
complex IV subunit 4, (CIV), 16 kDa, monoclonal sc-
58348 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA); and mitochondrial complex I subunit NDUFB8
(CI), 20 kDa (monoclonal ab110242), mitochondrial
complex II, succinate dehydrogenase complex subunit
B (CII), 30 kDa (monoclonal ab14714), mitochondrial
complex III subunit core 2 (CIII), 45 kDa (monoclonal
ab14745) and mitochondrial complex V ATP synthase
subunit α (CV), 55 kDa (monoclonal ab14748), all four
of which are included in theMitoProfile R© Total OXPHOS
Human WB Antibody Cocktail (ab110411; Abcam). The
secondary antibodies used were horseradish peroxidase-
conjugated goat anti-mouse and goat anti-rabbit (P-0447
and P-0448; Dako, Glostrup, Denmark).
All samples from the same muscle type were loaded on
the same gel. The signal intensity from eachmuscle sample
was normalized to the mean signal intensity of a human
standard loaded together with the samples.
Data analysis
For all statistical evaluations, a P value of <0.05 was
considered significant. Linear regression was used to
calculate the strength of association between CS activity
and the quantification of mitochondria-specific proteins
from the tricarboxylic acid cycle, β-oxidation pathway
and electron transport system across all types of murine
skeletal muscles. Respiratory capacities, CS activity and
indices ofmitochondrial efficiency did not show aGausian
distribution; therefore a Kruskal–Wallis ANOVA and the
Mann–Whitney U test were used to reveal differences
between muscles. Pearson correlation coefficients were
calculated for the strength of association between P and
CS activity.
Results
Mass-specific respiration across mouse skeletal
muscle
Differences in mass-specific respiratory capacity across
different skeletal muscles in the mouse are presented in
Fig. 1A. For all respiratory states, SOLM was significantly
(P < 0.01) greater than both QUADM and GASTM. The
only difference observed between QUADM and GASTM
was in maximal fatty acid oxidation capacity, PETF, where
QUADM expressed a greater capacity (P = 0.028).
Mitochondrial respiratory capacity and content
Mass-specific respiration does not take into account
differences in mitochondrial content. When controlling
mass-specific respiration for mitochondrial content,
the differences in respiratory capacities across all
mouse skeletal muscles change (Fig. 1B). Specifically,
both QUADM and GASTM were greater than SOLM
during submaximal state 3 respiration through CI (PCI;
P = 0.005 and 0.001, respectively), maximal state 3
respiration (P; P = 0.007 and P < 0.001, respectively),
electron transport system capacity (ETS; P = 0.01
and P < 0.001, respectively) and submaximal state 3
respiration through CII (PCII; P = 0.021 and P = 0.001,
respectively). Mitochondrial content correlates directly
with overall respiratory capacity (Larsen et al. 2012). This
is shown here, because maximal state 3 respiration, or
oxidative phosphorylation capacity, P, strongly correlates
(r = 0.932, P < 0.001) with CS activity across all mouse
muscles (Fig. 1C). When analysing differences in CS
activity across groups, SOLM presents with more CS
activity than any other skeletal muscle (P < 0.001). The
only other difference was that CS activity in GASTM was
less than in QUADH (P < 0.002).
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Mitochondria-specific respiration across mouse
muscles
Although CS activity has been shown to correlate strongly
withmitochondrial content in humans (Larsen et al. 2012)
and also in horses (Hoppeler, 1990), it was necessary to
establish this inmouse skeletal muscle. In order to validate
measures of CS activity in mouse skeletal muscle, we
correlated those values to quantification of mitochondrial
enzymes from a subgroup of animals included in this
study (n= 4). The quantification of all mitochondrial
proteins analysed in QUADM, SOLM and GASTM is
Figure 1. Comparison of respiratory capacity and control in mouse skeletal muscles
Mass-specific (A) and mitochondria-specific respiration (B) across mouse quadriceps (QUADM; grey
bars), soleus (SOLM; filled bars) and gastrocnemius (GASTM; open bars). Abbreviations: LN, leak
respiration without adenylates; P, maximal state 3 respiration, i.e. oxidative phosphorylation capacity;
PCI, submaximal state 3 respiration through complex I (CI); PCII, submaximal state 3 respiration through
complex II (CII); and PETF, maximal fatty acid oxidation. Data are presented as means + SD. ∗P ≤ 0.05,
∗∗P ≤ 0.01 and ∗∗∗P ≤ 0.001. #Significant difference from GASTM, P < 0.05. C, Pearson correlation of
maximal oxidative phosphorylation system capacity, maximal state 3 respiration (P), versus citrate
synthase (CS) activity. Citrate synthase activity (x-axis) is plotted against P (y-axis) for all mouse skeletal
muscles. The grey circles represent QUADM, the filled circles SOLM and the open circles GASTM. r = 0.932,
P < 0.001.
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
61
Exp Physiol 00.00 (2012) pp 1–14 Mitochondrial function in man and mouse 7
illustrated in the Supplemental material (Fig. S1). All
quantifications of mitochondrial proteins correlated
strongly with measures of CS activity (Supplemental
material, Fig. S1), establishing its use as a valid biomarker
of mitochondrial content in mouse skeletal muscle.
Mitochondrial function in mouse quadriceps versus
human quadriceps
Mass-specific respirometric comparisons of QUADM
differed from its human counterpart during PETF
(P = 0.007), PCI (P = 0.05), P (P = 0.015) and ETS
(P = 0.002) respiratory states (Fig. 2A). When controlling
for mitochondrial content, the only difference between
QUADM and QUADH was observed at ETS (P = 0.038;
Fig. 2B).
Mitochondrial function in mouse soleus versus
human quadriceps
Mass-specific respiratory values from SOLM and QUADH
mitochondria are presented in Fig. 3A. They differed
during leak respiration in absence of adenylates (LN;
P < 0.001), PETF (P < 0.001), PCI (P = 0.005) and PCII
(P = 0.002).When controlling formitochondrial content,
the differences between SOLM andQUADH were observed
at PETF (P = 0.002), PCI (P < 0.001), P (P < 0.001) and
ETS (P < 0.001) respiratory states (Fig. 3B).
Mitochondrial function in mouse gastrocnemius
versus human quadriceps
Mass-specific differences for all respiratory states except
PCII were lower in GASTM when compared with QUADH
(Fig. 4A; LN, P = 0.05; PETF, P < 0.001; PCI, P = 0.003;
P, P = 0.003; and ETS, P < 0.001). When controlling
for mitochondrial content, the only differences between
GASTM and QUADH were at PCI (P = 0.05) and PCII
(P = 0.007) respiratory states (Fig. 4B).
Mitochondrial coupling control
The leak control ratio during β-oxidation (LCRETF),
representing the electron coupling control during
fat oxidation, differed between QUADM and SOLM
(P = 0.015) and between QUADM and QUADH
(P = 0.005). The phosphorylation system control ratio
(PSCR) did not differ between any mouse muscles (Fig.
5); however, all themousemuscles presentedwith a higher
PSCR than the human muscle (P < 0.001).
Discussion
The aim of this study was to analyse respiratory capacity
and control in several mouse muscles and to compare and
contrast those values with skeletal muscle mitochondrial
function measured in muscle from young and healthy
human subjects.We have severalmain findings, as follows:
(i) qualitative differences in mitochondrial function exist
between mouse skeletal muscles; (ii) respiratory capacity
in young, healthy mouse skeletal muscle does correspond
well to that of young, healthy human skeletal muscle; and
(iii) in contrast to our hypothesis, mitochondrial function
of the QUADM, not SOLM, more closely resembles that of
human skeletal muscle.
There is discussion on whether the respiratory capacity
of skeletal muscle depends solely on mitochondrial
content orwhether differences exist across skeletalmuscles
with varying biochemical make-up (Picard et al. 2012).
There is some evidence in support of the supposition that
differences in oxidative potential between skeletal muscles
can be accounted for by themitochondrial volume density
between the muscles (Hoppeler et al. 1987; Schwerzmann
et al. 1989), although these studies were limited either
by measuring PCI and PCII only individually, but not
collectively, in preparations of isolated mitochondria or
by perfusion limitations to the skeletal muscle. Other
evidence suggests, as do the results presented here, that
a respiratory difference between oxidative and glycolytic
muscle mitochondria does exist when taking into account
mitochondrial content (Jackman & Willis, 1996; Picard
et al. 2008). All data reporting differences between
oxidative and glycolytic muscles report a higher
respiratory capacity per mitochondrion in glycolytic
muscle (Jackman & Willis, 1996; Picard et al. 2008).
Respiratory differences across skeletal muscle fibre types
have also been shown in human subjects using in vivo
imaging techniques (Amara et al. 2007; Conley et al. 2007).
Here we maintain that there are differences in respiratory
capacity per mitochondrion across different skeletal
muscles and that the more glycolytic muscle possesses
greater respiratory capacity for a given mitochondrial
content (Fig. 1B).
The mechanism(s) explaining these functional
differences across skeletal muscle fibre types are
largely unknown. Mitochondria do, however, vary
morphometrically betweenfibre types, withmitochondria
of fast-twitch muscles possessing a thinner and longer
reticular network and mitochondria of slow-twitch
muscles expressing a thicker and more truncated
reticulum (Ogata & Yamasaki, 1997). The mitochondria
expressed in different fibre types are also sometimes
subjected to very a different metabolic strain. Glycogen
stores are markedly greater in fast-twitch glycolytic
muscles when compared with slow-twitch oxidative
muscles (Greenhaff et al. 1991; Tsintzas et al. 1995),
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as are the maximal rates of glycogenolysis within each
respective muscle type (Greenhaff et al. 1991). The greater
respiratory capacity per mitochondrion in glycolytic
muscle is necessary and may be explained by the greater
glycolytic strain per unit mitochondria during intense
to maximal exertion. Biochemical protein expression
supports this idea, because severalmitochondrial enzymes
directly involved in the function of the tricarboxylic
acid cycle and electron transport chain, e.g. NADH
dehydrogenase, have been reported to possess greater
expression in glycolytic compared with oxidative skeletal
muscle (Glancy & Balaban, 2011).
Normalization of respiration plays a large role
in whether or not differences are observed between
oxidative and glycolytic fibres; oxidative fibres express
greater respiratory capacity when normalized to tissue
weight (Fig. 1A), because they possess considerably
higher mitochondrial content (Fig. 1C). This is in
Figure 2. Respiratory capacity and control between mouse quadriceps (QUADM) and human quadriceps
(QUADH)
Mass-specific (A) and mitochondria-specific respiration (B). Data are presented as means + SD. ∗P ≤ 0.05
and ∗∗P ≤ 0.01. C, Bland–Altman plots representing the mean difference and the limit of agreement
between QUADM and QUADH across respiratory states. The continuous line represents the mean of
the differences between QUADM and QUADH and the dashed lines represent the level of agreement
(mean ± 2SD). The smaller the range between these two limits, the better the agreement.
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agreement with previous reports (Ponsot et al. 2005;
Picard et al. 2008). Normalization to mitochondrial
content is required for comparison of true differences
in respiratory capacity between skeletal muscles.
Respirometric analysis of mitochondria isolated from rat
soleus, extensor digitorum longus, gastrocnemius and
tibialis anterior foundnodifference in respiratory capacity
in subsarcolemmal or intermyofibrillar populations when
normalized to mitochondrial protein content (Yajid
et al. 1998).Mitochondrial isolation, however, disrupts the
united heterogeneous mitochondrial reticulum, resulting
in unnaturally circular and disconnected organelles
(Schwerzmann et al. 1989; Picard et al. 2011). This
carries the risk of contaminating the isolated fractions
Figure 3. Respiratory capacity and control between mouse soleus (SOLM) and human quadriceps
(QUADH)
Mass-specific (A) and mitochondria-specific respiration (B). Data are presented as means + SD. ∗∗P ≤ 0.01
and ∗∗∗P ≤ 0.001. C, Bland–Altman plots representing the mean difference and the limit of agreement
between SOLM and QUADH across respiratory states. The continuous line represents the mean of
the differences between SOLM and QUADH and the dashed lines represent the level of agreement
(mean ± 2SD). The smaller the range between these two limits, the better the agreement.
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with proteins not native to the mitochondria (Chretien
et al. 1995; Picard et al. 2011), losing mitochondria-
specific contents (Brooks, 2002; Brooks & Hashimoto,
2007; Picard et al. 2011) and modifying overall function
(Pande & Blanchaer, 1970; Benz, 1994; Saks et al. 1998,
2010; Villani et al. 1998; Kunz et al. 2000; Milner et al.
2000; Kuznetsov et al. 2008; Picard et al. 2010). Moreover,
respirometric normalization to mitochondrial protein
followingmitochondrial isolation has since been rebutted,
because it does not correlate with the total area of the
cristae (Leary et al. 2003). Respirometric normalization to
a biomarker of mitochondrial content, such as CS, which
is different between muscles, was not analysed (Yajid et al.
1998). In human skeletal muscle, CS activity can serve as
a valid representative biomarker of mitochondrial volume
density, total cristae area and respiratory capacity (Larsen
Figure 4. Respiratory capacity and control between mouse gastrocnemius (GASTM) and human
quadriceps (QUADH)
Mass-specific (A) and mitochondria-specific respiration (B). Data are presented as means + SD. ∗P ≤ 0.05,
∗∗P ≤ 0.01 and ∗∗∗P ≤ 0.001. C, Bland–Altman plots representing the mean difference and the limit of
agreement between GASTM and QUADH across respiratory states. The continuous line represents the
mean of the differences between GASTM and QUADH and the dashed lines represent the level of
agreement (mean ± 2SD). The smaller the range between these two limits, the better the agreement.
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et al. 2012).We also validate CS activity as a representative
biomarker of mitochondrial content in mouse skeletal
muscle, because there were strong correlations with CS
activity and quantification of all mitochondrial proteins
analysed (Supplemental material, Fig. S1). An additional
benefit to the use of measurements of CS activity is
that they can be made from the same skeletal muscle
preparation used to collect respirometric values (Picard
et al. 2008; Larsen et al. 2012), as was done in the present
study.
The ability to use animal models for human
mitochondrial function is important, because
mitochondria are intimately associated with both
health and disease. Use of the mouse as a representative
model of human mitochondrial function, however,
has come into question (Lemieux & Warren, 2012).
Differences in molecular profiles between mouse and
human skeletal muscle indirectly support these claims.
However, the assertion that mouse mitochondrial
function deviates greatly from that in the human has
never empirically been tested until now. Using saponin-
permeabilized skeletal muscle preparations fromQUADM
and QUADH, we show that the differences in respiratory
control across species are minor or negligible (Fig. 2B).
In contrast to isolated mitochondrial preparations, this
specific mitochondrial preparation allows for direct
access to skeletal muscle mitochondria while preserving
the cytocellular ultrastructure (Lin et al. 1990; Saks et al.
1991, 1998; Kuznetsov et al. 2008; Gnaiger, 2009; Pesta
& Gnaiger, 2011; Picard et al. 2011) as well as subcellular
interactions (Veksler et al. 1987; Lin et al. 1990; Saks et al.
1998;Milner et al. 2000; Kuznetsov et al. 2008; Picard et al.
2011). Cellular bioenergetics and metabolic channelling
are reliant upon these characteristics (Saks et al. 1998;
Kay et al. 2000; Kuznetsov et al. 2008; Gnaiger, 2009).
Accordingly, this specific mitochondrial preparation
serves as the best model in which to examine differences
between skeletal muscle types and also to compare and
contrast function across species.
In contrast to our hypothesis, it was respiratory capacity
and control of the QUADM, not SOLM, that better
represents human skeletal muscle mitochondrial function
(Figs 2B versus 3B). These data also refute previous reports
that the SOLM may serve as a better representative of
human skeletal muscle based on molecular modelling
(Kho et al. 2006). Bland–Altman plots further verified this
finding (Figs 2C, 3C and 4C). These Bland–Altman plots
are graphical representations of the differences between
the respirometric analysis of mouse muscle and human
muscle against the mean for each respective respiratory
state. This method determines the mean difference
(measurement bias) between the two measurements in
question, as well as the 95% limit of agreement of the
mean difference (2SD). The smaller the range between
these two limits, the better the agreement.
It should be noted thatmitochondrial electron coupling
control during fat oxidation is more similar between
SOLM and QUADH (Fig. 5). The LCRETF is determined
from two respiratory states, a leak state (LN) and a
higher respiratory state (PEFT). These corresponding states
are paired by an identical substrate supply (malate +
octanoyl carnitine). The ratio of these two states reflects
electron coupling efficiency during fat oxidation, from a
theoretical minimum of 0.0, indicating a fully coupled
system, to a value of 1.0, representing a fully non-coupled
(dyscoupled) system(Gnaiger, 2009).Thus,whileQUADM
was most similar to QUADH respiratory capacities, it
may be more accurate to state that mouse skeletal
muscles can provide a useful model to test hypotheses
relating to human skeletal muscle with the caveat that
species differences are real, very specific, different across
muscle types, andmust be considered before extrapolating
directly to human skeletal muscle. We also confirmed that
young, healthy mice may serve as representative models of
mitochondrial performance in young, healthy and non-
sedentary humans. The comorbidities of a sedentary,
caged and ad libitum-fed lifestyle (Martin et al. 2010) do
not appear to affect mitochondrial function within the
first 8–10 weeks of life.
One difference that did exist between all mouse
skeletal muscles and the human muscle was the PSCR.
This is the ratio of maximal state 3 respiration to ETS
capacity and represents the degree of constraint of
the maximal oxidative phosphorylation capacity by the
phosphorylation system or ATP synthase (Gnaiger, 2009).
With no restriction, the PSCR approaches a ratio of
1.0, which we observed in all mouse muscles (Fig. 5),
as seen in other studies (ter Veld et al. 2005; Aragone´s
et al. 2008). We observed that human skeletal muscle
Figure 5. Mitochondrial coupling control across all groups
Leak-control ratios (LCRs) for the coupling control of electron
transport through the electron-transferring flavoprotein (ETF)
during β-oxidation (LCRETF) and phosphorylation system control
ratio (PSCR) across mouse quadriceps (QUADM; light grey bars),
mouse soleus (SOLM; dark grey bars), mouse gastrocnemius
(GASTM; open bars) and human quadriceps (QUADH; filled
bars). Data are presented as means + SD. ∗P ≤ 0.05, ∗∗P ≤ 0.01
from QUADM. ∗∗∗P < 0.001 from all mouse skeletal muscle.
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
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presented with an average PSCR of 0.71, which is also
comparable to other reported values (Boushel et al. 2007).
A ratio less than 1.0, as observed in humans, suggests
that electron transport through complexes I–IV is limited
by ADP phosphorylation. When facilitating non-coupled
respirationwith the proton ionophore FCCPby collapsing
the electron gradient prior to phosphorylation, a higher
electron transport and attendant respiration is reached
(QUADH respiration; Fig. 2B). Oxidative phosphorylation
capacity (P) is more than capable of utilizing the oxygen
delivered during maximal whole-body exercise (Boushel
et al. 2011), where oxygen delivery is limiting. Thus,
the excess capacity for electron transport following
uncoupling in human skeletal muscle mitochondria
possibly serves a functional role during exercise in isolated
muscle groups where maximal work is not limited by
oxygen supply (Andersen & Saltin, 1985). The functional
role of an excess electron transport capacity in human
skeletalmusclemitochondriamerits further investigation.
Conclusion
If differences in murine and human mitochondrial
function did exist then it would be both difficult
and cavalier to apply results collected from mice to
a larger and different human population, particularly
if neither the group sampled nor the population was
clearly defined. Here we discriminate between skeletal
muscle mitochondrial function in mice and humans. We
provide evidence disproving any excessive discordance
or discrepancy that has been claimed to exist between
mouse and human mitochondria unless specifically
examining the phosphorylative restraint of ATP synthase
on oxidative phosphorylation (Lemieux &Warren, 2012).
Specifically, young, healthy mouse quadriceps serves as
a suitable representative for mitochondrial function in
young, healthy human vastus lateralis. This allows for
more assurance when progressing from descriptive to
inferential statistics between healthy young mouse and
human mitochondria.
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Supporting Information
Additional Supporting Information may be found in the
online version of this article:
SUPPLEMENTAL FIGURE S1. Quantification of
mitochondria-specific enzymes across mouse skeletal
muscles. Using a subsection of animals (n = 4)
the expression of various mitochondrial proteins were
quantified (mean± SD) in quadricep (QUAD, grey bars),
soleus (SOL,blackbars), and lateral gastrocnemius (GAST,
white bars). The respective correlation of these values
to citrate synthase (CS) activity was also examined in
QUAD (grey filled points), SOL (black filled points), and
GAST (white filled points). Protein quantification and
correlation to CS activity for mitochondrial complex I (A
& B), mitochondrial complex II (C&D), mitochondrial
complex III (E & F), mitochondrial complex IV (G & H),
mitochondrial complexV (I& J), 3-hydroxyacyl coenzyme
a dehydrogenase (HAD, K & L), and CS (M & N).
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Studies regarding mitochondrial modifications in human skeletal muscle following
acclimatization to high altitude are conflicting, and these inconsistencies may be due to the
prevalence of representing mitochondrial function through static and isolated measurements
of specific mitochondrial characteristics. The aim of this study, therefore, was to investigate
mitochondrial function in response to high-altitude acclimatization through measurements
of respiratory control in the vastus lateralis muscle. Skeletal muscle biopsies were obtained
from 10 lowland natives prior to and again after a total of 9–11 days of exposure to 4559m.
High-resolution respirometry was performed on the muscle samples to compare respiratory
chain function and respiratory capacities. Respirometric analysis revealed that mitochondrial
function was largely unaffected, because high-altitude exposure did not affect the capacity
for fat oxidation or individualized respiration capacity through either complex I or complex II.
Respiratorychain functionremainedunaltered,becauseneither couplingnor respiratorycontrol
changed in response to hypoxic exposure. High-altitude acclimatization did, however, show
a tendency (P = 0.059) to limit mass-specific maximal oxidative phosphorylation capacity.
These data suggest that 9–11 days of exposure to high altitude do not markedly modify
integrated measures of mitochondrial functional capacity in skeletal muscle despite significant
decrements in the concentrations of enzymes involved in the tricarboxylic acid cycle and
oxidative phosphorylation.
(Received 17 March 2012; accepted after revision 24 May 2012; first published online 25 May 2012)
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Surprisingly little is known regarding hypoxia-dependent
control of mitochondrial function. Previous observations
of mitochondrial modifications following acclimatization
to altitude have been inconsistent. Initial studies (Tappan
et al. 1957; Valdivia, 1958; Reynafarje, 1962; Hochachka
et al. 1983) reported greater expression of indirectmarkers
suggestive of oxidative potential in both animals and
humans native to high altitude, leading investigators to
speculate that acclimatization may improve respiratory
capacity and mitochondrial function in response to
an increasingly hypoxic environment (Hochachka et al.
1983). This preliminary theory was challenged when
further studies of lowlanders sojourning to high/extreme
altitudes reported either a dramatic loss of skeletal
muscle mitochondria (Hoppeler et al. 1990; Howald
et al. 1990; Levett et al. 2012) or negligible changes in
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society DOI: 10.1113/expphysiol.2012.066092
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mitochondrial characteristics, such as enzyme activities,
following acclimatization (Green et al. 1989, 1992, 2000a;
MacDougall et al. 1991; Mizuno et al. 2008; Levett
et al. 2012), even despite significant reductions in
skeletal muscle mass (MacDougall et al. 1991; Mizuno
et al. 2008). Additionally, several studies have reported
evidence to suggest an improvement in mechanical
efficiency during exercise at sea level following prolonged
or intermittent hypoxic exposure (Green et al. 2000b;
Gore et al. 2001; Katayama et al. 2004; Saunders et al.
2009). Other studies have failed to verify this change
in exercise economy through consistent and intermittent
hypoxic exposure (Lundby et al. 2007; Siebenmann et al.
2012). Intermittent hypoxic exposure has also failed to
facilitate changes in mitochondrial efficiency (Robach
et al. 2012). Hitherto, in humans, hypoxia-mediated
changes in mitochondrial physiology are far from
understood.
Changes in muscle oxidative capacity have often
been implied by static measurements of mitochondrial
protein concentrations/activity or morphometric
analysis, representing mitochondrial content or volume,
respectively. Relying exclusively on such measurements
for the characterization of mitochondrial function and
oxidative potential is incomplete, because the evaluation
of mitochondrial function requires direct functional
measures of intact mitochondria to assess potential
changes in oxidative phosphorylation, electron transport,
coupling control and efficiency. For example, mass-
specific maximal oxidative phosphorylation capacity
(P), as measured by high-resolution respirometry, was
revealed to be the strongest determinant of endurance
performance in highly trained athletes, while the
correlation between performance as a measure of
mitochondrial content was negligible (Jacobs et al.
2011).
Altitude-induced alterations in whole-body protein
turnover (Holm et al. 2010), including several
mitochondrial proteins (Vigano` et al. 2008) from
this study, have previously been reported. Enzyme
levels involved in the tricarboxylic acid (TCA) cycle
and oxidative phosphorylation were lower following
acclimatization, as was previously reported with
a similar length of hypoxic exposure (Mizuno
et al. 1990). To elucidate whether these enzymatic
alterations are reflected in mitochondrial respiratory
chain function, we assessed mitochondrial respiration
in permeabilized skeletal muscle fibres at sea
level and after 9–11 days of exposure to high
altitude. We hypothesized that mass-specific oxidative
phosphorylation capacities would parallel these findings
and also diminish following acclimatization to high
altitude.
Methods
Subjects
Ten healthy, young and physically active lowland male
subjects voluntarily participated in this study. Subject
characteristics (means± SEM) were as follows: age,
26± 1 years; height, 181± 1 cm; and weight, 79± 2 kg.
All subjects were scanned for body composition in a
dual-energy X-ray absorptiometer (DEXA; Lunar, GE
Medical Systems, Madison, WI, USA) prior to high-
altitude ascent and again 1 day after return to sea level.
Body composition as measured by DEXA showed no
differences between sea level baseline (BL) scans compared
with those collected after 9–11 days of high-altitude
acclimatization (HA), because fat mass was 13.4± 4.2
and 13.2± 4.5 kg, respectively, while lean body mass
was 63.7± 6.1 and 63.6± 6.1 kg, respectively. Baseline
measurements of maximal oxygen consumption (V˙O2 max)
were 4.3± 0.1 l min−1. These values decreased as a result
of the high altitude (3.0± 0.6 l min−1) but returned to
BL values upon the provision of supplemental oxygen
at altitude, simulating normoxic breathing at sea level
(4.4± 0.1 l min−1), suggesting no difference in training
status between times of data acquisition. Formore detailed
subject characteristics see Lundby et al. (2008). All subjects
provided informed, written consent after being presented
with oral andwritten explanations regarding experimental
procedures and protocol. The study was conducted in
accordance with the principles of the Declaration of
Helsinki and was approved by the local ethical committee
for Frederiksberg and Copenhagen Communities.
Experimental protocol
A more detailed description of the experimental protocol
has been given previously (Robach et al. 2007; Lundby
et al. 2008). Subjects reported to and remained at the
laboratory (Copenhagen, 42m above sea level) 3 days
prior to acquisition of BL measurements, where activity
was controlled and caloric intake monitored. Subjects
later flew to Italy and were transported (including partial
hike) to a high-altitude hut (Gnifetti hut, 3647m), where
they stayed for 2 days. On the third day at high altitude,
subjects hiked to the Capanna Regina Margherita hut
(4559m), where they remained for the subsequent 9 days.
This specific hypoxic exposure to high altitude was chosen
because it is long enough to induce some degree of
physiological adaptation to hypoxia (Horstman et al. 1980;
Bender et al. 1988; Lundby et al. 2003, 2006; Zungu et al.
2007;Nordsborg et al.2010),with longerhypoxic exposure
facilitating no further changes in oxidative capacity of
the leg (Lundby et al. 2006). The ascent profile was
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Table 1. Blood analyses
Conditions Serum EPO (mIU ml−1) [Hb] (g l−1) PaCO2 (mmHg) PaO2 (mmHg) SaO2 (%)
BL 8.7 ± 3.7 144 ± 8 40.4 ± 2.0 103.2 ± 13.8 98.6 ± 0.5
HA 12.2 ± 3.0∗ 169 ± 13∗ 29.2 ± 1.9∗ 50.5 ± 3.2∗ 83.4 ± 2.7∗
Blood gases, haemoglobin (Hb) and serum erythropoietin (EPO) concentrations were obtained for baseline (BL) measurements in
normoxic conditions at sea level and following 11 days (2 days at 3647 m and 7–9 days at 4559 m) of high-altitude (HA) exposure.
Abbreviations: PaCO2 , arterial partial pressure of carbon dioxide; PaO2 , arterial partial pressure of oxygen; and SaO2 , percentage
arterial oxygen saturation as also reported by Robach et al. (2007). The calculation of statistical differences from normoxia was
performed using the Wilcoxon test. Values are presented as means ± SD. ∗ Significant difference (P < 0.01).
uniform across all subjects. Skeletal muscle biopsies were
collected at altitude throughout days 7–9 of exposure to
4559m (9–11 days of high-altitude exposure in total),
with three or four subjects being sampled per day. Three
days prior to sample acquisition at high altitude, the
subject’s activity was controlled as it was at baseline
and everyone was fed isocaloric diets with negligible
differences in macronutrient content versus baseline
feeding. No food or caffeine was allowed 12 h prior to
skeletal muscle biopsy in either BL or HA conditions.
In summary, muscle biopsies were obtained on two
separate occasions, the first at BL and the second during
HA.
Blood samples
Venous blood was sampled during supine rest from a
forearm vein. Blood samples were allowed to clot at
4◦C, centrifuged, and the serum was then stored at –
20◦C for later analysis. Arterial blood was obtained from
the right femoral artery for immediate determination
of blood gases, as previously described (Calbet et al.
2006a,b).
Blood analyses
Arterial blood was sampled anaerobically in heparinized
syringes and was immediately analysed for haemoglobin
concentration ([Hb]), oxygen saturation (SaO2) and the
partial pressure of oxygen (PaO2 ; ABL700; Radiometer,
Copenhagen, Denmark). Serum concentration of
erythropoietin (EPO) was assessed with an enzyme-
linked immunosorbent assay (ELISA) kit (R&D Systems,
Minneapolis, MN, USA). All blood analyses are shown
in Table 1. Serum EPO and [Hb] increased from
BL to HA, with values changing from 8.7± 3.7 to
12.2± 3.0 mIUml−1 and from 147± 8 to 170± 13 g l−1
(mean± SD), respectively. The arterial partial pressure
of CO2 (PaCO2) diminished from 40.6± 2.1 to
29.1± 2.0 mmHg as both PaO2 and SaO2 also decreased
from105.7± 15.7 and 98.5± 0.6 to 50.5± 3.0 mmHgand
83.6± 2.9%, respectively (Robach et al. 2007).
Skeletal muscle sampling
Skeletal muscle biopsies were obtained from the vastus
lateralis muscle under local anaesthesia (1% lidocaine) of
the skin and superficial muscle fascia, using the Bergstrøm
technique (Bergstrom, 1962) with a needle modified for
suction. The majority of the biopsy was directly dissected
free of fat and connective tissue, frozen in liquid nitrogen,
and stored at –80◦C for later analysis. A small section of
the muscle was then used immediately for measurements
of mitochondrial respiration.
Skeletal muscle preparation
The small portion of the muscle biopsy (2–6mg)
that was to be used to measure mitochondrial
respiration was immediately placed in ice-cold biopsy
preservation solution (BIOPS) containing 10mM
CaK2EGTA buffer, 7.23 mM K2EGTA buffer, 0.1μM free
calcium, 20mM imidazole, 20 mM taurine, 50mM 2-
(N-morpholino)ethanesulfonic acid hydrate (K-Mes),
0.5 mM dithiothreitol, 6.56 mM MgCl2.6H2O, 5.77 mM
ATP and 15mM phosphocreatine (pH 7.1). Muscle
samples were then gently dissected with two pairs of
sharp forceps, achieving a high degree of fibre separation,
which was verified microscopically, followed by chemical
permeabilization via incubation in 2ml of BIOPS with
saponin (50μgml−1) for 30min at 4◦C (Kuznetsov
et al. 2004). Samples were washed with a mitochondrial
respiration medium (MiR05) containing 0.5 mM EGTA,
3mMMgCl2.6H2O, 60mMpotassium lactobionate, 20mM
taurine, 10mM KH2PO4, 20mM Hepes, 110mM sucrose
and 1 g l−1 bovine serum albumin (pH 7.1), weighed,
and added to a respiratory chamber. This technique of
permeabilization allows for the study of mitochondrial
function ex vivo in intact skeletal muscle samples with
only very small biopsy samples using high-resolution
respirometry (Boushel et al. 2007).
Mitochondrial respiration
Muscle bundles were blotted andmeasured for wet weight
in a balance controlled for constant relative humidity,
providing hydration consistency and stability of weight
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measurements. Samples were then added to respective
chambers where respiration was observed in MiR05 at
30◦C using the high-resolution Oroboros Oxygraph-2k
(Oroboros, Innsbruck, Austria). The Oxygraph is a two-
chamber titration-injection respirometer with an oxygen
detection limit of up to 0.5 pmol s−1 ml−1. Standardized
instrumental calibrations were performed to correct
for back diffusion of oxygen into the chamber from
the various components, leak from the exterior, and
sensor oxygen consumption. Oxygen flux was resolved by
software allowing non-linear changes in the negative time
derivative of the oxygen concentration signal (Oxygraph
2k; Oroboros, Innsbruck, Austria). Data obtained at the
experimental temperature (30◦C) were multiplied by a T-
factor corresponding to a Q10 of 2 (multiplication factor
for a 10◦C difference) equalling 1.62 for extrapolation
to body temperature adjustments (Gnaiger, 2009). All
experiments were carried out in a hyperoxygenated
environment (chamber oxygen concentration maintained
above 300 nmol ml−1) to prevent potential limitations
in oxygen diffusion. All measurements were made in
duplicate.
Respiratory titration protocol
Titrations of all of substrates, uncouplers and inhibitors
(SUIT) were added in series. Leak respiration in the
absence of adenylates (LN) was induced with the addition
of malate (1.5 mM) and octanoyl carnitine (0.2 mM).
This state represents the oxygen consumption of an
unaltered and intact electron transport system in the
absence of adenylates. In the LN state, the chemiosmotic
gradient is at maximum and oxygen flux is at a
minimum, indicating proton leak, slip and cation cycling.
As all electron transport system complexes are coupled
in this state, all oxygen consumption represents the
spontaneous dyscoupling of the system (Pesta & Gnaiger,
2012). Lipid oxidative phosphorylation capacity (PETF)
and maximal electron flow through electron-transferring
flavoprotein (ETF) was determined following the addition
of ADP (4.8 mM). Electron-transferring flavoprotein is
located on the matrix face of the inner mitochondrial
membrane and supplies electrons from β-oxidation to
coenzymeQ (Eaton et al. 1996). The ETF-linked transfer
of electrons requires the metabolism of acetyl-CoA,
hence the addition of malate, in order to facilitate
convergent electron flow into the Q-junction from both
complex I (CI) and ETF, allowing β-oxidation to proceed.
The contribution of electron flow through NADH
dehydrogenase, CI, is far below capacity; therefore, the
rate-limiting metabolic branch here is electron transport
through ETF such that malate-+ octanoyl carnitine-
+ADP-stimulated respiration is representative of, rather
than specific to, electron capacity throughETF (Eaton et al.
1996; Saks et al. 1998;Gnaiger, 2009; Pesta et al. 2011; Pesta
& Gnaiger, 2012). Maximal CI specific state 3 respiratory
capacity (PCI) was induced with glutamate (19mM).
Previous data have demonstrated that octanolyl carnitine
+ malate respiration constitute approximately 30% of
respiration stimulated by octanoyl carnitine + malate +
glutamate (Pesta et al. 2011), supporting the suggestion
that electron transport through CI in the respiratory
state PETF is not at capacity. Furthermore, following
the titration of glutamate into the respiration medium,
electron transport through ETF is inhibited, isolating
the transport of electrons through CI (Saks et al. 1998).
Maximal state 3 respiration, oxidative phosphorylation
capacity (P), was induced with the addition of succinate
(9.5 mM). Maximal state 3 represents respiration that is
resultant to saturating concentrations of ADP as well as
substrates specific for CI and succinate dehydrogenase,
complex II (CII), and demonstrates the mitochondrial
capacity to catalyse a sequential set of redox reactions
that are partly coupled to the production of ATP via ATP
synthase. Convergent electron input to CI and CII has
been shown toprovidehigher respiratory values compared
with the isolated respiration of either CI (pyruvate
+ malate or glutamate + malate) or CII (succinate
+ rotenone; Gnaiger, 2009) and, accordingly, is more
representative and physiologically relevant to the study
of mitochondrial function. Inhibition of CI by addition of
rotenone (1μM) led to state 3 respiratory capacity specific
to CII (PCII). Oligomycin (1μM) was added to inhibit
ATP synthase, demonstrating oligomycin-induced leak
respiration (LOmy). Phosphorylative restraint of electron
transport through complex II was assessed by uncoupling
ATPsynthase (complex V) from the electron transport
system with the titration of the proton ionophore,
carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone
(FCCP; 0.7μM per addition up to optimal concentrations
ranging from 2.5 to 4μM). The integrity of the
outer mitochondrial membrane was assessed with the
addition of cytochrome c (19μM). Cytochrome c had no
additive effect on respiration (3.1 and 5.2% at BL and
HA, respectively), confirming mitochondrial membrane
intactness throughout all skeletal muscle samples. Finally,
antimycin A (12μM) was added to terminate respiration
by inhibiting cytochrome bc1 complex, allowing for the
determination of residual oxygen consumption in the
chamber. The concentrations of substrates and inhibitors
used were based on prior experiments conducted for
optimization of the titration protocols.
Data analysis
For all statistical evaluations, a P value of <0.05 was
considered significant. Statistical analysis of differences
in mitochondrial respiratory capacity between BL and
C© 2012 The Authors. Experimental Physiology C© 2012 The Physiological Society
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HA were calculated using a univariate analysis of variance
(SPSS Statistics 17.0, SPSS, Chicago, IL, USA). The effect
of high-altitude exposure on blood gases, haemoglobin,
serum EPO and maximal oxygen uptake from BL to HA
(two repeatedmeasures)were evaluatedwith theWilcoxon
test (StatviewVersion 5.0., SAS Institute,Cary,NC,USA).
Results
Mass-specific mitochondrial respiratory states
There were no significant changes in substrate-controlled
mass-specific respiration states when comparing BL with
HA (Fig. 1) for any respiratory states. There were no
differences in mass-specific leak respiration without
adenylates (LN, P = 0.824); the capacity for fatty acid
oxidation (PETF, P = 0.917); CI-specific oxidative capacity
(PCI; P = 0.479), CII-specific oxidative capacity (PCII;
P = 0.239); oligomycin-induced leak (LOmy) respiration
(P = 0.895); or residual oxygen consumption following
the addition of antimycin A (P = 0.871) when comparing
baseline values with those measured following 9–11 days
of high-altitude exposure. There was a trend, however,
for maximal oxidative phosphorylation (P) to decrease
following acclimatization (P = 0.059).
Mitochondrial efficiency and coupling control
Coupling control ratios indicative of the efficiency of
chemiosmotic coupling along the respiratory system were
examined (Table 2). In skeletal muscle mitochondria, the
ETF coupling control (the efficiency of electron transfer
Figure 1. Respiration measurements
Substrate uncoupler inhibitor titration (SUIT) protocol for skeletal muscle samples taken first at sea level, for baseline
(BL) measurements, and again following 11 days of high-altitude (HA) exposure (2 days at 3647 m and 7–9 days
at 4559 m). All titrations, presented from left to right, were added in series. Leak respiration in the absence of
adenylates (LN) was induced with the addition of malate (1.5 mM) and octanoyl carnitine (0.2 mM). Lipid oxidative
phosphorylation capacity (PETF) and maximal electron flow through electron-transferring flavoprotein (ETF) were
determined following the addition of ADP (4.8 mM). Maximal NADH dehydrogenase, complex I (CI), specific
state 3 respiratory capacity (PCI) was induced with glutamate (19 mM). Maximal state 3 respiration, oxidative
phosphorylation capacity (P), was induced with the addition of succinate (9.5 mM). Inhibition of CI by addition of
rotenone (1 μM) led to state 3 respiratory capacity specific to complex II (CII; PCII). Oligomycin (1 μM) was added to
inhibit ATP synthase, demonstrating oligomycin-induced leak respiration (LOmy). Differential respiratory capacities
across the mitochondrial respiratory system were made evident throughout the SUIT protocol utilized, validating
our mitochondrial preparation. In both conditions, BL and HA, respiration increased significantly following the
addition of ADP, again with the addition of glutamate, and increased even further in response to succinate. In
both conditions, respiration decreased with the inhibition of CI via rotenone, and was further diminished following
oligomycin-induced inhibition of ATP synthase. The calculation of statistical differences between respiratory states
and groups was performed using a multivariate analysis of variance. Values are presented as means ± SEM in units
of picomoles of O2 consumed per second per milligram tissue wet weight (pmol s−1 mg−1). † Difference from the
previous state of respiration (P < 0.001); and ‡ difference from same BL measurement (P = 0.059).
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Table 2. Mitochondrial efficiency
ETF coupling Respiratory Leak (LOmy)
Conditions control control ratio coupling control
BL 0.39 ± 0.02 4.44 ± 0.42 0.24 ± 0.02
HA 0.42 ± 0.02 4.02 ± 0.30 0.26 ± 0.02
Three separate coupling control ratios were determined
from mitochondrial respiration measurements made from
skeletal muscle tissue samples obtained at sea level for
baseline (BL) measurements and again following 11 days
of high-altitude (HA) exposure (2 days at 3647 m and 7–
9 days at 4559 m). Electron-transferring flavoprotein (ETF)
coupling control is the ratio between leak without adenylates
(LN) and maximal fatty acid oxidative capacity (PETF); the
classic respiratory control ratio (state 3/state 4 respiration) is
the ratio of maximal oxidative phosphorylation (P; state 3
respiration) and oligomycin-induced leak respiration (LOMY,
state 4 respiration); and leak coupling control is the ratio
between LOmy and P. Coupling control ratios are ratios of
oxygen flux at a specific and constant mitochondrial substrate
state. Values are presented as means ± SEM with P < 0.05.
from β-oxidation to coenzymeQ10), the respiratory
control ratio and the leak coupling control (the
efficiency of electron transfer down the electron transport
system) were all unaffected (P = 0.256, 0.422 and 0.530,
respectively) by exposure to high altitude.
Discussion
The main finding of this study is that mitochondrial
function is not greatly affected by 9–11 days of exposure
to high altitude. More specifically, the sojourn to
high altitude did not affect PETF or individualized
respiration capacity through complex I and II (PCI and
PCII, respectively). Chemiosmotic coupling efficiency,
as measured by ETF coupling control, leak control
coupling and the respiratory control ratio, was
not modified following acclimatization. Opposed to
declines in TCA- and oxidative phosphorylation-specific
enzymatic characteristics (Vigano` et al. 2008), the
functional capacity of mitochondria in skeletal muscle
is retained with subacute exposure to high altitude.
Of note, however, mass-specific maximal oxidative
phosphorylation capacity, P, in human skeletalmuscle did
express a trend (P = 0.059) to decrease after high-altitude
exposure.
Hypoxic influence on the mitochondria has become a
topic of interest because several mitochondrial proteins
have been identified as being regulated by hypoxia-
inducible factor (HIF; Semenza et al. 2006; Semenza,
2007). Although the data have been inconsistent, it
is generally assumed that hypoxic exposure has a
diminishing effect on mitochondria. Twenty-four hours
of hypoxic exposure reduced oxygen consumption in cell
suspensions of primary fibroblasts in a HIF-dependant
manner (Papandreou et al. 2006). Hypoxic exposure,
ranging from 9 to 75 days, has been shown to modify
skeletal muscle by affecting biochemical expression and
mitochondrial morphology (Mizuno et al. 1990, 2008;
Hoppeler & Vogt, 2001; Vogt et al. 2001; Hoppeler
et al. 2003; Lundby et al. 2003, 2009; Vigano` et al.
2008; Perrey & Rupp, 2009; Levett et al. 2012). The
physiological significance of thesemodifications, however,
is far from understood. The present study demonstrates
how respirometric analysis of mitochondrial function
is largely unaltered despite large (∼1.2- to 1.4-fold)
changes in mitochondrial proteins specific for the TCA
cycle or oxidative phosphorylation (Vigano` et al. 2008)
of similar exposure times. One drastic limitation of
many studies investigating biochemical adaptation in
skeletal muscle following hypoxic exposure is that they
are often limited in analysing only isolated enzymatic
modifications. Respirometric measurements allow for
more complete analysis of integrated cellular function. As
such, the data presented are more comprehensive because
they can differentiate between diminished expression of
an enzyme versus the functional capacity of a subcellular
system.
Functional measurements of oxidative capacity of
the skeletal muscle were largely unaffected following
high-altitude exposure. Supporting these data, we were
previously unable to detect differences in various
respiratory states using high-resolution respirometry
following intermittent hypoxic exposure for 4 weeks
at the equivalent of 3000m for 16 h day−1 (Robach
et al. 2012). The present study did, however, find a
trend suggestive of a lessened oxidative capacity in
skeletal muscle. The TCA-specific enzymes, such as
aconitase and oxoglutarate dehydrogenase, showed a
decrease following acclimatization (Vigano` et al. 2008)
and may serve to explain the trend for a decrease in
P. Aconitase facilitates the isomerization of citrate to
isocitrate; however, this occurs near equilibrium and is not
rate limiting. Oxoglutarate dehydrogenase, a rate-limiting
enzyme in the TCA cycle, catalyses the decarboxylation
of 2-oxoglutarate, the transfer of coenzyme A (CoA) to
what becomes succinyl-CoA, and the reduction of NAD+
to NADH, and functions in vivo near maximal enzymatic
rate (Read et al. 1977; Cooney et al. 1981). The enzyme
activity of oxoglutarate dehydrogenase has been reported
to serve as a reliable marker indicating the capacity of
oxygen consumption in vivo during maximal exercise
involving small and isolated muscle groups (Blomstrand
et al. 1997, 2011). When using NADH-related substrates,
such as malate and glutamate, TCA cycle metabolites
citrate and 2-oxoglutarate are exchanged for malate by
the tricarboxylate and2-oxoglutarate carriers, respectively,
reducing the contribution of electron transport from
NADHproducedvia the reaction catalysedbyoxoglutarate
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dehydrogenase (Gnaiger, 2009). As such, the measureable
decreases would not be expected for either PCI or PCII but
only for total respiratory capacity, P.
Maximal values of oxygen consumption when
performed in acute normoxic conditions were no
different from BL values (Fig. 2). A slightly depressed P
capacity would not be expected to limit V˙O2 max, because
mitochondrial respiratory capacity exceeds maximal
oxygen delivery during maximal whole-body exercise
(Boushel et al. 2011).
In the present study, mitochondria-specific enzymes
involved in fatty acid oxidation decreased after
high-altitude exposure. Specifically, trans-enoyl-CoA
isomerase, enoyl-CoA-hydratase and the carnitine
acetyltransferase decreased (Vigano` et al. 2008). The ETF
subunit declined in a similar manner with acclimatization
(Vigano` et al. 2008). These results support previous
findings that demonstrate a nutrient-partitioning shift
towards a greater dependency on glucose oxidation and
a reduction of lipid oxidation following acclimatization
(Cartee et al. 1991; Azevedo et al. 1995; Roberts et al.
1996; Braun, 2008). The present study shows that skeletal
muscle mitochondria retain respiratory capacity for fat
oxidation after high-altitude exposure.
One mechanism thought to affect mitochondrial
density in response to hypoxic adaptation is the
suppression of mammalian target of rapamycin and
subsequent protein synthesis (Murray, 2009). In the
present study, mammalian target of rapamycin decreased
(Vigano` et al. 2008), while whole-body protein break-
down increased (Holm et al. 2010). This is thought
to affect mitochondrial autophagic remodelling and
possibly suppress mitochondrial biogenesis. However,
maintenance of mitochondria-specific protein synthesis
has been reported despite global decreases in cellular
proliferation during the energetic stress associated with
caloric restriction in mice (Miller et al. 2012). Data
presented in the present study may suggest, similar to
those reported during caloric restriction, that overall
mitochondria-specific protein synthesis is maintained
along with functional parameters.
The fractional synthetic protein rate in the present
study was previously reported to increase in myofibrillar
compartments of the skeletal muscle but not in
sarcoplasmic compartments, suggesting that protein
turnover in the myofibrillar compartments may be
maintained while the subsarcolemmal compartment
experiences losses (Holm et al. 2010). Potential hypoxia-
mediated changes in mitochondrial physiology may affect
subpopulations of mitochondria in the skeletal muscle
differently. Two separate mitochondrial populations exist
in the skeletal muscle, the intermyofibrillar (IMF)
and the subsarcolemmal (SS) populations. The IMF
populations are situated near myofibrils and primarily
support the energetic requirements ofmuscle contraction,
while SS populations exist immediately beneath the
sarcolemma and support energetic requirements that
sustain membrane transport and cytoplasmic processes.
The biochemical characterization and regulation of these
two populations are different from one another (Krieger
et al. 1980; Cogswell et al. 1993; Iossa et al. 2002).
Recent evidence supports our previous findings (Holm
Figure 2. Maximal exercise capacity
Measurements of maximal oxygen consumption (in litres per minute) obtained at baseline sea level (BL), after
9–11 days of high-altitude exposure (HA), and again at high altitude with oxygen supplementation, i.e. acute
normoxia representing sea level (SL), using an incremental cycle ergrometer exercise protocol. Values are presented
as means ± SEM. ∗ Significant difference from SL (P < 0.05).
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et al. 2010), because subsarcolemmal mitochondrial
populations express a greater reduction in volume density
(73.1% loss) comparedwith intermyofibrillar populations
(14.3% loss) following acclimatization by 66 days of high-
altitude exposure (Levett et al. 2012). The extent to
which mitochondrial populations may be affected in
response to acclimatization as well as how these different
populations affect overall mitochondrial function require
further investigation.
Several studies have reported that there is an
improvement in mechanical efficiency during exercise
at sea level following prolonged or intermittent hypoxic
exposure (Green et al. 2000b; Gore et al. 2001; Katayama
et al. 2004; Saunders et al. 2009), while others have not
been able to verify any change in mechanical efficiency
(Lundby et al. 2007; Siebenmann et al. 2012). Our data
show that 9–11 days of exposure to high altitude has no
effect on respiratory chain electron slippage, proton leak
or coupling control, suggesting no change in metabolic
efficiency in skeletal muscle mitochondria following 9–
11 days of exposure to high altitude. In support of
these findings, we recently demonstrated, through similar
indices of mitochondrial coupling, that there is also
no evidence to suggest that respiratory system function
or efficiency is altered with 4 weeks of exposure to
intermittent hypoxia (Robach et al. 2012).
The findings in the present study may have direct
application to human performance at sea level and high
altitude.Wehavepreviously determined thatmass-specific
oxidative phosphorylation capacity in vastus lateralis is
the strongest determinant of endurance capacity at an
elevation of approximately 1000m (Jacobs et al. 2011).
Oxidative capacity remained largely unaltered following
9–11 days of high-altitude exposure, while haemoglobin
concentrations increased (Robach et al. 2007; Lundby
et al. 2008). Perhaps endurance capacity would improve,
as opposed to V˙O2 max which did not (Fig. 2), along with
the ability to transport oxygen upon returning to sea
level. Training in hypoxic conditions while living near
sea level has been thought possibly to improve exercise
performance at sea level. While hypoxic exercise training
does result in greater morphometric (Schmutz et al. 2010)
and biochemical expressions (Vogt et al. 2001) suggestive
of enhanced oxidative capacity in skeletal muscle, these
results do not translate into functional improvements in
exercise capacity at sea level (Vogt et al. 2001; Schmutz
et al. 2010; Vogt & Hoppeler, 2010). They do, however,
improve exercise capacity in hypoxia (Vogt & Hoppeler,
2010).
Determinants of exercise performance change as
elevation increases, shifting from more convective
limitations of oxygen transport and peripheral origin
of fatigue at lower elevations to diffusive limitations
of oxygen and centrally mediated origin of fatigue at
higher elevations (Amann et al. 2007; Robach et al. 2008;
Jacobs et al. 2012). Approximately 14 days was previously
determined appropriate to spend at moderate altitude
prior to a competition inorder to enhance exercise capacity
along with the improvement in oxygen-carrying capacity
(Schuler et al. 2007). As elevation increases, at somewhere
between 3500 and 4500m and above, the diffusive
limitations of oxygen transport negate improvements
in oxygen-carrying capacity (Robach et al. 2008; Jacobs
et al. 2012). Thus, maintaining mitochondrial capacity,
as is presented in the present study, or even enhancing
mitochondrial capacity (Vogt et al. 2001; Schmutz et al.
2010; Vogt & Hoppeler, 2010) may be necessary in order
to maintain, or improve, exercise capacity.
Critical variables that could intervene in the regulation
of whole-body exercise and skeletal muscle respiration
(i.e. physical activity, the time course of adaptation and
the severity of altitude) were taken into consideration
in the present study. Subjects were neither overly active
nor extensively sedentary prior to and again following
high-altitude exposure. Thus, training status did not
differ between baseline and high-altitude data collections,
which was verified by the similar measurements of
exercise capacity at BL and while given supplemental
oxygen at high altitude, acute normoxia (SL; Fig. 2).
Physical activity was also controlled for 3 days prior
to each data collection at both BL and HA. Although
physical activity cannot be conclusively ruled out as a
means for inducing any modification to mitochondrial
function, as a control group was never introduced, there
is strong evidence to suggest that our results were not
a product of any changes in activity. The adequacy
of the time course of acclimatization as well as the
severity of altitude are demonstrated by the blood gas
analyses, reduction of V˙O2 max, and increases in both
serum EPO and [Hb]. Several changes in different
proteins were also detected (Vigano` et al. 2008). Animals
exposed to hypoxia for different lengths of time have
shown contrasting results. Rats subjected to 11% O2
for 2 versus 4 weeks were reported to experience a
different influence on respiration inmitochondria isolated
from the right ventricle and left ventricle. Two weeks
of hypoxia significantly increased fatty acid-induced
state 3 respiration (malate and palmitoyl-L-carnitine) in
mitochondria isolated from the right ventricle but not
the left ventricle (Zungu et al. 2007), whereas 4 weeks
had no effect on right ventricular respiration but reduced
left ventricular ETF-specific state 3 respiration (Zungu
et al. 2008). Whether a longer duration of hypoxic
exposure or a different severity of hypoxia would alter
the results of the present study is unknown. Owing
to reported changes in mitochondrial characteristics in
skeletal muscle with longer exposures to high elevations
(Green et al. 1989; Hoppeler et al. 1990, 2003; Howald
et al. 1990; Levett et al. 2012), this question merits further
investigation.
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In conclusion, mitochondrial function does not appear
to be greatly affected by 7–9 days of acclimatization to
4559m (total of 9–11 days of high-altitude exposure) in
healthy lowlanders. We interpret our findings to suggest
that during the catabolic physiological state induced by a
subacute high-altitude sojourn (Holm et al. 2010), muscle
mitochondrial function is preserved to maximize oxygen
consumption in the face of a pronounced reduction in
oxygen transport capacity.
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ABSTRACT Modifications of skeletal muscle mito-
chondria following exposure to high altitude (HA) are
generally studied by morphological examinations and
biochemical analysis of expression. The aim of this
study was to examine tangible measures of mitochon-
drial function following a prolonged exposure to HA.
For this purpose, skeletal muscle biopsies were ob-
tained from 8 lowland natives at sea level (SL) prior to
exposure and again after 28 d of exposure to HA at
3454 m. High-resolution respirometry was performed
on the muscle samples comparing respiratory capacity
and efficiency. Exercise capacity was assessed at SL and
HA. Respirometric analysis revealed that mitochondrial
respiratory capacity diminished in complex I- and com-
plex II-specific respiration in addition to a loss of
maximal state-3 oxidative phosphorylation capacity
from SL to HA, all independent from alterations in
mitochondrial content. Leak control coupling, respira-
tory control ratio, and oligomycin-induced leak respira-
tion, all measures of mitochondrial efficiency, im-
proved in response to HA exposure. SL respiratory
capacities correlated with measures of exercise capacity
near SL, whereas mitochondrial efficiency correlated
best with exercise capacity following HA. This data
demonstrate that 1 mo of exposure to HA reduces
respiratory capacity in human skeletal muscle; however,
the efficiency of electron transport improves.—Jacobs,
R. A., Siebenmann, C., Hug, M., Toigo, M., Meinild,
A.-K., Lundby, C. Twenty-eight days at 3454-m altitude
diminishes respiratory capacity but enhances efficiency
in human skeletal muscle mitochondria. FASEB J. 26,
000–000 (2012). www.fasebj.org
Key Words: acclimatization  exercise  mitochondrial efficiency
 respiratory control
The majority of our understanding regarding skele-
tal muscle mitochondrial changes when exposed to
hypoxia comes from morphological examinations and
biochemical analysis of expression following some de-
gree of hypoxic exposure. Studies conducted in com-
bination with mountain climbing expeditions to Mt.
Everest have reported severe decrements in mitochon-
drial volume (1, 2) paralleled by losses in mitochon-
dria-specific enzymes (1, 3) attendant to an extended
exposure to extreme high altitude (HA; 5000 m).
Other studies fail to corroborate these findings (4–6),
as they report negligible losses in mitochondrial en-
zymes following extreme HA exposure. Another com-
plication to data interpretation is the allusion that these
static measurements can accurately characterize
changes in functional parameters of mitochondria.
We previously reported that 9–11 d of exposure to
HA did not largely affect oxidative capacity or efficiency
of electron transport in human skeletal muscle (7). The
preservation of mitochondrial function occurred in the
face of pronounced reductions in several mitochon-
1 Correspondence: Institute of Physiology, ZIHP, University
of Zürich, Office 23 H 6, Winterthurerstrasse 190, 8057
Zürich, Switzerland. E-mail: carsten.lundby@access.uzh.ch
doi: 10.1096/fj.12-218206
Abbreviations: BIOPS, biopsy preservation solution; CI,
complex I (NADH dehydrogenase); CII, complex II (succi-
nate dehydrogenase); COX, cytochrome-c oxidase; CS, citrate
synthase; ETF, electron-transferring flavoprotein; ETS, elec-
tron transport system respiratory capacity; Fio2, oxygen frac-
tion of inspired air; FCCP, carbonyl cyanide p-(trifluorome-
thoxy) phenylhydrazone; HA, high altitude; HH, hypobaric
hypoxia; LCR, leak control ratio; LCRETS, leak control ratio of
oligomycin-induced leak respiration to electron transport
system respiratory capacity; LN, normal leak respiration;
LOMY, oligomycin-induced leak respiration; MiR05, mito-
chondrial respiration medium 05; MiR06, mitochondrial res-
piration medium 06 (MiR05  catalase); MOM, mitochon-
drial outer membrane; NH, normobaric hypoxia; P, maximal
state 3 respiration or oxidative phosphorylation capacity; PCI,
submaximal state 3 respiration specific to complex I; PCII,
submaximal state 3 respiration specific to complex II; PETF,
fatty acid oxidative capacity; RCR, respiratory control ratio;
ROX, residual oxygen consumption; SL, sea level; TMPD,
N,N,N=,N=-tetramethyl-1,4-benzenediamine, dihydrochloride;
Vo2max, maximal oxygen consumption; Wmax, maximal power
output; ww, wet weight
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dria-specific proteins (8). Duration of hypoxic expo-
sure, however, has considerable effect on physiological
adaptation. Shorter durations of hypoxic exposure
have failed to affect mitochondrial volume density (1)
and mitochondrial enzyme expression (9) while longer
durations led to a decrease in both parameters (1, 9).
Our previous findings (7) directly demonstrated that
relying exclusively on static measurements for the char-
acterization of mitochondrial function and oxidative
potential is insufficient. Respirometric analysis in con-
junction with biochemical assessments is more appro-
priate to differentiate between changes in enzymatic
expression vs. an alteration in the functional capacity of
a subcellular system. In the current study, we assessed
mitochondrial respiratory chain function and biochem-
ical expression of mitochondria-specific enzymes in
permeabilized skeletal muscle fibers near sea level (SL)
and again after 28 d of exposure to HA. We hypothe-
sized that the previous trend for a diminished oxidative
phosphorylation capacity (7) will become more pro-
nounced following a longer exposure to HA.
MATERIALS AND METHODS
Ethical approval
Experimental protocols involving human subjects were ap-
proved by the Ethical Committee for the Eidgenössische
Technische Hochschule Zürich (EK 2011-N-51), in accor-
dance with the declaration of Helsinki. Prior to the start of
the experiments, informed oral and written consents were
obtained from all participants.
Subjects
Eight young and physically active lowland male subjects
voluntarily participated in this study. Subject characteristics
(meanssd) were age 26  4 yr, height 180  1 cm, and
weight 76  6 kg. All subjects were recreationally active; they
were neither excessively sedentary nor highly trained. The
subjects had a baseline maximal oxygen uptake (Vo2max) of
3.9  0.3 L/min and maximal power output (Wmax) of 321 
28 W, assessed during an incremental test to exhaustion at SL.
None of the subjects were taking any medications or had any
known family history of type 2 diabetes, severe obesity, or
cardiovascular diseases. Subjects were scanned for body com-
position in a dual-energy X-ray absorptiometer (Lunar iDXA;
GE Healthcare, Madison, WI, USA) prior to HA ascent and
again 1–3 d after return to sea level.
Experimental design
Subjects reported to the laboratory in Zurich (432 m) several
times throughout a 5-wk duration prior to HA ascent for
acquisition of baseline (SL) measurements. Subsequently,
subjects were transported by train to an HA research station
located at the Jungfraujoch Research Station in the Swiss Alps
(3454 m). Here, all subjects remained for the next 28 d. The
ascent profile was uniform across all subjects.
Exercise tests
Exercise tests to obtain values of Vo2max were completed
on an electronically braked bicycle ergometer (Monark,
Varberg, Sweden). The exercise protocol started with a 5-min
collection of resting Vo2 followed by 2 consecutive absolute
submaximal workloads, 100 and 150 W, in normoxia and 75
and 125 W in hypoxia, that were maintained for 5 min each.
Thereafter, the workload increased 25 W/min until voluntary
exhaustion. During the last minutes of the test, subjects were
vigorously encouraged to perform to complete exhaustion,
and the achievement of Vo2max was established by standard
criteria in all tests (10). Subjects wore a face mask covering
their mouth and nose for breath collection (Hans Rudolph,
Kansas City, MO, USA), and O2 and CO2 concentrations in
the expired gas were continuously measured and monitored
as breath-by-breath values (Innocor, Innovision, Odense,
Denmark). The gas analyzers and the flowmeter of the
applied spirometer were calibrated prior to each test.
In total, subjects completed 4 maximal exercise tests. The
first was an initial normobaric normoxia test (SL baseline). At
3 d after the SL test, a normobaric hypoxia (NH) test took
place where the subjects breathed a hypoxic mixture (oxygen
fraction of inspired air Fio20.134; Alti-Trainer; SMTEC,
Nyon, Switzerland), approximately the equivalent of breath-
ing at 3500 m. The third test was a short-term hypobaric
hypoxia (HH) test, performed on d 8 following arrival at 3454
m. The last test was a chronic hypobaric hypoxia Vo2max test
completed within the final 2 d of the 28-d exposure to 3454 m
(HA test).
Skeletal muscle sampling
Skeletal muscle biopsies were obtained from the m. vastus
lateralis at SL and again after 28 d of exposure to HA at 3454
m. Samples were collected under local anesthesia (1% lido-
caine) of the skin and superficial muscle fascia, using the
Bergström technique (11) with a needle modified for suction.
The biopsy was immediately dissected free of fat and connec-
tive tissue and divided into sections for measurements of
mitochondrial respiration.
Skeletal muscle preparation
The biopsy was sectioned into parts to measure mitochondrial
respiration. Each part was immediately placed in ice-cold
biopsy preservation solution (BIOPS) containing 2.77 mM
CaK2EGTA buffer, 7.23 mM K2EGTA buffer, 0.1 M free
calcium, 20 mM imidazole, 20 mM taurine, 50 mM 2-(N-
morpholino)ethanesulfonic acid hydrate (K-MES), 0.5 mM
dithiothreitol (DTT), 6.56 mM MgCl2 · 6H2O, 5.77 mM ATP,
and 15 mM phosphocreatine (pH 7.1). Muscle samples were
then gently dissected with the tip of two 18-gauge needles,
achieving a high degree of fiber separation verified micro-
scopically, followed by chemical permeabilization via incuba-
tion in 2 ml of BIOPS with saponin (50 g/ml) for 30 min in
4°C (12). Lastly, samples were washed with mitochondrial
respiration medium 05 (MiR05) containing 0.5 mM EGTA, 3
mM MgCl2 · 6H2O, 60 mM K-lactobionate, 20 mM taurine, 10
mM KH2PO4, 20 mM HEPES, 110 mM sucrose, and 1 mg/ml
BSA (pH 7.1) for 10 min in 4°C.
Mitochondrial respiration measurements
Muscle bundles were blotted dry and measured for wet weight
(ww) in a balance-controlled scale (XS205 DualRange Ana-
lytical Balance; Mettler-Toledo AG, Greifensee, Switzerland)
maintaining constant relative humidity, providing hydration
consistency, as well as stability of weight measurements.
Respiration measurements were performed in mitochondrial
respiration medium 06 (MiR06; MiR05  catalase 280 IU/
ml). Measurements of oxygen consumption were performed
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at 37°C using the high-resolution Oxygraph-2k (Oroboros,
Innsbruck, Austria) with all additions in each substrate,
uncoupler, and inhibitor titration protocol added in series.
Standardized instrumental calibrations were performed to
correct for back diffusion of oxygen into the chamber from
the various components, leak from the exterior, oxygen
consumption by the chemical medium, and sensor oxygen
consumption at SL and at HA. Chemical calibrations were
performed to determine, and later control for, the amount of
nonmitochondrial autooxidation that occurs in the respira-
tory chambers during cytochrome-c oxidase (COX) analysis at
SL and HA. For this calibration, we measured oxygen con-
sumption over time in the respiratory chamber using MiR06,
free of any biological sample, with the additions of cyto-
chrome c (10 M), ascorbate (2 mM), and N,N,N=,N=-tetram-
ethyl-1,4-benzenediamine, dihydrochloride (TMPD; 500 M)
titrated into the chamber. With this calibration, we are able to
establish the linear relationship between the degree of non-
biological oxygen consumption via auto-oxidation of chemi-
cals added to the medium across different oxygen concentra-
tions within the chamber. Oxygen flux was resolved by
software, allowing nonlinear changes in the negative time
derivative of the oxygen concentration signal (DatLab; Oro-
boros, Innsbruck, Austria). All experiments were carried out
in a hyperoxygenated environment to prevent any potential
oxygen diffusion limitation, with oxygen concentration within
the chamber ranging between 250 and 400 M.
Respiratory titration protocols
Two different titration protocols were applied in the study
(Table 1). Each protocol was specific to the examination of
individual aspects of respiratory control through a sequence
of coupling and substrate states induced via separate titra-
tions. Protocol 1 was specific for the analysis of respiratory
capacity and coupling control efficiency during both fatty
acid oxidation and maximal oxidative phosphorylation, and
also coupling control efficiency during submaximal state 3
respiration specific to complex II [CII (succinate dehydroge-
nase); PCII]. Protocol 2 was specific for the analysis of
respiratory capacity and coupling control efficiency during
submaximal state 3 respiration specific to complex I [CI
(NADH dehydrogenase); PCI], as well as respiratory capacities
of maximal state 3 respiration and PCII. All respirometric
analyses were made in duplicates, and all titrations were
added in series as presented. The concentrations of sub-
strates, uncouplers, and inhibitors used were based on prior
experiments conducted for optimization of the titration
protocols. Protocols 1 and 2 were modified from refs. 7 and
13, respectively.
Protocol 1
Normal leak respiration (LN) in absence of adenylates was
induced with the addition of malate and octanoyl carnitine.
The LN state represents the resting oxygen consumption of an
unaltered and intact electron transport system free of adenyl-
ates. Maximal electron flow through electron-transferring
flavoprotein (ETF) and fatty acid oxidative capacity (PETF)
were determined following the addition of ADP. In the PETF
state, the ETF-linked transfer of electrons requires the metab-
olism of acetyl-CoA, hence, the addition of malate, in order to
facilitate convergent electron flow into the Q junction from
both CI and ETF, allowing -oxidation to proceed. The
contribution of electron flow through CI is far below capacity,
and so, here, the rate-limiting metabolic branch is electron
transport through ETF, such that malate  octanoyl carnitine 
ADP-stimulated respiration is representative of, rather than
specific to, electron capacity through ETF (7, 14–17). PCI was
induced following the additions of pyruvate and glutamate.
Maximal state 3 respiration or oxidative phosphorylation
capacity (P) was then induced with the addition of succinate.
This maximal state 3 state represents respiration that is
resultant to saturating concentrations of ADP and substrate
supply for both CI and CII. Convergent electron input to CI
and CII provides higher respiratory values compared to the
isolated respiration of either CI (pyruvate/glutamate 
malate or glutamatemalate) or CII (succinate rotenone)
(15, 18). Consequently, P presents more physiological rele-
vance to the study of mitochondrial function (19) and is
necessary to establish confirmation of a complete and intact
electron transport system. P demonstrates a naturally intact
electron transport system’s capacity to catalyze a sequential
set of redox reactions that are partially coupled to the
production of ATP via ATP synthase. Compared to a corre-
spondent leak state with an equivalent substrate supply, P
maintains a lower electrochemical gradient across the inner
mitochondrial membrane. That gradient is dictated by the
degree of coupling to the phosphorylation system (15, 16). As
an internal control for compromised integrity of the mito-
chondrial preparation, the mitochondrial outer membrane
(MOM) was assessed with the addition of cytochrome c.
Oligomycin was added, inhibiting ATP synthase, demonstrat-
ing oligomycin-induced leak respiration (LOMY). The LOMY
state is the corresponding leak state to P and is comparable to
classic state 4 respiration (20). In LOMY, the chemiosmotic
gradient is at maximum, resultant to the combination of
maximal substrate supply and inhibition of ATP synthase.
Oxygen flux is at a minimum and is representative of proton
leak, slip, cation cycling, and overall dyscoupling (15, 16, 19,
21). Phosphorylative restraint of electron transport was as-
sessed by uncoupling ATP synthase (complex V) from the
electron transport system with the titration of the proton
ionophore, carbonyl cyanide p-(trifluoromethoxy) phenylhy-
drazone (FCCP) reaching the electron transport system re-
spiratory capacity (ETS) state. The inner mitochondrial mem-
brane potential is completely collapsed, with an open
transmembrane proton circuit, in the ETS respiratory state.
The uninhibited flow of electrons through the respiratory
system can, therefore, indirectly serve as an indication of
maximal mitochondrial membrane potential. Rotenone and
TABLE 1. Titration protocols
Protocol
Substrate, uncoupler, and inhibitor
concentrations
1 M (2 mM), OC (0.2 mM), ADP (5 mM).
P (5 mM), G (10 mM, ) S (10
mM), Cyt C (10 M), O (1
M), FCCP (1.5–3 M), Rot (0.5
M), AmA (2.5 M)
2 M (2 mM), P (5 mM), G (10
mM), ADP (5 mM), S (10 mM), Cyt
C (10 M), Rot (0.5 M), AmA (2.5
M), Asc (2 mM), a TMPD (500 M)a
Two different titration protocols were used in this study, and are
indicated as protocol 1 and protocol 2 in the left column. Right
column shows the sequence and concentration of substrates, uncou-
plers, and inhibitors added during respirometric analysis. M, malate;
OC, octanoyl carnitine; ADP, adenosine diphosphate; P, pyruvate; G,
glutamate; S, succinate; Cyt C, cytochrome c; O, oligomycin; FCCP,
carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone; Rot, rote-
none; AmA, anti-mycin a; Asc, ascorbate; TMPD, N,N,N=,N=-tetram-
ethyl-1,4-benzenediamine, dihydrochloride. aImmediate sequential,
nearly simultaneous, addition to the respiration medium within the
chamber.
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antimycin A were added, in sequence, to terminate respira-
tion by inhibiting CI and complex III (cytochrome bc1
complex), respectively. With CI inhibited, PCII can be mea-
sured. Inhibition of respiration with antimycin A then allows
for the determination and correction of residual oxygen
consumption (ROX), indicative of nonmitochondrial oxygen
consumption in the chamber.
Protocol 2
LN was induced with the addition of malate, pyruvate, and
glutamate. PCI and maximal electron flow through CI were
determined following the addition of ADP. P was then
induced with the addition of succinate. Cytochrome c was
added to validate the integrity of the MOM. Rotenone was
added to inhibit electron flow through CI to achieve PCII.
Antimycin A was added, inhibiting respiration through com-
plex III, allowing for the determination of ROX. Finally,
ascorbate and TMPD were simultaneously titrated into the
chambers to assess COX (complex IV) activity. TMPD and
ascorbate are redox substrates that donate electrons directly
to COX, and activity was measured by pmol O2 · min
1 · mg
ww1. COX activity has been shown to strongly correlate with
mitochondrial volume density and total cristae area (both
measured via transmission electron microscopy) in addition
to respiratory capacity (21).
Validation of titration protocols and mitochondrial
membrane integrity
Differences in individual respiratory state capacities across
the mitochondrial respiratory system were made evident
throughout each of the titration protocols utilized at both SL
and HA. Respirometric analysis from protocol 1 is repre-
sented in Fig. 1A. Sequential changes in respiratory states at
SL and HA confirm that all skeletal muscle preparations and
protocols were successful in producing valid responses.
Malate- and octanoyl carnitine-induced leak respiration, LN,
increased (P0.001) following the addition of ADP, signify-
ing the capacity for fatty acid oxidation, PETF. There was
another increase from PETF following the addition of pyruvate
and glutamate, stimulating PCI (P0.001). Respiration again
increased (P0.001) with succinate addition, representing P.
There was no increase (P0.894) from P after cytochrome c
addition, verifying an intact MOM. Respiration did then
decrease (P.001) following the addition of oligomycin into
the respiration medium, achieving LOMY. Uncoupling elec-
tron transport through complexes I–IV from ATP synthase
increased (P0.001) oxygen consumption to a maximum at
ETS state. Respiration was reduced (P0.001) after inhibition
of CI with rotenone, generating PCII. Finally, respiration
diminished (P0.001) to an absolute minimum following the
addition of anti-mycin, achieving ROX.
Respirometric analysis from protocol 2 is represented in
Fig. 1B. Both SL and HA measurements show that malate-,
pyruvate-, and glutamate-induced LN increased (P0.001)
with the addition of ADP, signifying PCI. Respiration in-
creased (P0.001) again following succinate addition, reach-
ing P. There was no increase (P0.807) from P once cyto-
chrome c was added, verifying an intact MOM. Respiration
then decreased (P0.001) following the addition of rotenone
after inhibition of CI with rotenone, achieving PCII, and again
(P0.001) following the addition of anti-mycin, achieving
ROX.
Citrate synthase (CS) activity
CS activity was assayed in homogenates of the skeletal
muscle samples used in respiration measurements. The
contents of the Oxygraph-2k chambers (2 ml each) were
removed after each respiration experiment and washed
once with 2 ml of MiR05. Triton X-100 (1%) and 2 l of a
protease inhibitor cocktail (cat. 539134; Sigma-Aldrich, St.
Louis, MO, USA) were added to the combined solutions
(content and wash) and then homogenized for 30 s with a
T10 basic Ultra-Turrax homogenizer (IKA, Staufen, Ger-
many) near maximum speed. The homogenate was then
centrifuged for 15 min at 4°C, and the supernatant was
removed, frozen in liquid nitrogen, and stored at 80°C.
As has been previously described (22), CS activity was
measured fluorometrically at 412 nm and 25°C (CS assay
kit; Sigma-Aldrich), according to the manufacturer. The
Figure 1. Respirometric analysis protocols. Titration protocols for skeletal muscle samples with all titrations, presented from left
to right, added in series. A) Protocol 1 induced LN; maximal electron flow through ETF and PETF; PCI; P, an internal control
for compromised integrity of the mitochondrial preparation, the MOM, assessed with the addition of cytochrome c (Cyt C);
LOMY; ETS state; PCII; and ROX. B) Protocol 2 induced LN; PCI; P, assessed with Cyt C; PCII; and ROX. Shaded bars indicate the
collective average from all baseline (SL) and HA respirometric measurements. Individual data are reported for each respective
respiratory state as SL measurements (solid circles) or HA measurements (open circles). *P  0.001.
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strength of association between CS activity and mitochon-
drial volume density, total cristae area, and respiratory
capacity has previously been demonstrated (21).
Data analysis
For all statistical evaluations, a value of P  0.05 was consid-
ered significant. Various statistical models were used for
analysis (SPSS Statistics 17.0; SPSS, Chicago, IL, USA). Paired-
sample t tests were used to test the null hypothesis stating no
difference between SL and HA values for body composition,
body weight, CS and COX activities, mitochondrial respira-
tory capacities (normalized to corresponding CS activities),
and mitochondrial efficiency. The sequential Vo2max and
Wmax were analyzed by a 1-way ANOVA on repeated measure-
ments. In addition to CS activity, mass-specific respiration was
also normalized to COX activity [(respiratory state/COX) 
100], and respiratory capacities as a percentage of COX were
analyzed with a 1-way ANOVA. Whenever an ANOVA showed
significance, the differences were examined using pairwise
comparisons with a Bonferroni adjustment. Linear regression
was used to calculate the strength of association between P
and COX activity, as well as parameters of mitochondrial
respiratory capacity and efficiency, with corresponding mea-
surements of exercise capacity at both SL and HA.
RESULTS
Body composition and weight
Neither percentage body fat from total mass (16.34.7
to 16.14.6%), as measured by DEXA, nor body weight
(76.15.8 to 75.85.6 kg) were different following
altitude exposure.
Maximal exercise capacity and power output
All Vo2max and Wmax data are presented in Fig. 2. SL Vo2max
values (52.04.3 ml·min1·kg1) were significantly greater
(P0.001) than NH (44.43.7 ml·min1·kg1), HH
(43.83.6 ml·min1·kg1), and HA (42.8ml·min1·kg1)
values. There was no difference in Vo2max values across all
tests done in hypoxia. Wmax also decreased (P0.05) from
the SL (32128 W) test when compared to HN (25420 W;
P0.001), HH (27720 W; P0.037), and HA (27541 W;
P0.029). There were no differences in Wmax values across
all tests done in hypoxia.
CS and COX activities
There were no measurable changes in skeletal muscle
mitochondrial content over time from SL to HA, as
indicated by the negligible changes in CS (22.66.7 to
24.54.9 nmol·min1·mg ww1, P0.560) and COX
(11221 to 11651 pmol O2·min
1·mg ww1, P0.845)
activities.
Respirometric analysis across time, in response to HA
exposure
Respiratory states that were achieved in both titration
protocols (LN, PCI, P, and PCII) did not significantly differ
between protocols at SL or HA and were consequently
grouped together, with respect to time, for analysis. The
respiratory states that significantly changed in response
to HA exposure were LN (P0.036), PCI (P0.035), P
(P0.042), PCII (P0.031), and LOMY (P0.007). All
respiratory states exhibited a loss of capacity following the
altitude exposure (Fig. 3A).
Associations between COX activity and oxidative
phosphorylation capacity
When normalizing respiration rates to COX activity,
analysis also showed that PCI (P0.002), P (P0.002),
and PCII (P0.027) diminished from SL to HA (Fig.
3B). LN respiration had a tendency (P0.06) to de-
crease. Pearson correlation analysis of mass-specific
(pmol O2·min
1·mg ww1) P and COX (Fig. 4) show a
positive correlation at both SL (P0.022) and at HA
(P0.013), with Pearson correlation coefficients of
0.782 and 0.819, respectively.
Mitochondrial coupling efficiency
Mitochondrial leak control and coupling control ratios
were analyzed (Table 2). The leak control ratio (LCR)
of LOMY to ETS respiratory state (LCRETS), indicative of
coupling efficiency across the entire respiratory chain,
demonstrated an improvement (P0.047) following
HA exposure. The respiratory control ratio (RCR),
ratio of maximal state 3 respiration, P, to state 4
respiration, LOMY, was the only coupling control ratio
that significantly (P0.037) improved with HA expo-
sure.
Association between mitochondrial parameters and
maximal whole-body oxygen consumption near SL
and at HA
Independent linear regression analyses showed strong
positive relationships between SL mitochondrial respi-
ratory capacities and SL Vo2max values, including PCI
Figure 2. Maximal oxygen consumption and power output.
Measurements of Vo2max (left y axis) are represented by
circles and Wmax (right y axis) by triangles throughout the
duration of the study (x axis). *P  0.05 vs. normoxic values.
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and P as the best (r20.594 and 0.575, P0.021 and
0.024, respectively), while there were no significant
correlations with SL mitochondrial efficiency. Alterna-
tively, exercise capacity measured at HA following 28 d
of HA exposure correlated best with indices of mito-
chondrial efficiency, specifically RCR and LCRETS
(r20.442 and 0.464, respectively, P0.05). All signifi-
cant correlations between exercise capacity and mito-
chondrial respiratory capacity were lost following HA
exposure, with the best correlation being PETF (r
20.204,
P0.154).
DISCUSSION
There are several new findings gained through these
experiments. First, respiratory capacity of the skeletal
muscle is attenuated with 28 d of exposure to 3454 m
altitude. Second, this loss occurred independently from
any decrement in mitochondrial content, as indicated
by unchanged CS and COX activities. Third, indices of
mitochondrial efficiency improved following HA expo-
sure, providing evidence for an enhancement in skele-
tal muscle mitochondria coupling efficiency. Fourth,
whereas mitochondrial respiratory capacity strongly
correlates with exercise capacity near sea level, exercise
capacity in hypoxia following HA exposure exhibits
better concordance with the efficiency of electron
transport in skeletal muscle.
Respiratory control with HA exposure
We have previously shown negligible changes in mito-
chondrial function in 10 human subjects following 2 d
of exposure to 3647 m and another 9 at 4559 m (7).
There was, however, a tendency (P0.059) for respira-
tion to decrease with HA exposure. Here, we show that
mitochondrial oxidative capacity is diminished with 28
d of HA exposure (Fig. 3). Our past findings combined
with these current results suggest that there is a pro-
gressive loss of skeletal muscle respiratory capacity with
HA exposure, and this attenuation is dependent on the
length of exposure. The influence of elevation on these
mitochondrial alterations cannot be stated, as only one
altitude (3454 m) has been shown to alter respiratory
control of the muscle.
Morphological vs. functional changes in mitochondria
with HA exposure
The current study detected a loss of respiratory capacity
independent from changes in mitochondria-specific
enzymes, CS and COX. Although we previously re-
ported the loss of certain proteins specific to the
mitochondria (8), we did not assess alterations in either
CS or COX. Both of these enzymes possess extremely
Figure 3. Mitochondrial respiratory capacities. Respirometric analysis was collected from the skeletal muscle in 8 subjects during
baseline (SL) collections and then again following 28 d of HA exposure at 3454 m (HA) A) LN, PETF, PCI, P, PCII, LOMY, and
ETS state. Solid bars represent SL measurements; open bars represent HA measurements. Data are presented as means  se.
B) Analysis of LN, PCI, P, and PCII as a percentage of COX activity. Shaded bars represent COX activity, set to 100%. Solid bars
represent SL measurements, open bars represent HA measurements. Data are presented as means  sd. *P  0.05 for HA vs.
SL values.
Figure 4. Correlation between COX and P. Pearson correla-
tion coefficients were calculated to investigate the correlation
between P and COX activity at baseline (SL; black circles) and
again following 28 d exposure to 3454 m (HA; white circles)
with Pearson correlation coefficients of 0.782 and 0.819,
respectively. Solid line represents the regression line for the
correlation at SL; dotted line represents the regression line
for the correlation at HA.
6 Vol. 26 December 2012 JACOBS ET AL.The FASEB Journal  www.fasebj.org86
tight associations with mitochondrial volume density,
total cristae area, and mass-specific respiratory capacity
of human skeletal muscle and thus serve as reliable
biomarkers of mitochondrial volume and content in
skeletal muscle (21). We confirm these reports, as we
found COX activity to strongly correlate with mass-
specific P at both SL and HA (Fig. 4). Previous studies
have failed to observe a change in CS after a 21-d
expedition to 6194 m (4), after 14 and 31–32 d of
incremental hypoxic exposure (9), and following 75 d
of exposure to 5250 m (6). We also failed to detect a
change in CS activity, suggesting that functional modi-
fications of cellular oxygen utilization occur in skeletal
muscle mitochondria with hypoxic exposure.
Several studies report that lowland natives participat-
ing in high/extreme-altitude expeditions experience
losses of mitochondrial volume and content by 	20–
25% (1–3). However, the experimental designs of these
studies were to accompany mountain climbing expedi-
tions to extreme altitudes and record the physiological
adaptations during such a tremendous event. The
energy expenditure resulting from the extreme physi-
cal rigors of high/extreme-altitude mountaineering
alone (23) often results in significant losses in both
body and skeletal muscle mass (2, 6, 9, 24). This limits
the ability to distinguish hypoxia-facilitated changes in
mitochondria from those associated with either partic-
ipation in extreme endurance events or energy balance
(25). Negligible differences in body fat percentages
along with preservation of total body mass and Wmax in
the present study imply maintenance of energy balance
and suggest that the effects on the mitochondria were
the result of HA exposure per se.
Mitochondrial efficiency with HA exposure
Indices of coupling efficiency improved (Table 2),
while LOMY respiration decreased, with 28 d of HA
exposure (Fig. 3A), all of which demonstrate an im-
provement in mitochondrial efficiency. The leak state
LOMY is directly reflective of proton leak across the
mitochondrial inner membrane using in situ mitochon-
drial preparations (19). We previously failed to observe
improvements in several indices of mitochondrial effi-
ciency following 4 wk of exposure to the equivalent of
3000 m normobaric hypoxia for 16 h/d (26) and then
again in subjects exposed to 4559 m for 11 d (7). Here,
we calculated both leak control and coupling control
ratios as an indication of mitochondrial efficiency.
LCRs are produced between two respiratory states, a
leak state (i.e., low respiration, state 4) to a higher
respiratory state (i.e., fatty acid oxidation, submaximal
state 3). These corresponding states are paired by an
identical substrate supply. The reference state is de-
fined by the leak state, i.e., flux in the PETF state is
greater than in the LN state, given the same substrate
supply (malate  octanoyl carnitine) and serves as the
reference state. LCRs help describe mitochondrial cou-
pling efficiency, with a theoretical minimum of 0.0,
indicating a fully coupled system, to a value of 1.0,
representing a fully noncoupled (dyscoupled) system
(15). Alternatively, coupling control ratios are based on
the theory that a tightly coupled electron transport
system is distinguished from a dyscoupled system by the
magnitude of difference between two steady respiratory
states, with the reference state being the state defined
by the minimum oxygen flux (20). The most common
coupling control ratio is the RCR (state 3 respiration/
state 4 respiration). In the previous study in which we
failed to identify a change in mitochondrial efficiency
following 4 wk of intermittent hypoxic exposure, we
analyzed the LCR for efficiency of electron transport
through CI (LCRCI; leak state being malate- pyruvate-
stimulated LN and respiratory state being PCI) and the
reciprocal coupling control ratio (PCI/LN) (26). Here,
we support these findings, as there were also no im-
provements to these specific indices of mitochondrial
coupling efficiency following HA exposure (Table 2).
We did, however, fail to observe the current findings
when subjects were exposed to HA for only 11 d (7).
Thus, alterations in mitochondrial efficiency also ap-
pear to be dependent on duration of hypoxic exposure.
Phosphorylation efficiency has been reported to
drop with ADP limitation at high oxygen levels, and
then improve at low oxygen tensions (27). Proton leak
and uncoupled respiration were found to be repressed
in low oxygen, which, in turn, reduces energy expendi-
ture for membrane potential maintenance (27). This
hypoxia-induced improvement in bioenergetic effi-
ciency suggests a decrease of mitochondrial oxidant
production, as mitochondrial production of superox-
ide is closely related to mitochondrial coupling effi-
TABLE 2. Mitochondrial efficiency
Condition LCRETF LCRCI LCRCII LCRETS RCR PSCR
SL 0.23  0.13 0.08  0.03 0.50  0.10 0.31  0.09 3.23  0.85 1.10  0.34
HA 0.13  0.08 0.04  0.03 0.42  0.12 0.23  0.06* 3.84  0.78* 1.17  0.18
Data are presented as means  sd. Various determinations of mitochondrial coupling efficiency were collected at baseline (SL) and then
again after 28 d of exposure to 3454 m (HA). Indices of efficiency included leak control ratios (LCRs) for the efficiency of electron transfer
through ETF during  oxidation (LCRETF; ratio of LN to PETF); during CI respiration (LCRCI; ratio of LN to PCI); CII respiration (LCRCII; ratio
of LOMY to PCII); and efficiency across the entire electron transport system (LCRETS; ratio of LOMY to ETS state); and coupling control ratios for
the degree of coupling across the entire respiratory system with the respiratory control ratio (RCR; ratio of P to LOMY) and for the degree of
dyscoupling as a result of the phosphorylative restraint on electron transport through complexes I–IV by ATPsynthase, phosphorylation system
control ratio (PSCR; ratio of ETS to P). Difference between SL and HA calculations: P  0.109, 0.063, 0.091, 0.047, 0.037, and 0.662 for indices
of mitochondrial coupling efficiency from left to right. *P 0.05 vs. SL.
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ciency during respiration (28). This adaptation to HA
exposure may occur as a response to the initial increase
in oxidative stress common with HA exposure (29, 30).
Mitochondria and exercise capacities near SL and
at HA
Normoxic Vo2max values are known to correlate
strongly with mitochondrial characteristics, including
volume density (31) and oxidative capacity of the
muscle (32). We verify this correlation as Vo2max, and
both PCI and P exhibited strong correlations. The best
predictor of endurance performance in highly trained
athletes is skeletal muscle oxidative capacity (13). Less
is known on how mitochondrial parameters associate
with performance in a hypoxic environment. The de-
gree to which Vo2max is lost from normoxia to moderate
hypoxia in endurance athletes has been partially attrib-
uted to differences in mitochondrial function indepen-
dent of respiration capacity (33). Here, we show that
respiration capacity loses its relationship to exercise
capacity following HA exposure. Moreover, Vo2max
values following 28 d of exposure to HA correlated with
HA indices of mitochondrial efficiency as opposed to
respiratory capacities. These data suggest that the im-
portance of mitochondrial parameters on exercise per-
formance shift from a primary significance of respira-
tory capacity (13) to one of efficiency when going from
normoxic to hypoxic exercise. The efficiency of cellular
oxygen utilization becomes paramount because of the
increasing diffusion limitations of oxygen transport that
parallel the increase in elevation (34) vs. the convective
limitation in oxygen delivery near sea level (35).
Study limitations
The correlational evidence of exercise capacity with
respiratory capacity and efficiency at SL and HA, re-
spectively, are based on a small sample size using
individual univariate regression analyses. Interpreta-
tion of correlational analysis, especially with small sam-
ple sizes, should always be tempered. In addition, this
study lacks data that provide evidence of potential
mechanisms that may explain the loss of mitochondrial
respiration capacity or the reciprocal improvement in
coupling efficiency. While it is speculation, one poten-
tial mechanism that may explain the improvement in
mitochondrial efficiency is a decrease in uncoupling
protein 3 (UCP3) concentration. Cycling efficiency is
inversely proportional to UCP3 concentration in the
skeletal muscle (36), and UCP3 has previously been
reported to decrease in parallel with improvements in
mitochondrial efficiency in cardiac muscle following
hypoxic exposure in mice (37). A loss of UCP3 in
human skeletal muscle has been reported to occur
following hypoxic exposure (1), and this may serve to
explain the improvement in skeletal muscle mitochon-
drial coupling efficiency shown in the present study.
CONCLUSIONS
We find that 28 d of exposure to 3454 m reduces
oxidative capacity in human skeletal muscle mitochon-
dria. These alterations in oxidative capacity occur inde-
pendent from changes in mitochondrial content. In
addition to the loss of oxidative capacity in the skeletal
muscle is an improvement in mitochondrial coupling
efficiency with HA exposure. Lastly, correlation of these
mitochondrial parameters to measures of exercise capac-
ity suggest that respiratory capacity is the most important
mitochondrial characteristic relative to exercise perfor-
mance near SL, as mitochondrial efficiency correlates
more with performance in hypoxic environments.
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Jacobs RA, Rasmussen P, Siebenmann C, Díaz V, Gassmann
M, Pesta D, Gnaiger E, Nordsborg NB, Robach P, Lundby
C. Determinants of time trial performance and maximal incremen-
tal exercise in highly trained endurance athletes. J Appl Phys-
iol 111: 1422–1430, 2011. First published September 1, 2011;
doi:10.1152/japplphysiol.00625.2011.—Human endurance perfor-
mance can be predicted from maximal oxygen consumption (V˙ O2max),
lactate threshold, and exercise efficiency. These physiological param-
eters, however, are not wholly exclusive from one another, and their
interplay is complex. Accordingly, we sought to identify more specific
measurements explaining the range of performance among athletes.
Out of 150 separate variables we identified 10 principal factors
responsible for hematological, cardiovascular, respiratory, musculo-
skeletal, and neurological variation in 16 highly trained cyclists.
These principal factors were then correlated with a 26-km time trial
and test of maximal incremental power output. Average power output
during the 26-km time trial was attributed to, in order of importance,
oxidative phosphorylation capacity of the vastus lateralis muscle (P
0.0005), steady-state submaximal blood lactate concentrations (P 
0.0017), and maximal leg oxygenation (sO2LEG) (P  0.0295),
accounting for 78% of the variation in time trial performance. Vari-
ability in maximal power output, on the other hand, was attributed to
total body hemoglobin mass (Hbmass; P  0.0038), V˙ O2max (P 
0.0213), and sO2LEG (P  0.0463). In conclusion, 1) skeletal muscle
oxidative capacity is the primary predictor of time trial performance in
highly trained cyclists; 2) the strongest predictor for maximal incre-
mental power output is Hbmass; and 3) overall exercise performance
(time trial performance  maximal incremental power output) corre-
lates most strongly to measures regarding the capability for oxygen
transport, high V˙ O2max and Hbmass, in addition to measures of oxygen
utilization, maximal oxidative phosphorylation, and electron transport
system capacities in the skeletal muscle.
mitochondria; oxidative phosphorylation; oxygen transport and utili-
zation; skeletal muscle; hemoglobin
THE PRODUCT of an athlete’s maximal oxygen consumption
(V˙ O2max)  lactate threshold  exercise efficiency can predict
endurance performance (4, 44–46). This general calculation of
performance is likely appropriate because it broadly accounts
for most physiological parameters involved in exercise. The
purpose of this study is therefore to isolate the most dominant
physiological variables of performance and identify the stron-
gest determinant(s) of exercise performance in highly trained
endurance athletes.
An individual’s V˙ O2max is limited primarily by cardiac out-
put, locomotor muscle blood flow, and oxygen-carrying capac-
ity of the blood (1, 47, 52) while also expressing a strong linear
correlation with mitochondrial volume density (85). The con-
straint of oxygen consumption has been recognized to limit
exercise performance for nearly a century (20, 33), and a large
V˙ O2max is a prerequisite for high endurance capability (72, 74,
78). The ability to maintain a given workload with lower blood
lactate concentrations, however, correlates more reliably to
endurance performance than V˙ O2max among groups of trained
individuals (17, 22, 70) and is said to be the strongest broad-
spectrum predictor of exercise performance in highly trained
endurance athletes (17, 55). The lactate threshold is a theoret-
ical workload facilitating an accelerated accumulation of blood
lactate attendant to a disproportionate rise in glycolytic flux
and lactate appearance over oxidative phosphorylation and
lactate disposal, respectively (9, 24). The physiological deter-
minants of maintaining relatively low concentrations of lactate
are believed to parallel the mitochondrial capacity of the
skeletal muscle (35, 84). Additionally, skeletal muscle oxida-
tive capacity, once thought to be indicated by percentage of
type 1 (oxidative) muscle fibers (2), correlates strongly with
exercise efficiency (18), which also accounts for a significant
variation in exercise performance among highly trained ath-
letes (14, 58). Oxidative phosphorylation capacity of the skel-
etal muscle appears central to all three physiological compo-
nents used to predict endurance performance (V˙ O2max, lactate
threshold, and exercise efficiency) although its relation to
exercise performance in a homogeneous group of trained
athletes has never been directly demonstrated.
Accordingly, during a recent study involving 16 highly
trained endurance cyclists (Siebenmann C, Robach P, Jacobs
RA, Rasmussen P, Nordsborg N, Díaz V, Christ A, Olsen NV,
Maggiorini M, Lundby C, unpublished observations), we ac-
quired a considerable physiological data set and correlated
these to time trial performance and maximal incremental ex-
ercise capacity. As oxidative capacity of the skeletal muscle
appears to have the most common interrelation between
V˙ O2max, lactate threshold, and exercise efficiency we hypoth-
esize that maximal oxidative phosphorylation capacity of the
skeletal muscle is the strongest determinant of time trial per-
formance in highly trained athletes.
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METHODS
Volunteers
Sixteen highly trained endurance athletes (15 men, 1 woman, age
29  6 yr, height 179  8 cm, body weight 69  9 kg) from various
countries in North America and Europe were volunteers in the current
study. All of them regularly participated in endurance competitions on
at least the national level in disciplines related to cycling, i.e., road
cycling, triathlon, cycle cross, and/or mountain bike. All volunteers
gave written informed consent to participate in the study. The study
was approved by the Ethics Committee of Zürich (2010–066/0) and
Vaud (215/10) (Switzerland), and conformed to the Declaration of
Helsinki.
Experimental Protocols
All the experimental procedures of the study were performed at the
hospital La Vallée (Le Sentier, Switzerland). At least 24 h was given
to all subjects in between separate exercise tests.
Maximal incremental exercise capacity. This measure of perfor-
mance was tested on an electronically braked bicycle-ergometer in an
upright position (Monark 839E, Varberg, Sweden). The exercise
protocol started with a warm-up period of 5 min at a workload of 150
W followed by 5 min at 200 W except for the female athlete who
warmed up at 100 and 150 W. Thereafter, the workload was increased
by 25 W/min until failure. During the last minutes of the test,
volunteers were vigorously encouraged to perform to complete ex-
haustion. Volunteers wore a face mask covering mouth and nose for
breath collection, and O2 and CO2 concentration in the expired gas
were continuously measured and monitored as breath-by-breath val-
ues. The gas analyzers and the flowmeter of the applied spirometer
(Quark, Cosmed, Rome, Italy) were calibrated prior to each test. After
the test breath-by-breath values were visually controlled and averaged
over 30 s. The highest average value was determined for V˙ O2max, and
all the other parameters were selected at the same time except for
maximal workload (Wmax), which was calculated as WmaxWcompl
25  (t/60), with Wcompl being the last completed workload and t the
number of seconds in the not-completed workload.
Time trial performance. To evaluate exercise performance in a
scenario similar to competitions, volunteers performed a time trial
using their own personal bike mounted on an electrically braked cycle
trainer (Fortius Virtual Reality Trainer, Tacx, Rotterdam, Nether-
lands). The combination with a commercially available software
allowed for the simulation of a predefined route on a portable
computer. We selected a final section of the Milan-San Remo race
with a length of 26.15 km. This route consists of a first flat part (4.8
km, average incline 0.23%), a first climb (5.5 km, 4.19%), a downhill
part (3.1 km, 6.79%), a second flat part (8.6 km, 0.25%) and the
final climb (4.15 km, 3.13%). Volunteers’ body weight was measured
before each trial for software-based calculation of the appropriate
resistance. After warming up for a minimum of 10 min volunteers
could rest again and start the test whenever they felt ready. Through-
out the test volunteers were free to manually change gears, drink and
eat ad libitum, and were allowed visual feedback on the computer
screen that displayed their speed and covered distance. The rear wheel
of each bike was fitted with a power meter (Powertap Highly
trained, CycleOps, Madison, WI), which monitored power output
over the whole course. Volunteers were vigorously encouraged during
all tests.
Exercise efficiency. We assessed V˙ O2 and respiratory exchange
ratio (RER) at an absolute set submaximal steady-state cycling.
Breath-by-breath values during the last minute of 5-min increments
(150 W and 200 W for men; 100 W and 150 W for the woman)
were averaged. Energy expenditure (EE) per minute was calculated
from submaximal V˙ O2 values and RERs (57). Delta efficiency (DE)
was then calculated as the ratio of the change in work (kcal/min)
by the change in energy expended (kcal/min) at the two submaxi-
mal workloads multiplied by 100: DE (%)  (Work rate/
EE)·100.
Arterial blood measurements. After local anesthesia with 2% lido-
caine, a 20-gauge catheter (model 80115.09R, Vygon laboratories,
Ecouen, France) was inserted percutaneously using the Seldinger
technique into the radial artery. Arterial blood was sampled anaero-
bically in heparinized syringes and immediately analyzed for hemo-
globin concentration ([Hb]), O2 saturation (SaO2), O2 tension (PaO2),
and lactate concentration by means of the ABL 800 Flex (Radiometer,
Copenhagen, Denmark). Blood O2 content (CaO2) was computed from
the following formula: CaO2  (1.34  [Hb]  SaO2)  (0.003 
PaO2). Arterial samples were collected at rest, 150 W, 200 W, and at
exhaustion.
Intravascular volumes. Hemoglobin mass (Hbmass) was quanti-
fied by a modified (56) carbon monoxide (CO)-rebreathing tech-
nique (11). After the subject had stayed for 20 min in a semire-
cumbent position, 2 ml of blood was sampled from an antecubital
vein without stasis through a 20-gauge catheter and immediately
analyzed in quadruplicate for 1) percent carboxyhemoglobin
(%HbCO) and hemoglobin concentration ([Hb]) on a hemoximeter
(ABL 800 Flex, Radiometer, Copenhagen, Denmark), and 2) he-
matocrit (4 min at 13,500 rpm). A bolus (1.5 ml/kg) of 99.997%
CO (CO N47, Air Liquide) containing 0.1 ppm of nickel tetrac-
arbonyl or ferrous pentacarbonyl was then rebreathed for 8 min. At
the end of the rebreathing period, another similarly obtained and
analyzed 2-ml blood sample was obtained. The change in %HbCO
between the first and second measurement was used to calculate
Hbmass, taking into account the amount of CO remaining in the
rebreathing circuit at the end of the procedure (2.2%) (11). The
RCV, blood and plasma volumes were derived from Hbmass, [Hb],
and hematocrit (11) as assessed by the same operator for the entire
study. The Hbmass values expressed the average of duplicate
measurement. The coefficient of variation for Hbmass, asses-
sed from duplicate baseline during the lead-in period, and expres-
sed as the percent typical error (i.e., SD of difference scores/2),
was 2.6%.
Near-infrared spectroscopy (NIRS). Thigh (sO2LEG) and cerebral
(sO2BRAIN) measures of tissue oxygenation were obtained by NIRS
(NIRO-200, Hamamatsu, Japan). The method has been previously
described (69). Briefly, both measurements assume a homogeneous
medium and use spatially resolved spectroscopy coupled to an ana-
lytical solution of the diffusion equation (69). NIRS reflects primarily
capillary oxygenation although the signal is also affected by the
arterial and venous blood and, for the muscle, myoglobin. The NIRO-200
uses an internal calibration derived independently from the pathway
length of the infrared light. Changes in cerebral sO2BRAIN oxygen-
ation were relative to the values obtained at rest and reported as
cerebral sO2BRAIN. NIRS measurements in skeletal muscle provide
the oxygenation status of the hemoglobin in the microvasculature of
the tissue (with a small contribution from myoglobin in skeletal
muscle) thereby reflecting the balance between oxygen consumption
(drive to reduce oxygenation) and delivery (drive to maintain oxy-
genation). NIRS values have been shown to correlate well with
femoral venous oxygen saturation and can serve as a substitute
measure of oxygen extraction (21).
Middle cerebral artery velocity. Transcranial doppler (TCD) mea-
surements of cerebral blood velocity were performed (Doppler-
box, DWL, überlingen, Germany). The TCD-transducer was fixed
above the temporal bone with a headband to carry out measure-
ments on the proximal part of the middle cerebral artery (MCA).
To achieve the best signal-to-noise ratio both probe position and
insonation depth (40 – 60 mm) were carefully adjusted for each
individual. The MCA velocity was computed from the integral of
the maximum frequency Doppler shifts over one heartbeat and
averaged over 30 s.
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Blood pressure. Arterial pressure was measured with a transducer
(MLT844, AD Instruments, Australia) connected to the arterial line
placed at the level of the heart (4th intercostal space). Blood pressure
data were collected and stored with Powerlab (AD Instruments,
Australia).
Muscle function. Volunteers were seated on a wooden plate with no
backrest and the angle of the knee joint was between 85 and 95
degrees. A mark was made on the subject’s thigh in relation to the
edge of the chair to ensure precise repositioning. A strap was placed
around the lower leg, just above the ankle joint. The strap was secured
to a rigid pole that was attached to a strain gauge. The strain gauge
was calibrated twice a day, once in the morning and again in the
afternoon. Force recordings were sampled at 1 kHz. Self adhesive
electrodes (5  9 cm, Platinium Neurostimulation Electrodes, Axel-
gaard, Fallbrook, CA) were placed on the rectus femoris muscle at
25% of the distance from spina iliaca anterior superior to the proximal
part of patella. The electrodes were fixed by tape (Fixomull stretch,
BSN medical GmbH, Hamburg, Germany) and remained in position
for the rest of the experiment. This was done to ensure no measure-
ment errors due to repositioning of electrodes and to reduce the time
elapsed from the end of exercise to investigation. Five to ten sub-
maximal and close to maximal contractions were performed prior to
determination of the optimal stimulation intensity. The stimulation
intensity used was 440  70 mA with a range between 220 and 500
mA. The stimulations were delivered using a single 200-s pulse, and
voltage was 400 V (Digitimer DS7AH, Digitimer, Hertfordshire, UK).
Optimal stimulation intensity was determined by increasing stimula-
tion current from 50 mA until the current was at least 20% higher than
the current eliciting a maximal twitch response. At first, an optimal
stimulation intensity was determined by rapid increments of stimula-
tion currents. When an optimal intensity was determined a stimulation
current vs. twitch force curve was constructed with increments of 50
mA or less to ensure that a maximal twitch response was obtained.
After determination of the optimal stimulation intensity, the subject
was asked to perform a 5-s maximal voluntary contraction (MVC)
with stimulation occurring 3 s into the 5 s contraction (superimposed
twitch, TWS). Five seconds after the MVC another stimulation was
performed to determine the twitch force (TW). This procedure was
repeated every minute, three times in total. Maximal values for MVC,
TWS, and TW were recorded. The superimposed twitch force was
related to the twitch force recorded 5 s after the MVC and termed
percent voluntary activation: VA%  [1  (TWS/TW)]  100. One
minute after the third MVC the subject was asked to generate 	50%
of the force recorded during MVC. When the force was constant after
5–20 s a stimulation was performed. After another minute of rest, the
procedure was repeated at 	75% of MVC. The measurements were
performed to ensure that the applied procedure could be used to assess
%VA. The control measurements revealed %VA to be 64.3  12.3
and 84.2  9.1 at 50% and 75% of MVC, respectively. After the time
trial, volunteers were rapidly moved to the wooden plate and reposi-
tioned as they were previously. After 45 s, a 5-s MVC was performed
with a stimulation again being delivered 3 s into and 5 s after the
MVC, as described above. The procedure was repeated three times
starting every 30 s. Following 5 min of recovery the same series of 3
MVC and stimulations were performed. This protocol was used to
assess central (neuromuscular) vs. peripheral (skeletal muscle) fatigue
following time trial performance. The aim prior to exercise was to
determine maximal twitch force. Accordingly, sufficient time, 60 s,
was allowed to elapse between stimulations to avoid stimulation-
induced fatigue. Following exercise, however, the aim was to examine
whether a loss of twitch force had occurred with concern that maximal
twitch force could recover during the elapsed time between measure-
ments. Therefore the compromise was to allow only 30 s between
stimulations after exercise. Since we used the maximal obtained
twitch force in the calculations there is no error in the interpretation of
the data with this approach.
Skeletal muscle biopsy. Under local anesthetics using the Berg-
ström technique (6) with a needle modified for suction, skeletal
muscle biopsies were obtained while the subject was at rest and a
minimum of 24 h following last exercise training bout. The biopsy
was dissected free of fat and connective tissue and divided into
sections for mitochondrial respiration and muscle buffer capacity
measurements. The section used for muscle buffer capacity was
frozen immediately.
Mitochondrial respiration. A subsample of the biopsy (	20 mg)
was sectioned into four parts to measure mitochondrial respiration.
Each part was immediately placed in ice-cold biopsy preservation
solution (BIOPS) containing 2.77 mM CaK2EGTA buffer, 7.23
mM K2EGTA buffer, 0.1 M free calcium, 20 mM imidazole, 20
mM taurine, 50 mM 2-(N-morpholino)ethanesulfonic acid hydrate
(MES), 0.5 mM dithiothreitol, 6.56 mM MgCl2·6H2O, 5.77 mM
ATP, and 15 mM phosphocreatine (pH 7.1). Muscle samples were
then gently dissected using forceps and fibers were chemically
permeabilized via incubation in 2 ml of BIOPS containing saponin
(50 g/ ml) for 30 min (49). Before each sample was added to its
respective respiration chamber, the wet weight was measured
(XS205 DualRange Analytical Balance, Mettler-Toledo AG, Swit-
zerland). Respiration measurements were performed in mitochon-
drial respiration medium 06 (MiR06) containing 0.5 mM EGTA, 3
mM MgCl2·6H2O, 60 mM K-lactobionate, 20 mM taurine, 10 mM
KH2P04, 20 mM HEPES, 110 mM sucrose, 1 g/l bovine serum
albumin, and catalase 280 IU/ml (pH 7.1). Measurements of
oxygen consumption were performed in duplicate at 37°C using
the high-resolution Oxygraph-2k (Oroboros, Innsbruck, Austria)
with all additions of substrates, uncouplers, and inhibitors added in
series. All experiments were carried out in a hyperoxygenated
environment to prevent any potential oxygen diffusion limitation.
Two substrates, uncoupler, and inhibitor titration (SUIT) protocols
were used in the study. Each protocol was specific to the exami-
nation of individual aspects of respiratory control through a se-
quence of coupling and substrate states induced via separate
titrations. A more complete listing of and thorough explanations
for the standard nomenclature regarding various respiratory states,
SUIT protocols, coupling control, and flux control ratios can be
found in detail elsewhere (67, 68). Briefly, oxidative phosphory-
lation (OXPHOS) capacity (P; usually compared with originally
defined state 3 respiration) is the ADP-activated mitochondrial
respiratory state of oxidative phosphorylation with saturating con-
centrations of ADP, inorganic phosphate, oxygen, and defined
reduced substrates. Mitochondrial electron transfer system capac-
ity, E, is the experimentally induced noncoupled (fully uncoupled)
state, in which ADP, inorganic phosphate, oxygen, and defined
substrates are present at saturating levels along with the titration of
an established amount of uncoupler to optimum concentrations
facilitating maximal noncoupled respiration through the electron
transport system (ETS) (67).
The specific SUIT protocol was used to measure OXPHOS
capacity (P) in the permeabilized skeletal muscle preparations.
Maximal values of P were induced with the additions of malate (2
mM), octanoyl carnitine (0.2 mM), glutamate (10 mM), succinate
(10 mM), and saturating adenosine diphosphate concentrations
(ADP; 5 mM). Such a protocol provides saturating concentrations
of substrates for both NADH dehydrogenase, complex I, and
succinate dehydrogenase, complex II. The integrity of the outer
mitochondrial membrane was assessed with the addition of cyto-
chrome c (10 M). The addition of cytochrome c had no additive
effect on respiration with negligible increases of 3.4%, respec-
tively, confirming intact and viable mitochondria in the skeletal
muscle samples. Maximal noncoupled ETS respiration (E) was
then measured following the titration of carbonyl cyanide p-
(trifluoromethoxy)phenylhydrazone (FCCP; a total of 1.5 M in
steps of 0.5 M). Last, residual oxygen consumption, indicative of
nonmitochondrial oxygen consumption, was assessed following
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the inhibition of complexes I and III with the addition of rotenone
(0.5 M) and antimycin A (2.5 M), respectively.
Citrate synthase activity. Citrate synthase (CS) activity was
assayed in homogenates of all skeletal muscle samples used for
respiration measurements. The content of the oxygraph chamber (2
ml) was removed after each respiration experiment and washed
twice with 2 ml of MiR06. The solutions were combined, homog-
enized for 60 s with an Ultra-Turrax homogenizer at maximum
speed, frozen in liquid nitrogen, and stored at 80°C. The activity
of citrate synthase was measured spectrophotometrically at 412 nm
and 37°C. Eight-hundred microliters of homogenate was added to
200 l medium containing 0.1 mM 5,5-dithio-bis-(2-nitrobenzoic)
acid (DTNB), 0.5 mM oxaloacetate, 0.31 mM acetyl coenzyme A,
5 mM triethanolamine hydrochloride, 50 M EDTA, and 0.1 M
Tris-HCl (pH 8.1) (81).
Skeletal muscle buffer capacity. The method was previously de-
scribed in Ref. 39. After having adjusted pH of the sample to 7.1 with
0.01 M NaOH, the sample was titrated to pH 6.0 by serial additions
of 0.01 M HCl followed by titration back to pH 7.1 by serial additions
of 0.01 M NaOH. The pH was measured after each addition. The
non-HCO3 physiochemical buffer capacity was determined from the
number of moles of H required to change pH from 7.1 to 6.5 and was
expressed as micromoles H per kilogram dry weight per unit of pH
(59). The in vivo muscle buffer capacity was calculated as the change
in muscle lactate from rest to exhaustion divided by the change in
muscle pH (79).
Statistics
From the studies we obtained 6 intravascular volumes, 22 measures of
mitochrondrial function, 40 measures of pulmonary gas exchange, 6
measurements of exercise efficiency, 24 arterial blood gas or metabolite
measurements, 36 measures of cardiac performance and blood pressure,
4 measurements of cerebral blood flow, and 14 measures of vastus
lateralis and cerebral oxygenation. In total 152 different measurements
were recorded and all were the average of 2–6 separate exercise tests. We
recorded two separate measures of exercise performance, and these are
presented along with V˙ O2max for our 16 volunteers in Table 1.
The first objective of the analysis was to reduce the number of
variables to 16 to have sufficient degrees of freedom to perform a
statistical analysis. Of the 152 potential determinants we excluded 59
variables because they were either redundant (i.e., showed high correla-
tion with a related variable) or because no a priori hypothesis could be
justified. This left 73 variables for further evaluation for the main
analysis. Those variables were grouped into six groups relating them to
efficiency, pulmonary performance, cerebral factors, muscular factors,
cardiac-vascular factors, or oxygen transport. If appropriate, each variable
was allowed to enter two groups as long as the total number of variables
in one group did not exceed 15 (n  1). Following calculation of a
nonparametric correlation matrix (Kendall’s tau-b), we performed a
multiple stepwise regression (Pearson) of the principal factors in each
group to identify the variables for which the majority of the variance
could be attributed. Factor analysis describes variability among observed
variables in terms of a potentially lower number of unobserved variables
called factors. The underlying unobserved, or latent, variable, however, is
not of interest for this study and principal factor analysis was simply used
to reduce the number of variables entering the analysis. Only the variables
with loadings on the first three principal factors larger than 0.6 were
considered for further analysis. The resulting variables selected are
presented in Fig. 1.
RESULTS
Maximal Incremental Power Output
Following multiple stepwise regression analysis for deter-
minants of maximal incremental power output, Hbmass was
identified as best single parameter (r2  0.48, P  0.0027).
Table 1. Measures of exercise performance along with V˙ O2max
Subject Height, cm Weight, kg
V˙ O2max, ml  min1  kg1 TTmean, W/kg Incrementalmax, W/kg
Ranking Value Ranking Value Ranking Value
First quartile
O 177 70 1 80.44 7 4.35 2 6.31
B 180 72 2 77.32 8 4.34 7 5.99
C 176 65 3 76.87 1 5.06 1 6.89
L 193 76 4 74.30 2 4.62 3 6.28
Second quartile
I 173 62 5 72.24 4 4.50 9 5.88
F 176 62 6 71.95 6 4.43 5 6.08
P 175 76 7 71.79 10 3.98 10 5.86
S 164 63 8 71.51 12 3.91 15 4.89
Third quartile
N 178 65 9 71.44 5 4.48 4 6.20
M 173 60 10 69.39 14 3.64 8 5.94
G 188 74 11 69.20 3 4.52 6 6.05
H 183 69 12 68.36 9 4.14 11 5.82
Fourth quartile
Q 183 80 13 68.00 16 3.60 14 5.37
K 170 59 14 64.15 13 3.74 12 5.79
T 182 76 15 63.12 11 3.93 13 5.55
J 194 87 16 58.33 15 3.61 16 4.88
Mean 179 70 70.53 4.18 5.86
SD 8 8 5.57 0.42 0.51
Numbers in italics preceding values identify subjects according to their ranking, e.g., subject O ranks 1st in maximal oxygen consumption (V˙ O2max), 7th in
average time trial power (TTmean), and 2nd in maximal power output during an incremental test (Incrementalmax).
1425PHYSIOLOGICAL DETERMINANTS OF EXERCISE IN HIGHLY TRAINED ATHLETES
J Appl Physiol • VOL 111 • NOVEMBER 2011 • www.jap.org93
Best two-parameter model included V˙ O2max (r2  0.69, P 
0.0005). The best fit three-parameter model, 78% (P 0.0003)
of the variation in maximal incremental power output, could be
explained by Hbmass (P  0.0038), V˙ O2max (P  0.0213), and
sO2LEG (P  0.0463).
Time Trial Performance
We performed multiple stepwise regression analysis on the
selected parameters and mean power output during the time trial.
This analysis revealed that for a single-parameter model the
oxidative phosphorylation capacity of the skeletal muscle, P,
provided the best fit (r2 0.47, P 0.0035). For a two-parameter
model submaximal lactate concentration improved the fit signif-
icantly (r2  0.68, P  0.0006). Finally, for the best fit three-
parameter model, 78% (P  0.0002) of the variation in time trial
performance could be explained by P (P  0.0005), submaximal
blood lactate concentrations (P  0.0017), and the leg oxygen-
ation (sO2LEG) at exhaustion (P  0.0295).
Fig. 1. Predictor variables correlation with exercise performance in highly trained cyclists. Ten principal factors of exercise performance (y-axis) plotted
according to exercise performance ranked quartiles from worst to best (x-axis). Range of exercise performance (W/kg) in each quartile was 3.60 –3.74,
3.91– 4.14, 4.34 – 4.48, and 4.50 –5.06 for worst to best average time trial power outputs (black circles); and 4.88 –5.55, 5.79 –5.88, 5.94 – 6.08, and
6.20 – 6.89 for worst to best maximal incremental power outputs (open circles). MAPrest, resting mean arterial pressure; P, maximal oxidative
phosphorylation capacity in skeletal muscle; E, electron transport system capacity in skeletal muscle; DE, percentage ratio of the change in work
performed per minute (5 min at 150 W to 5 min at 200 W) to the change in energy expended per minute; sO2, tissue oxygenation; sO2, changes in
tissue oxygenation from rest to maximal exercise at the end of the incremental test; %max, workload during time trial as percent of maximal power output
during the incremental test; Hbmass, total body hemoglobin; [Lac]sub, mean blood lactate concentrations during 5 min at 150 W and 5 min at 200 W;
V˙ O2max, maximal oxygen consumption. Data are presented as means  SE.
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Overall Exercise Performance
Performance of our two functional tests of exercise capacity
strongly correlated with one another. Average power output
during the time trial correlated with maximal power output
during the incremental exercise test (r2  0.82, P  0.001).
Finally, we performed cluster analyses on the correlation
matrix between performance parameters and predictor vari-
ables. For this we included the 10 main predictors as well as 9
“second tier” variables last excluded by the principal factor
analysis. We clustered variables on their correlation strength
(Kendall’s tau) with measures of aerobic performance, i.e.,
time trial mean power output and maximal incremental power
output. This analysis revealed that overall exercise perfor-
mance positively correlates best (Fig. 1) with parameters of
oxygen transport (V˙ O2max, Hbmass), extraction (sO2LEG), and
skeletal muscle oxidative capacity (both P and electron trans-
port system capacity, E).
DISCUSSION
This study presents several main findings regarding specific
determinants of exercise performance: 1) Hbmass correlates the
strongest with maximal incremental power output; 2) maximal
oxidative phosphorylation capacity of the skeletal muscle, P, is
the strongest determining factor relating to 26-km time trial
performance; and 3) primary factors determining overall (time
trial and maximal incremental power output) include measures
regarding the capability for oxygen transport, high V˙ O2max and
Hbmass, in addition to measures of oxygen utilization, P and
electron transport system capacities, E, in the skeletal muscle.
Maximal Incremental Power Output
Overall, 78% of the variance in maximal incremental power
output was attributable to, in order of significance, Hbmass,
V˙ O2max, and sO2LEG. An individual’s V˙ O2max establishes the
upper limit of aerobic capacity and is a requirement for highly
trained endurance capability (72, 74) with oxygen consumption
proportion to exercise workload. This study confirms previous
findings in showing that V˙ O2max is a significant correlate to
maximal incremental power output. Convective limitations in
oxygen delivery appear to be the primary physiological bottle-
neck of maximal oxygen consumption in humans (1, 4, 45).
Maximal oxidative phosphorylation capacity, P, in the skeletal
muscle has been shown to exceed the upper limit of oxygen
delivery during whole body maximal exercise (8) and thus
would not be expected as a significant correlate of maximal
incremental whole body exercise. The results from the present
study agree with and emphasize the importance of convective
oxygen capacity for maximal exercise intensities. Hbmass is the
physiological factor that correlates the strongest to maximal
incremental power output in highly trained endurance athletes
accounting for 48% of the variation. This supports previous
findings that have shown strong relationships between Hbmass
and V˙ O2max (28, 47, 61). While total blood volume is also
understood to complement Hbmass (47, 61, 77) we did not
examine the correlation between total blood volume and max-
imal incremental power output. Of the variables we excluded
from the potential 152 variables of interest, blood volume was
among them because of its redundancy (high correlation inher-
ently resulting from method of calculation) with Hbmass. Con-
vective transport of oxygen is also highly reliant on the
pumping capacity of the heart as maximal cardiac output is
understood to be a limiting factor at maximal workloads
engaging a significant percentage of total body muscle mass (1,
52). As we did not directly assess cardiac output in the present
study, high V˙ O2max values and the capacity for oxygen delivery
to the leg are both indirectly indicative of high cardiac capacity
and support maximal cardiac output as a dominant determinant
in maximal aerobic power output. Cardiac output and leg blood
flow both increase in parallel with an increase in work output
(12, 76). Accordingly, although not directly measured, the
significance of maximal cardiac output capacity is indirectly
suggested as vital to maximal incremental power output in the
present study.
The third strongest correlate to maximal incremental power
output in the best fit three-parameter model was sO2LEG.
Muscle oxygen extraction increases with increasing workload
during exercise (12). Maximal values of oxygen extraction
averaging 91% have been observed in healthy cyclists during
maximal exercise with values ranging from 87% to as high as
95% (27). As oxygen extraction is known to improve with
training (73) the present study demonstrates its relation to
maximal power output in highly trained athletes.
Time Trial Performance
The present study demonstrates that skeletal muscle oxida-
tive capacity is the strongest correlate to exercise endurance
among highly trained cyclists (average V˙ O2max  70.53
ml·kg1·min1; Table 1), accounting for 47% of the variation
in 26-km time trial performance. This specific mitochondrial
state, P, demonstrates the mitochondrial capacity to catalyze a
sequential set of redox reactions that are partially coupled to
the production of ATP via ATP synthase. Mitochondrial en-
zymes, content, volume density, and respiratory capacity all
increase linearly in response to training (19, 23, 34–36, 83) and
are elevated in trained vs. untrained counterparts (5, 23, 26, 37,
50, 51) as well as in moderate vs. highly trained athletes (17).
Acute reduction of mitochondrial oxidative capacity limits
maximal oxygen consumption in skeletal muscle (31, 62, 71).
Exercise training has a direct dose response on endurance
performance, skeletal muscle respiratory capacity, and mito-
chondrial markers in skeletal muscle of rats (23); however,
these animals varied significantly in level of training, unlike
the athletes in the present study. Homogeneous groups of
athletes have displayed differences in exercise efficiency (75),
lactate threshold, and endurance performance (16) without
differences in static measurements of mitochondrial content.
When normalizing mitochondrial respiratory rates to skeletal
muscle CS concentration, respiratory differences between
trained and untrained groups are ostensibly lost (23, 63). The
present study differentiates the importance of dynamic mito-
chondrial properties (e.g., maximal oxidative phosphorylation
and electron transport system capacities) on exercise perfor-
mance as opposed to previously quantified static mitochondrial
characteristics such as CS activity, which is used as a common
measure of mitochondrial content. CS activity did not signifi-
cantly correlate with time trial performance in the present
study, highlighting the importance of functional mitochondrial
analyses in combination with instantaneous “snap-shot” mea-
surements of individual mitochondrial characteristics.
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Submaximal arterial lactate concentrations, along with oxi-
dative phosphorylation capacity, accounted for 68% of the
variation in time trial performance. The ability to maintain a
given workload with lower blood lactate concentrations corre-
lates with endurance performance in trained individuals (17,
22, 53, 55, 70, 75) and this study confirms these results. World
class cyclists have been reported to maintain blood lactate
concentrations below 3 mM while cycling for 20 min at 80%
of their maximal workload: 	86% of V˙ O2max (54). Despite
similar aerobic capacities, cyclists with higher lactate thresh-
olds were able to maintain exercise at 88% of their V˙ O2max,
which happened to be at a slightly higher absolute power
output, for twice as long as those with comparatively low
lactate thresholds (16). The single strongest predictor of per-
formance has been repeatedly attributed to V˙ O2max percentage
at lactate threshold (16, 55).
Trained individuals oxidize more fat and less carbohydrate
than untrained counterparts at a given submaximal workload
(10, 32). As the subjects who performed best on the 26-km
time trial exercise test in the present study typically presented
with, respectively, lower arterial lactate concentrations for a
given submaximal workload (Fig. 1), those values did not,
however, correlate with quantification of fat oxidation via
respiratory exchange ratio values (R2  0.02; data not pre-
sented). Furthermore, maximal octanoyl-carnitine stimulated
respiration capacity, representative of the capacity for fatty
acid oxidation and maximal electron flow through electron-
transferring-flavoprotein dehydrogenase in the inner mitochon-
drial membrane, neither differed between subjects nor did
values correlate with exercise performance. We included all
relevant respiratory states in the factor analysis (1st step) and
only used those that could contribute for a large part of the
variation in the data set for the stepwise regression analysis
(2nd step). Thus we did examine measures of maximal fat
oxidative capacity in the analysis and they were not “signifi-
cant” in relation to exercise performance. Thus the oxidative
potential of the skeletal muscle can be thought to directly relate
to blood lactate measurements more so than nutrient partition-
ing. More robust oxidative capacities in skeletal muscle limit
the disproportionate increase in glycolytic flux at greater work-
loads. This, in turn, maintains a lower lactate concentration, as
lactate production is more effectively matched by pathways of
lactate disposal (84), explaining why skeletal muscle oxidative
capacity and low arterial lactate concentrations, together, cor-
relate well with time trial performance.
Human skeletal muscle respiratory capacity, more so than
fiber type, corresponds with time to fatigue during short inten-
sive exercise (41). Although fiber type is believed to be
important to endurance performance as exercise efficiency has
been primarily attributed to both percentage of type I fibers
(18, 29, 38, 48, 63) along with concentration of uncoupling
protein isotype 3 (63), it is the capillary density of the muscle
that is directly proportional to the respiratory capacity of that
muscle and not the fiber type (40). The importance of exercise
efficiency and its role on exercise performance has oft been a
topic of discussion (7, 15, 18, 38, 42, 43, 54, 64, 65). Suggested
increases in efficiency of 1% has been proposed and to drop
	63 s off a 40-km time trial performance (43) while an 1.8%
greater efficiency has shown to parallel a 9% improvement in
work output obtained during a 1-h cycling performance test
(38). However, most empirical evidence demonstrates no dif-
ference in efficiency between elite, trained, or novice athletes
(7, 60, 64, 66, 82), denoting that exercise efficiency is not a
predictor of endurance performance in elite level cycling (64).
The present study calculated DE via two relatively low-inten-
sity power outputs (150 and 200 W, corresponding to 50% and
63% V˙ O2max, respectively). This may have introduced more
variability in DE values compared with those if more measure-
ments during steady-state exercise ranging from 50 to 90%
V˙ O2max were collected. Regardless, this study confirms and
supports previous findings as DE was not identified as a
primary contributing physiological factor of endurance perfor-
mance among a homogeneous group of highly trained athletes.
The third strongest correlate with time trial performance was
sO2LEG as the stronger athletes were able to reduce tissue
oxygenation the greatest (Fig. 1). Oxygen extraction signifi-
cantly correlates with oxygen consumption over various work-
loads (13) and oxidative capacity in the skeletal muscle has
been proposed to assist in facilitating the extraction of oxygen
during exercise (13). Measurement of sO2LEG was the only
variable strongly predictive of both maximal incremental
power output and time trial performance. The relationship
between oxygen extraction and oxidative capacity of the mus-
cle is not well understood and requires further investigation.
Overall Exercise Performance
This study demonstrated a high correlation of performance
between exercise tests in highly trained athletes. Maximal
incremental power output and time trial performance are
strongly correlated to one another (r2 0.82, P 0.001). Peak
power output obtained in these subjects during an all-out 30-s
sprint was also significantly correlated to maximal incremental
power outputs and time trial performance (P  0.01, data not
shown). Peak power output has been reported to correlate
highly with time trial performance (30) but seemingly more so
with average power output than time to completion of a time
trial (3). Although percent of maximal power output averaged
during time trial was 1 of the 10 best correlates of exercise
performance in the present study (Fig. 1), other variables were
observed to have stronger validity as determinants of exercise
performance.
The physiological variables most predictive of overall exer-
cise performance included parameters relating to both the
transport of oxygen and the capacity for cellular oxygen
utilization (Fig. 1). These data support other studies identifying
the collective importance of oxygen delivery and oxidative
capacity in regulating oxygen flux (31). The cluster analysis
supports regression analyses, as both P and E were strongly
predictive of overall exercise performance in highly trained
athletes along with V˙ O2max and Hbmass. In the specific mito-
chondrial state E, inner mitochondrial membrane potential is
collapsed with an open transmembrane proton circuit and thus
serves as an indication of mitochondrial membrane potential
(25, 67). As the transport of oxygen to the working skeletal
muscle during exercise is firmly recognized as an essential
factor determining performance, this study develops our un-
derstanding of the limitations to exercise performance in highly
trained athletes by illustrating the importance coupling a high
oxygen transport capacity with an equally sizable ability for
cellular oxygen utilization.
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Conclusion
In summary, this study identified several individual and
specific physiological variables detailing the determinants of
exercise capacity in highly trained cyclists. The primary pre-
dictors for time trial performance and maximal incremental
power output are skeletal muscle oxidative phosphorylation
capacity, P, and Hbmass, respectively. Overall exercise perfor-
mance is strongly attributed to means of oxygen transport
(Hbmass), ability to extract oxygen in the skeletal muscle
(sO2LEG), and the capacity for oxygen utilization within the
muscle (P, E).
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Changes in skeletal muscle respiratory capacity parallel that of aero-
bic fitness. It is unknown whether mitochondrial content, alone, can
fully account for these differences in skeletal muscle respiratory
capacity. The aim of the present study was to examine quantitative
and qualitative mitochondrial characteristics across four different
groups (n  6 each), separated by cardiorespiratory fitness. High-
resolution respirometry was performed on muscle samples to compare
respiratory capacity and efficiency in active, well-trained, highly
trained, and elite individuals. Maximal exercise capacity (ml
O2·min1·kg1) differed across all groups, with mean SD values of
51  4, 64  5, 71  2, and 77  3, respectively. Mitochondrial
content assessed by citrate synthase activity was higher in elite trained
compared with active and well-trained (29  7 vs. 16  4 and 19 
4 nmol·min1·mg wet wt1, respectively). When normalizing respi-
ration to mitochondrial content, the respiratory capacities during
maximal fatty acid oxidation (P  0.003), maximal state 3 respiration
(P  0.021), and total electron transport system capacity (P  0.008)
improved with respect to maximal exercise capacity. The coupling
efficiency of -oxidation, however, expressed no difference across
groups. These data demonstrate the quantitative and qualitative dif-
ferences that exist in skeletal muscle mitochondrial respiratory capac-
ity and efficiency across individuals that differ in aerobic capacity.
Mitochondrial-specific respiration capacities during -oxidation,
maximal oxidative phosphorylation, and electron transport system
capacity all correspondingly improve with aerobic capacity, indepen-
dent of mitochondrial content in human skeletal muscle.
exercise; skeletal muscle; fat oxidation
MEASURES OF WHOLE BODY CARDIORESPIRATORY fitness ostensibly
represent the state of health in humans (1, 12, 24–26, 31, 34).
Although maximal aerobic capacity is primarily limited by the
oxygen transport system (3, 44), i.e., maximal cardiac output
and oxygen-carrying capacity of the blood, mitochondrial con-
tent (7, 18) and skeletal muscle respiratory capacity (9) both
also share a strong positive correlation with maximal aerobic
capacity in humans. Morphometric examination and analysis
of biochemical expression show that mitochondrial density and
content increase in response to training (15, 16, 18) and differ
between untrained and trained individuals (20, 28, 33, 46).
Skeletal muscle oxidative capacity also increases with training
(36) and varies across groups differing in activity level (28, 33,
46). There is debate whether the increase in skeletal muscle
respiration capacity that parallels aerobic fitness can be ex-
plained by quantitative differences in mitochondrial content
alone (41, 45), or whether qualitative adaptations, such as
functional modifications in respiratory control and capacity,
also improve along with whole body aerobic capacity (13).
We previously determined that mitochondrial respiratory
capacity, particularly oxidative phosphorylation capacity (P)
and electron transport system capacity (ETS), are strongly
predictive of overall exercise capacity in highly trained athletes
(22). Over many other physiological variables, including total
hemoglobin mass and cerebral oxygenation, P, exclusively,
was identified as the strongest determinant of endurance per-
formance (22). Mitochondrial content does not always differ
between individuals who display significantly different exer-
cise capacities (38, 40), and yet skeletal muscle P is the
strongest predictor of endurance performance (22). Moreover,
prolonged exposure to hypoxia can diminish respiratory capac-
ity and enhance mitochondrial coupling efficiency, indepen-
dent from any change in mitochondrial content (23). Together,
these data suggest that qualitative differences in mitochondria
may exist independent from mitochondrial content.
Previous reported differences in skeletal muscle mitochon-
dria respiratory capacity across groups that differed in level of
cardiorespiratory fitness did not control for the significant
variation in mitochondrial content between the groups (33, 46).
No study has compared functional differences in mitochondria
between normal, healthy individuals vs. elite athletes. The aim
of this study is to analyze mitochondrial differences, both
quantitative and qualitative, across four different groups of
healthy and physically active subjects who differ in aerobic
capacity. As P is the strongest determining factor in endurance
performance (22) among a more homogenous group of athletes
with negligible differences in mitochondrial content (38), we
hypothesize that differences in mitochondria from AT to ET
individuals will possess distinct qualitative differences.
METHODS
Ethical Approval
All experimental protocols involving human subjects were ap-
proved by the Eidgenössische Technische Hochschule Zürich for
Kanton Zurich (2010–066/0 and EK 2011-N-51) and Kanton Vaud
(215/10), Switzerland, in accordance with the declaration of Helsinki.
Before the start of the experiments, informed oral and written consents
were obtained from all participants.
Subjects and Experimental Design
Subject characteristics are shown in Table 1. Twenty-four young
and physically active subjects (23 men and 1 woman) vol-
untarily participated in this study. No subjects were taking any
prescription medications nor had any known family history of type 2
diabetes, severe obesity, or cardiovascular diseases. Previous studies
Address for reprint requests and other correspondence: R. A. Jacobs, Institute of
Veterinary Physiology, Vetsuisse Faculty and Zurich Center for Integrative Hu-
man Physiology (ZIHP), Winterthurerstrasse 190, CH-8057 Zurich, Switzerland
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J Appl Physiol 114: 344–350, 2013.
First published December 6, 2012; doi:10.1152/japplphysiol.01081.2012.
8750-7587/13 Copyright © 2013 the American Physiological Society http://www.jappl.org344
 at Universitaet Zuerich on February 4, 2013
http://jap.physiology.org/
D
ow
nloaded from
 
99
show no main effect of sex on skeletal muscle oxidative capacity and,
consequently, grouped all data according to training status (28, 33,
46), as we have done in the present study. We divided the 24 subjects
into four different tiers, dependent on their aerobic capacity: active
(AT), well-trained (WT), highly trained (HT), and elite (ET). The AT
group performed physical activity or sport (climbing, mountain bik-
ing, tennis, karate, road cycling, hockey, skating, running, swimming,
or tour skiing) sporadically for an average of 1.58 days/wk, with no
regular routine; the WT group participated in some variation of a
regular exercise or sport program (climbing, running, Thai boxing, or
road cycling) for an average of 2.46 days out of the week; and HT and
ET athletes engaged in endurance exercise (triathlon training or
road/mountain/cyclo-cross cycling and road or mountain cycling for
HT and ET, respectively) on average for 2.49 and 2.81 days/wk,
respectively. All individuals were separated into their respective
groups based on aerobic capacities, which were obtained via tests of
maximal oxygen consumption (V˙ O2 max).
Exercise Tests
Exercise tests to obtain values of V˙ O2 max were completed on an
electronically braked cycle ergometer (Monark, Varberg, Sweden).
The exercise protocol started with a 5-min collection of resting
oxygen consumption (V˙ O2), followed by two consecutive absolute
submaximal workloads, 100 W and 150 W, which were maintained
for 5 min each. Thereafter, the workload increased 25 W/min until
voluntary exhaustion. During the last minutes of the test, subjects
were vigorously encouraged to perform to complete exhaustion, and
the achievement of V˙ O2 max was established by standard criteria in all
tests (2). Subjects wore a face mask covering their mouth and nose for
breath collection (Hans Rudolph, Kansas City, MO), and O2 and CO2
concentration in the expired gas was continuously measured and
monitored as breath-by-breath values (Quark, Cosmed, Rome, Italy
and Innocor, Innovision, Odense, Denmark). The gas analyzers and
flowmeters of each applied spirometer were calibrated before each
test.
Skeletal Muscle Sampling
Skeletal muscle biopsies were obtained from the m. vastus lateralis
under local anesthesia (1% lidocaine) of the skin and superficial
muscle fascia, using the Bergström technique (6), with a needle
modified for suction at rest in the morning, and in a fasted state at least
24 h after the last bout of exercise. The biopsy was immediately
dissected free of fat and connective tissue and divided into sections for
measurements of mitochondrial respiration.
Skeletal Muscle Preparation
The skeletal muscle samples were sectioned into parts to measure
mitochondrial respiration. Each part was immediately placed in ice-
cold biopsy preservation solution (BIOPS) containing 2.77 mM
CaK2EGTA buffer, 7.23 mM K2EGTA buffer, 0.1 M free calcium,
20 mM imidazole, 20 mM taurine, 50 mM 2-(N-morpholino)ethane-
sulfonic acid hydrate, 0.5 mM dithiothreitol, 6.56 mM MgCl2·6H2O,
5.77 mM ATP, and 15 mM phosphocreatine (pH 7.1). Muscle samples
were then gently dissected with the tip of two 18-gauge needles,
achieving a high degree of fiber separation verified microscopically.
Chemical permeabilization followed via incubation in 2 ml of BIOPS
with saponin (50 g/ml) for 30 min in 4°C (27). Lastly, samples were
washed with a mitochondrial respiration medium (MiR05) containing
0.5 mM EGTA, 3 mM MgCl2·6H2O, 60 mM potassium-lactobionate,
20 mM taurine, 10 mM KH2P04, 20 mM HEPES, 110 mM sucrose,
and 1 g/l bovine serum albumin (pH 7.1) for 10 min in 4°C.
Mitochondrial Respiration Measurements
Muscle bundles were blotted dry and measured for wet weight in a
balance-controlled scale (XS205 DualRange Analytical Balance, Met-
tler-Toledo), maintaining constant relative humidity and providing
hydration consistency as well as stability of weight measurements.
Respiration measurements were performed in mitochondrial respira-
tion medium 06 (MiR05 catalase 280 IU/ml). Measurements of V˙ O2
were performed at 37°C using the high-resolution Oxygraph-2k (Oro-
boros, Innsbruck, Austria) with all additions of each substrate, uncou-
pler, and inhibitor titration (SUIT) protocol added in series. Standard-
ized instrumental were performed to correct for back-diffusion of
oxygen into the chamber from the various components, leak from the
exterior, V˙ O2 by the chemical medium, and sensor V˙ O2. Oxygen flux
was resolved by software allowing nonlinear changes in the negative
time derivative of the oxygen concentration signal (Oxygraph 2k,
Oroboros, Innsbruck, Austria). All experiments were carried out in a
hyperoxygenated environment to prevent any potential oxygen diffu-
sion limitation.
Respiratory Titration Protocol
The SUIT protocol applied in the study has been previously de-
scribed (22). The protocol was specific to the examination of individ-
ual aspects of respiratory control through a sequence of coupling and
substrate states induced via separate titrations. All respirometric
analyses were made in duplicates, and all titrations were added in
series as presented. The concentrations of substrates, uncouplers, and
inhibitors used were based on prior experiments conducted for opti-
mization of the titration protocols. Leak respiration in absence of
adenylates (LN) was induced with the addition of malate (2 mM) and
octanoyl carnitine (0.2 mM). The LN state represents the resting V˙ O2
of an unaltered and intact electron transport system free of adenylates.
Maximal electron flow through electron transferring-flavoprotein
(ETF) and fatty acid oxidative capacity (PETF) were both determined
following the addition of ADP (5 mM). In the PETF state, the ETF
linked transfer of electrons requires the metabolism of acetyl-CoA,
hence the addition of malate, to facilitate convergent electron flow
into the Q-junction from both complex I (C1) and ETF, allowing
-oxidation to proceed. The contribution of electron flow through C1
is far below capacity, and so here the rate-limiting metabolic branch
is electron transport through ETF, such that malate  octanoyl
carnitine  ADP-stimulated respiration is representative of, rather
than specific to, electron capacity through ETF (11, 13, 35, 36, 39).
State 3 respiratory capacity specific to C1, NADH dehydrogenase
(PC1), was induced following the additions of pyruvate (5 mM) and
Table 1. Subject characteristics
Group Age, yr Height, cm Weight, kg
Absolute
V˙ O2max, l/min
Absolute
Wmax, W Relative Wmax, W/kg Years of Exercise Time Training/Year, h
Time Training/
Week, h
AT 26 4 181  5 77 5 3.96  0.39 326  27 4.2 0.4 8.8  5.6 190  88b,c,d 3.7  1.7b,c,d
WT 32 8 180  7 73 10 4.68  0.60 378  59 5.2 0.5a 13.9  5.3 493  141a,d 9.5  2.7a,d,g
HT 28 2 175  7 68 10 4.82  0.67e 389  45 5.8 0.3a,f 9  4.8 636  43a,d 12.3  0.8a,d,f
ET 28 6 179  8 68 6 5.24  0.52a 417  41a 6.2  0.3a,b 16  6.2 847  126a,b,c 16.4  2.6a,b,c
Physiological characteristics for all subjects (n  24) are means  SD. AT, active subjects (n  6); WT, well-trained subjects (n  6); HT, highly trained
subjects (n  6); ET, elite athletes (n  6); V˙ O2max, maximal oxygen consumption; Wmax, maximal power output. Difference ( P  0.05) from aAT, bWT, cHT,
and dET. Tendency of difference (0.05  P  0.1) from eAT, fWT, gHT, and hET.
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glutamate (10 mM). P was then induced with the addition of succinate
(10 mM). P demonstrates a naturally intact electron transport system’s
capacity to catalyze a sequential set of redox reactions that are
partially coupled to the production of ATP via ATP synthase. P
maintains an electrochemical gradient across the inner mitochondrial
membrane dictated by the degree of coupling to the phosphorylation
system (13, 35). As an internal control for compromised integrity of
the mitochondrial preparation, the mitochondrial outer membrane was
assessed with the addition of cytochrome c (10 M). There was no
indication of mitochondrial damage indicated by the average change
in respiration of 1.1% across all subjects (P  0.361) following
addition of cytochrome c. Phosphorylative restraint of electron trans-
port was assessed by uncoupling ATP synthase (complex V) from the
electron transport system with the titration of the proton ionophore,
carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (0.5 M per
addition up to optimum concentrations ranging from 1.5 to 3 M),
reaching ETS. Finally, rotenone (0.5 M) and antimycin A (2.5 M)
were added, in sequence, to terminate respiration by inhibiting C1 and
complex III (cytochrome bc1 complex), respectively. With C1 inhib-
ited, electron flow specific to complex II (C2), succinate dehydroge-
nase, and state 3 respiration through C2 (PC2) can be measured.
Inhibition of respiration with antimycin A then allows for the deter-
mination and correction of residual V˙ O2, indicative of nonmitochon-
drial V˙ O2 in the chamber.
Citrate Synthase Activities
Citrate synthase (CS) activities were assayed in homogenates of the
skeletal muscle samples used in respiration measurements. The con-
tents of the Oxygraph-2k chambers (2 ml each) were removed after
each respiration experiment and washed once with 2 ml of MiR05.
One percent Triton X-100 and 2 l of a protease inhibitor cocktail
(Sigma Aldrich cat. no. 539134) were added to the combined solu-
tions (content and wash) and then homogenized for 30 s with a T10
basic ULTRA-TURRAX homogenizer near maximum speed. The
homogenate was then centrifuged for 15 min at 4°C, and the super-
natant was removed, frozen in liquid nitrogen, and stored at 80°C.
As has been previously described (42), CS activity was measured
fluorometrically at 412 nm and 25°C (Citrate Synthase Assay Kit,
Sigma-Aldrich), according to the manufacturer.
Data Analysis
Significance was set at P  0.05, but P values of  0.10 are
also noted. Data are presented as means  SD. Mitochondria-specific
respiration was calculated by dividing mass-specific respiration
(pmol O2·min1·mg wet wt1) by the corresponding CS activity
(nmol·min1·mg wt1). Comparisons of age, weight, height, absolute
and relative V˙ O2 max, absolute and relative maximal power (Wmax),
years of exercise, respiratory capacities, CS, and indexes of mitochon-
drial coupling control were compared using a one-way ANOVA
(SPSS Statistics 17.0, SPSS, Chicago, IL). Significant main effects or
interactions were further analyzed by Tukey’s post hoc test. The time
of training per year and per week did not, however, display a Gaussian
distribution, and, therefore, a Kruskal-Wallis ANOVA and Mann-
Whitney U-tests were used to reveal differences between groups. An
analysis of covariance was also run on mass-specific respirometric
values with CS activities included as the covariant being controlled
for. Multiple linear regression analysis with backward elimination was
used to identify the strongest association between measurements of
mass-specific and mitochondrial-specific respiration to cardiorespira-
tory fitness.
RESULTS
V˙ O2 max
All groups differed in V˙ O2 max (Fig. 1). Group V˙ O2 max values
presented as means  SD, maximum and minimum, respec-
tively, in ml·min1·kg1, were as follows: AT (51.2  4.1,
46.9 and 55.5); WT (63.9  4.7, 58.9 and 68.8); HT (71.3 
1.7, 69.5 and 73.1); and ET (77.3  3.0, 74.1 and 80.4). The
AT group was lower (P  0.001) than all other groups. The
WT group was higher than AT (P 0.001), but lower than HT
(P  0.009) and ET (P  0.001). The HT group was higher
than both AT (P  0.001) and WT (P  0.009) groups, but
lower than the ET group (P  0.04).
Subject Characteristics
All subject characteristics are presented in Table 1. There
were no differences in age, height, weight, or years of exercise
across groups. The absolute Wmax only differed between the
ET and AT groups (P  0.01); however, the relative Wmax for
the AT group was lower than WT, HT, and ET (P  0.004,
P  0.001, and P  0.001, respectively). The ET also had a
greater relative Wmax than the WT group (P  0.002), and the
HT group showed a tendency for a higher relative Wmax than
the WT group (P  0.071). The time-spent training per week
and year demonstrated a progressive increase across groups, as
the AT group exhibited the least time-spent participating in
some form of physical activity, and the ET group had the most
time-spent.
CS Activity
CS values (nmol·min1·mg wet wt1) across groups (mean 
SD) were as follows: AT (16.2  4.9), WT (18.6  4.0), HT
(25.1 7.1), and ET (28.7 7.0). The only differences detected
in CS activity between groups were observed in ET compared
with AT (P  0.008) and WT groups (P  0.035). There was a
tendency for difference between AT and HT (P  0.072). CS
activity is an empirically established and reliable biomarker of
mitochondrial content (30). CS activities are presented in Fig. 2.
Respiratory Capacity
Mass-specific respiration. There were no differences in mass-
specific respiration (Fig. 3A) between AT and WT, WT and
HT, or between HT and ET groups at any respiratory states,
although PETF had a tendency to increase from AT to WT (P
0.056). The AT group had lower fat respiration, PETF (P 
0.012 and P  0.001), P (P  0.015 and P  0.001), ETS
(P  0.003 and P  0.001), and submaximal PC2 (P  0.005
and P  0.002) than the HT and ET groups, respectively. The
AT group also expressed lower LN (P  0.019) and submaxi-
Fig. 1. Aerobic capacities across groups. Individual values of maximal oxygen
consumption (V˙ O2 max) across groups are shown. AT, active; WT, well trained;
HT, highly trained; ET, elite. *Significance of P  0.05.
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mal PC1 (P  0.033) vs. the ET group. The WT group ex-
pressed lower respiration compared with the ET group during
P (P 0.009) and ETS (P 0.001) and had a tendency to have
lower PETF (P  0.052).
Mass-specific respiration when controlling for mitochon-
drial content. Significant differences in mass-specific respira-
tion were altered when controlling for CS activity as a cova-
riate (data not shown). The lower respiratory capacities of the
AT group vs. the HT group were only apparent during ETS and
PC2 (P 0.049), but showed a tendency for lower PETF, P, and
PC2 (P 0.069, 0.079, and 0.052, respectively). The AT group
expressed lower respiration compared with the ET group at
PETF (P  0.004), P (P  0.005), and ETS (P  0.003) and
had a tendency for lower PC2 (P  0.067). The WT group
expressed lower ETS than the ET group (P  0.033) and also
had a tendency for lower P (P  0.067). There were no dif-
ferences across groups during LN or PCI.
Mitochondria-specific respiration. Mass-specific respiration
does not take into account differences in mitochondrial content
between samples. Accordingly, respirometric analyses were
adjusted for CS activity, a biomarker shown to express strong
concordance with mitochondrial content and total cristae area,
as measured by transmission electron microscopy as well as
myocellular respiratory capacity (30). Figure 3B illustrates
mitochondrial-specific respiration across all groups. There
were no differences in mitochondrial-specific respiration be-
tween AT, WT, and HT groups across all respiratory states,
although there was a tendency for lower respiration in the AT
vs. the HT during PETF (P  0.056). When normalizing
respiration to mitochondrial content, P was greater in ET vs.
only AT (P  0.031), while PETF (P  0.003 and 0.048) and
ETS (P  0.015 and 0.029) were greater in ET compared with
both AT and WT, respectively. There was a tendency for P to
be lower in the WT vs. ET group (P  0.066). There were no
differences across all groups during LN, PC1, or PC2.
Mitochondrial Coupling Efficiency and Respiratory Control
We calculated the leak control ratio (LCR) as indication of
electron coupling efficiency during -oxidation (LCRETF), as
has been fully explained previously (23). The LCRETF did not
express any difference across groups (Fig. 4A). The phosphor-
ylation system control ratio (PSCR), ratio of P to ETS express-
ing the degree of maximal P constraint by the phosphorylation
Fig. 4. Mitochondrial coupling efficiency and respiratory control. A: leak control
ratio (LCR), electron coupling control during -oxidation (LCRETF) across groups.
B: phosphorylation system control ratio (PSCR) across groups.
Fig. 2. Citrate synthase (CS) activities. Individual values of CS activities are
presented across group as a biomarker of mitochondrial content. *Significance
from ET of P  0.05.
Fig. 3. Mitochondrial respiration control across groups. A: mass-specific respira-
tory capacity. B: mitochondria-specific respiratory capacity across groups. LN, leak
respiration in absence of adenylates; PETF, maximal electron flow through elec-
tron-transferring flavoprotein (ETF) and fatty acid oxidative capacity; PC1, sub-
maximal state 3 respiratory capacity specific to complex I; P, maximal state 3
respiration and oxidative phosphorylation capacity; ETS, electron transport system
capacity; PC2, submaximal state 3 respiratory capacity specific to complex II.
Values are means  SD. Significant difference of *P  0.05, **P  0.01, and
***P  0.001.
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system or ATP synthase (13), was also determined. While
skeletal muscle PSCR differs significantly between mice and
humans (21), it did not differ between groups that varied in
aerobic capacity (Fig. 4B).
Correlation Between Maximal Exercise Respiratory Capacities
All mitochondrial parameters examined in this study ex-
pressed a significant correlation to V˙ O2 max, except for the
PSCR (R 0.077, P 0.361). The second weakest correlation
(behind LN respiration) was between values of mitochondrial
content and exercise capacity (R  0.635, P  0.001). The
LCRETF was the only value showing a significant negative
correlation (R  0.462, P  0.012). Finally, multiple linear
regression analysis using backward elimination for mass-spe-
cific (Fig. 5A) and mitochondria-specific respiration (Fig. 5B),
respectively, calculated ETS as the best predictive mitochon-
drial parameter of V˙ O2 max.
DISCUSSION
In this study we divided one large group of healthy subjects
(n  24) into four different groups (n  6), dependent on their
aerobic capacity and studied mitochondrial function via respi-
rometric analysis. This study presents several novel findings.
First, qualitative, independent from quantitative, differences in
mitochondrial characteristics are apparent across groups of
healthy humans in accordance with V˙ O2 max. Fat respiration
(PETF), P, and electron transport across the entire respiratory
system (ETS) all improve, in combination with aerobic capac-
ity. Second, efficiency of coupling control during -oxidation
and phophorylative restraint of ATP synthase on electron
transport do not appear to differ across individuals with mark-
edly disparate measures of V˙ O2 max. Finally, ETS correlates
best, among all other respiratory states, to cardiorespiratory fit-
ness in humans.
There is a strong correlation between mitochondrial content
and maximal aerobic capacity in both humans and animals (17,
18, 20, 32). The subjects included in this study displayed this
correlation between CS and V˙ O2 max (P  0.001), although
differences in mitochondrial content were not apparent be-
tween all groups (Fig. 2). It has been suggested that oxidative
capacity of skeletal muscle is dependent purely on the quantity
of mitochondria in the muscle (19, 41). Here we present strong
evidence to suggest that there are qualitative improvements in
mitochondria that correspond with whole body aerobic capac-
ity, independent of mitochondrial content. The seemingly in-
consistent results between those presented here and past studies
(41) may be due to the fact that the former study used
substrates for respiration specific to either mitochondrial C1 or
C2 individually, but never collectively (41). Our data support
these previous findings, as we also failed to identify any
respiratory differences between any groups at PC1 or PC2
respiratory states when normalizing respiration to mitochon-
drial content (Fig. 3B). We stimulated P with saturating con-
centrations of ADP and substrate supply for both C1 and C2.
This convergent electron input of both complexes provides
higher respiratory values compared with the isolated respira-
tion of either C1 (pyruvate/glutamate malate or glutamate
malate) or C2 (succinate  rotenone) (13, 37). Accordingly, P
presents with more physiological relevance to the study of
mitochondrial function, as substrate provision for both com-
plexes is necessary to confirm a complete and intact electron
transport system and measure maximal respiratory capacity in
skeletal muscle (8).
Although the capacity for fat respiration differed between
AT and ET groups and also showed a tendency for improve-
ment in HT over AT (P  0.056), mitochondrial coupling
efficiency during fatty acid oxidation was the same across all
groups (Figs. 3B and 4A). Fat oxidation during exercise has
been reported as greater in trained vs. untrained individuals at
the same relative workload (43). Moreover, a greater percent-
age of energy expenditure during exercise comes from fat
oxidation in trained vs. untrained subjects at the same absolute
workload (43). There is also a greater intramuscular triglycer-
ide content in trained vs. untrained humans (20), which also
increases and becomes localized next to the mitochondria in
response to exercise training (18) and is increased in active vs.
nonactive individuals (14). One training study has reported
improvements in mass-specific mitochondrial respiratory ca-
pacity, along with improvements in mitochondrial fat metab-
olism when sedentary individuals trained for 10 wk, while
mitochondrial content, as assessed by mitochondrial DNA, did
not increase (36). Unfortunately, mitochondrial DNA does not
strongly correlate with measures of mitochondrial content and
total cristae area, as assessed by transmission electron micros-
copy or myocellular respiratory capacity (30), and thus does
not adequately serve as biomarker of mitochondrial content.
Therefore, satisfactory mitochondrial-specific analysis of PETF
Fig. 5. Correlation of ETS capacity and V˙ O2 max across groups. A: mass-
specific respiration. B: mitochondrial-specific respiration.
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could not be analyzed (36). We extend on previous findings
and show that the capacity for fat oxidation improves with
cardiorespiratory fitness; however, efficiency appears unal-
tered.
Another qualitative difference in mitochondria observed ac-
ross groups differing in aerobic fitness was ETS (Fig. 3B).
Oxidative capacity of skeletal muscle is known to improve
with overall fitness (28), although specific modifications in
mitochondrial function in relation to fitness are much less
understood. Differences in mass-specific respiration capacity
in young and older subjects matched for aerobic capacity are
negligible until respiration is normalized to mitochondrial
content, where a reduction in respiratory capacity becomes
apparent (29). Endurance-trained individuals present with a
greater substrate flux through the tricarboxylic acid cycle over
sedentary individuals, independent from any difference in ATP
synthesis (5). The greater flux through the tricarboxylic acid
cycle without an increase in ATP led authors to speculate that
resting mitochondrial respiration in endurance-trained individ-
uals is uncoupled from ATP synthesis to a greater degree than
their sedentary counterparts (5). Here we show that ET athletes
have a greater capacity for electron transport across the entire
respiratory chain vs. AT and WT subjects, even though they
present with similar phosphorylative restraint of electron trans-
port (Fig. 5B). In the ETS state, the inner mitochondrial
membrane potential is completely collapsed with an open
transmembrane proton circuit. The uninhibited flow of elec-
trons through the respiratory system can, therefore, indirectly
serve as an indication of maximal attainable mitochondrial
membrane potential. A larger capacity for electron transport
with similar phosphorylative restraint allows for a superior
uncoupling capacity, which appears to correspond with aerobic
capacity. Across all states of respiration measured, ETS fit best
with cardiorespiratory fitness (Fig. 5A). This correlation re-
mained even when controlling for differences in mitochondrial
content across all groups (Fig. 5B), further demonstrating the
qualitative differences in mitochondrial function that are asso-
ciated with whole body aerobic fitness in humans.
This study specifically highlights significant qualitative
changes in mitochondria by means of respiratory capacity.
Less is known in regards to how mitochondrial efficiency
fluctuates with aerobic capacity. While an improvement in the
coupling efficiency of electron transport during -oxidation
was not apparent across groups, the coupling control across the
entire respiratory chain could not be determined with this SUIT
protocol. Previous studies utilizing mitochondrial isolation
techniques report no change in coupling control (4), while
others report an improvement in mitochondrial efficiency be-
tween trained vs. sedentary individuals (10, 46). The mallea-
bility of mitochondria in response to training merits further at-
tention.
One possible limitation in the present study is the supra-
physiological concentrations of oxygen that are required during
respirometric analysis to overcome diffusive limitations of the
samples (35), and the potential alterations in mitochondrial
function that may accompany this hyperoxygenated environ-
ment. This, however, is not believed to have influenced our
results or conclusions, as all samples were treated similarly and
exposed to the same oxygen concentrations.
In summary, both mitochondrial quantity and quality im-
prove with aerobic capacity. Qualitative differences in mito-
chondria across levels of cardiorespiratory fitness were not
fully understood and questioned to even exist. As such, we
divided 24 healthy and aerobically fit individuals into four
groups that differed in whole body aerobic exercise capacity.
Across these healthy individuals, both quantitative and quali-
tative mitochondrial variations were evident. Those with elite
aerobic capacities displayed superior respiratory capacity over
those who were active or well-trained. Specifically, these
qualitative differences observed across groups were specific to
greater capacities for fat oxidation, oxidative phosphorylation,
and electron transport across the entire respiratory system.
These results make it apparent that mitochondrial modifica-
tions with improving cardiorespiratory fitness comprise more
than just an increase in mitochondrial content. It is important
and necessary to differentiate mitochondrial content from func-
tion in future studies.
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3. Discussion and outlook 
The aim of my Ph.D. studies was to put together a compilation of work that 
contributed to the scientific literature and improved our comprehensive understanding 
of mitochondrial physiology. Specifically we analyzed: 1.) the mitochondrial potential 
to utilize lactate; 2.) alterations on respiratory chain function across different skeletal 
muscle types with age; 3.) similarities and differences in mouse and human skeletal 
muscle function; 4.) hypoxia-induced alterations on mitochondrial function; and 5.) 
mitochondrial function and its relation to aerobic capacity and sports performance. 
Summarized below are the conclusions for each of the six studies for which this 
dissertationis comprised of. 
 
Study 1: Lactate metabolism in human skeletal muscle mitochondria 
Using high-resolution respirometry on mitochondrial preparations of human skeletal 
muscle in situ, a technique that specifically does not alter the native reticular structure 
of the mitochondria, we observed that mitochondria are capable of utilizing lactate as 
a substrate for respiration. Lactate stimulated respiration did not occur, however, in 
the presence of “malate + lactate” alone, as compared to “malate + pyruvate”, 
indicating that lactate is not being shuttled across the MIM intact and oxidized in the 
mitochondrial matrix. Respiration only occurred when lactate and NAD+ were titrated 
into the respiration medium together. This suggests that in order to cross the MIM and 
be further oxidized, lactate must first be converted to pyruvate by lactate 
dehydrogenase (LDH). The question is whether LDH exists within the MIS or 
exclusively in the cytosol? The specific mitochondrial preparation used, saponin-
permeabilized or “skinned” skeletal muscle technique, has repeatedly demonstrated 
the loss of cytosolic components, including LDH (160, 163, 164, 179, 227, 253, 254, 
291) providing evidence to suggest that any LDH that was measured in our sample 
must be entrapped in the mitochondrion itself. The concentration of the LDH 
measured in our samples was approximately 5% of that previously was measured in 
whole tissue homogenates. The mitochondrial reticular network accounts for 
approximately 5% of the volume density of skeletal muscle fibers (117, 119). Finally, 
exogenous titrations of LDH did not further stimulate respiration. All these 
observations suggest that LDH is present within the MIS, however we were unable to 
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empirically verify this postulation. The presence of LDH within mitochondria has 
repeatedly been demonstrated in different tissues and cell-types across several species 
(4, 8, 27, 30, 36, 47, 67, 72, 73, 103, 149, 182, 186, 188, 207, 213, 223, 269, 270, 279, 
299). Additionally, LDH has even been shown to have a genetic tag for mitochondrial 
allocation (116). While we cannot definitively exclude the possibility that lactate and 
NAD+ stimulated respiration was facilitated by remnants of cytosolic LDH or LDH 
that may be tethered to the MOM, our data and previous reports of mitochondrial 
LDH, suggest the existence of LDH is within the MIS but not the matrix, and that the 
mitochondrion, itself, possesses the ability to oxidize lactate as a substrate. 
 
Study 2: Age-induced alterations in skeletal muscle mitochondria 
Here we directly demonstrated impairments of respiratory chain function in aging 
glycolytic and white skeletal muscle. These impairments were not observed in 
skeletal muscle that is primarily composed of slow-twitch red oxidative muscle fibers. 
Therefore our data indicate that skeletal muscle consisting primarily of type 2 fast 
twitch glycolytic fibers are predisposed to progressive impairments in mitochondrial 
function with age as type I slow twitch oxidative fibers appear to be protected against 
functional degradation. Mitochondrial function varies across different skeletal muscle 
types in general, irrespective of age, however specific alterations with age occur in 
more glycolytic muscle. These alterations include an increase in submaximal state 3 
respiration specific to mitochondrial complex I, PCI, when controlling for complex I 
protein expression and an increase in maximal state 3 respiration / oxidative 
phosphorylation capacity, P, when controlling for mitochondrial complex III protein 
expression. Electron coupling efficiency also declined with age in more glycolytic 
skeletal muscle whereas it was preserved in oxidative skeletal muscle. The higher 
respiration through CI and CIII in combination with the deterioration in coupling 
efficiency all suggests an increase in oxidant production. Though oxidative muscle 
largely maintained mitochondrial function with age, electron-coupling control during 
fat oxidation did diminish. Taken together, this is the first study to identify actual and 
specific alterations in respiratory chain function in skeletal muscle with age (131).   	  
Study 3: Mitochondrial function in mouse vs. man 
Robert J. Lefkowitz and Brian K. Kobilka both won the Nobel Prize in Chemistry in 
2012 for their work specific to G-protein-coupled receptors (42, 56, 190, 312) while 
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Sir John B. Gurdon and Shinya Yamanaka won the Nobel Prize in Physiology or 
Medicine for their work demonstrating that mature cells can be reprogrammed to 
become pluripotent cells (13, 183, 204, 212). The year prior, the Nobel Prize in 
Physiology or Medicine was divided between Bruce A. Beutler and Jules A. 
Hoffmann for their work pertaining to the activation of innate immunity (105, 261, 
271, 327) and Ralph M. Steinman for his detection of the dendritic cell and 
identifying its role in adaptive immunity (45, 125). The work of these Nobel laureates 
have two things in common: 1) Their work has contributed greatly to their respective 
fields (obviously!); and 2.) A significant amount of their work was done in a mouse 
model. The role in which animals play for the development and progression of human 
medicine is unquestionable and this fact is understated. Murine modeling of human 
biology across the sciences accounts for a majority of the animal research conducted. 
Research relating to mitochondrial physiology is no different, as much research uses 
mouse tissue to mimic that of humans. There have been suggestions, albeit few and 
far between, that the mouse may not be a proper model for the study of mitochondria 
(171) or questions concerning which murine muscle best represents that of the human 
m. vastus lateralis (145). The degree of conservation between mouse and human 
genomes allows for the study of murine biology to largely characterize that of humans 
(52). There remains, however, a biological divergence between species that is not 
always so apparent and can lead to scientific misdirection if not properly recognized. 
Accordingly we empirically determined the resemblance of murine skeletal muscle to 
that of human. We found that mouse skeletal muscle mitochondrial function does 
resemble that of human m. vastus lateralis, however the semblance across species is 
highly dependent on the skeletal muscle type (130). It is the mouse quadricep muscle 
that most closely resembles human quadricep muscle, while murine soleus and 
gastrocnemius muscle expressed a greater divergence in function. This refutes 
previous work that suggested that mouse modeling of human skeletal muscle 
mitochondrial function is inadequate (171) and also that mouse soleus more closely 
resembles that of human quadricep (145). Overall, we provide evidence that skeletal 
muscle mitochondrial function, specifically respiratory control and capacity, are 
similar between mice and humans, however no mouse skeletal muscle provides an 
exact equivalent to that of human muscle. Thus future research must take into 
consideration the specific differences and similarities between mouse and human 
skeletal muscle to help address their specific interests and aims of study.   
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Studies 4 & 5: Progressive adaptation of skeletal muscle 
mitochondria to hypoxia 
A degree of mitochondrial dysfunction has been identified in individuals suffering 
from COPD (206), sleep apnea (273), and cystic fibrosis (7, 51), all diseases or 
disorders that negatively effect oxygen transport throughout the body. It is not known 
whether the differences in mitochondrial function observed in individuals presenting 
with these diseases are from the disease per se or rather and indirect effect of hypoxia 
on the tissue. Accordingly, we set out to identify the hypoxia-mediated changes 
specifically in skeletal muscle mitochondria with high-altitude exposure. Exposure of 
humans to such altitudes is a challenge to homeostatic maintenance of oxygen flux as 
a result of the gradual decrease in the partial pressure of oxygen (PO2) attendant to the 
diminishing barometric pressure (311). 
 
In the first study (129) we found that acute and short duration exposure to high 
altitude does not greatly affect mitochondrial function. Exposure to high altitude for 
9-11 days (7-9 days at 4,559 m) did not affect the capacity for fat oxidation or 
individualized respiration capacity through complex I and II, PCI and PCII, 
respectively, in human skeletal muscle. Chemiosmotic coupling efficiency during fat 
respiration also did not change following acclimatization. Functional characteristics 
of mitochondria do not always tightly parallel those of biochemical expression, as 
declines in TCA-and oxidative phosphorylation-specific enzymatic characteristics 
(293) did not equate with functional modifications to respiration in our study. 
Although the functional capacity of mitochondria in skeletal muscle was largely 
retained with subacute exposure to high altitude, mass specific maximal oxidative 
phosphorylation capacity, P, in human skeletal muscle did express a trend (p = 0.059) 
to decrease after high altitude exposure. This observation made us question whether 
our length of high altitude exposure was long enough to allow sufficient adaptation 
and so we conducted an additional study where subjects remained at high altitude for 
a longer duration. 
 
In the second study (135) we observed that one month of exposure to 3,454 m led to 
alteration in respiratory function in skeletal muscle. Respiratory capacity of the 
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skeletal muscle was attenuated with high altitude exposure and this loss was 
independent from any indication of a decrease in mitochondrial content. There was 
also evidence of a reciprocal improvement in mitochondrial electron coupling 
efficiency. Finally, mitochondrial respiratory capacity correlated best with exercise 
capacity near sea level, however exercise capacity at 3,454 m following one month of 
high-altitude exposure was associated with the efficiency of electron transport, and 
not respiratory capacity, in skeletal muscle. These adaptations indicate that skeletal 
muscle mitochondria are quite capable and proficient in responding to a reduction in 
environmental oxygen by limiting respiratory capacities and becoming more efficient 
in harnessing the oxygen that is delivered to the tissue for bioenergetic purposes. The 
correlation with mitochondrial parameters and exercise demonstrate that skeletal 
mitochondria adapts to best exploit the limiting factor in oxygen delivery. At high 
altitude when the diffusive limitations in oxygen transport become more pronounced 
and limits the capacity for physical activity (133), mitochondria adapt accordingly to 
maintain function despite the lower oxygen tensions. 
 
Studies 6 & 7: The role of mitochondria in health, fitness, and sports 
performance 
Athletics and sport around the world serves as a billion dollar industry. For this very 
reason there is much research aimed at evaluating the most effective training 
strategies and the most important physiologic variables attributed to sports 
performance. Human endurance performance can approximated by maximal oxygen 
consumption (VO2max), lactate threshold, and exercise efficiency (14, 137-139). These 
physiologic parameters, however, are not wholly exclusive from one another with the 
common link being association to the mitochondria. Accordingly, we sought to clarify 
and more precisely identify the physiological variable(s) most tightly correlating to 
exercise performance. We found that VO2max and total hemoglobin mass were the two 
physiological variables that could best predict maximal incremental exercise capacity 
in highly trained athletes. These results suggest that the capacity to transport oxygen 
to the muscle is limiting, and thus of utmost importance, during maximal incremental 
exercise to fatigue. This has been demonstrated before (5). The novelty of the study, 
however, was the variable that we discovered best-predicted endurance performance 
in these athletes. Maximal state 3 respiration, or mass-specific respiratory capacity of 
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the m. vastus lateralis was the strongest predictor of endurance performance among 
these athletes (134). Moreover, mitochondrial content as assess by citrate synthase 
activity, a measurement that has demonstrated a strong correlation with mitochondrial 
content as assessed by electron transmission microscopy in both humans and horses 
(118, 169), expressed no relation with performance in this group of athletes. When 
grouping exercise capacity together, taking into account both incremental exercise 
and endurance performances, VO2max, total hemoglobin mass, oxidative 
phosphorylation capacity, and electron transport system capacity were the best 
predictors of performance. In short, it is the transport and utilization of oxygen that is 
the most important to exercise performance. Interestingly the predictability of 
exercise performance by the respiratory capacity of the skeletal muscle has also been 
demonstrated in elite racehorses, where those horses with the highest respiratory 
capacity were also the strongest racers (Dominique-Marie Votion, unpublished 
findings). In summary, if you want to bet on sports performance then put your money 
on the mitochondria. 
 
With the majority of research investigating the role of mitochondrial “dysfunction” in 
disease, the role of mitochondria in healthy individuals is much less understood. The 
research included in this dissertationwas predominately collected from reasonably 
young and healthy humans and mice, aside from the mature mouse skeletal muscle 
analyzed. 
Health is a universal term that encompasses many states. While health is a broad term 
and one that is hard to define with a single measurement, maximal exercise capacity 
(VO2max) may serve as the best individual quantification of overall health in humans 
(1, 81, 136, 143, 150, 180, 219). After discovering that respiratory capacity of the 
skeletal muscle best predicts endurance performance in highly trained athletes with no 
association between performance and mitochondrial content, we were interested in 
assessing more qualitative differences in mitochondria across an entire “healthy” 
group separated by aerobic capacity. We found that qualitative measures of 
mitochondrial function do indeed improve in individuals that possess a higher aerobic 
capacity. Specifically these improvements include the ability to oxidize fat, total 
oxidative phosphorylation capacity and also electron transport capacity (132). All 
these qualitative differences were independent from the differences of mitochondrial 
content across groups. Again, similar finding exist in horses as they also demonstrate 
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mitochondrial improvements with training and across different levels of fitness (296, 
297). 
 
Closing 
There is much that remains unknown regarding mitochondria. The collection of 
studies presented in this thesis, however, help to illuminate some previous questions 
regarding mitochondrial physiology. In general, qualitative adjustments in 
mitochondrial function appear to be more pronounced than previously believed. 
Specifically, mitochondria possess the ability to oxidize lactate, age-associated 
modifications in respiratory chain function are apparent in fast-twitch skeletal muscle, 
mouse and human skeletal muscle mitochondrial function is similar but dependent on 
skeletal muscle type, exposure to high altitudes facilitates a progressive adaptation in 
respiratory control and capacity, and finally mitochondrial function is an extremely 
important variable in sports performance of which differs greatly with aerobic 
capacity. As there are many more questions to be answered in regards to 
mitochondria, I look forward to spending my indefinite future further investigating 
the inner workings of this organelle in its relations with both health and disease. 
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